US20040039263A1 - System and method for diagnosing and monitoring respiratory insufficiency for automated remote patient care - Google Patents

System and method for diagnosing and monitoring respiratory insufficiency for automated remote patient care Download PDF

Info

Publication number
US20040039263A1
US20040039263A1 US10/646,243 US64624303A US2004039263A1 US 20040039263 A1 US20040039263 A1 US 20040039263A1 US 64624303 A US64624303 A US 64624303A US 2004039263 A1 US2004039263 A1 US 2004039263A1
Authority
US
United States
Prior art keywords
patient
recorded
measure
measures
monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/646,243
Other versions
US7258670B2 (en
Inventor
Gust Bardy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/646,243 priority Critical patent/US7258670B2/en
Publication of US20040039263A1 publication Critical patent/US20040039263A1/en
Priority to US11/879,654 priority patent/US8231539B2/en
Priority to US11/894,302 priority patent/US8231540B2/en
Application granted granted Critical
Publication of US7258670B2 publication Critical patent/US7258670B2/en
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A61B5/02055Simultaneously evaluating both cardiovascular condition and temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0535Impedance plethysmography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/0816Measuring devices for examining respiratory frequency
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1112Global tracking of patients, e.g. by using GPS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1116Determining posture transitions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/60ICT specially adapted for the handling or processing of medical references relating to pathologies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2505/00Evaluating, monitoring or diagnosing in the context of a particular type of medical care
    • A61B2505/03Intensive care
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/0215Measuring pressure in heart or blood vessels by means inserted into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/3621Heart stimulators for treating or preventing abnormally high heart rate
    • A61N1/3624Heart stimulators for treating or preventing abnormally high heart rate occurring in the atrium, i.e. atrial tachycardia
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/92Computer assisted medical diagnostics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/92Computer assisted medical diagnostics
    • Y10S128/923Computer assisted medical diagnostics by comparison of patient data to other data

Definitions

  • the present invention relates in general to respiratory insufficiency diagnosis and analysis, and, in particular, to an automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof throughout disease onset, progression, regression, and status quo.
  • respiratory insufficiency due to primary diseases of the lungs is one of the leading causes of acute and chronic illness in the world.
  • respiratory insufficiency involves either difficulty in ventilation or in oxygenation. The former is manifest by increases in the arterial partial pressure of carbon dioxide and the latter is manifest by decreases in arterial partial pressure of oxygen.
  • the term “respiratory insufficiency” will refer to ventilatory insufficiency and/or to problems in oxygenation due to diseases of the lung.
  • respiratory insufficiency Common causes of respiratory insufficiency include bronchitis, emphysema, pneumonia, pulmonary emboli, congestive heart failure, tumor infiltration of the lung and abnormalities of the interstitium of the lungs that may be infectious in origin, due to immunological abnormalities, or as a result of exposure to environmental pathogens.
  • the effects of respiratory insufficiency range from cough to impairment during physical exertion to a complete failure of lung function and respiratory arrest at any level of activity.
  • Clinical manifestations of respiratory insufficiency include respiratory distress, such as shortness of breath and fatigue, cough, and reduced exercise capacity or tolerance.
  • these devices can store more than thirty minutes of per heartbeat and respiratory cycle data recorded on a per heartbeat, per respiration, binned average basis, or on a derived basis from, for example, atrial or ventricular electrical activity, minute ventilation, patient activity score, cardiac output score, arterial or mixed venous oxygen score, cardiopulmonary pressure measures, and the like.
  • atrial or ventricular electrical activity minute ventilation
  • patient activity score cardiac output score
  • arterial or mixed venous oxygen score CAD
  • cardiopulmonary pressure measures and the like.
  • the proper analysis of retrieved telemetered signals requires detailed medical subspecialty knowledge, particularly by pulmonologists and cardiologists.
  • these telemetered signals can be remotely collected and analyzed using an automated patient care system.
  • An automated patient care system is described in a related, commonly assigned U.S. Pat. No. 6,312,378, issued Nov. 6, 2001, the disclosure of which is incorporated herein by reference.
  • a medical device adapted to be implanted in an individual patient records telemetered signals that are then retrieved on a regular, periodic basis using an interrogator or similar interfacing device.
  • the telemetered signals are downloaded via an internetwork onto a network server on a regular, e.g., daily, basis and stored as sets of collected measures in a database along with other patient care records.
  • the information is then analyzed in an automated fashion and feedback, which includes a patient status indicator, is provided to the patient.
  • the monitoring device can communicate a warning signal to an external device when arrhythmias are predicted.
  • the Nappholz device is limited to detecting tachycardias. Unlike requirements for automated respiratory insufficiency monitoring, the Nappholz device focuses on rudimentary ECG signals indicative of malignant cardiac tachycardias, an already well established technique that can be readily used with on-board signal detection techniques.
  • the Nappholz device is patient specific only and is unable to automatically take into consideration a broader patient or peer group history for reference to detect and consider the progression or improvement of lung disease.
  • the Nappholz device has a limited capability to automatically self-reference multiple data points in time and cannot detect disease regression even in the individual patient.
  • the Nappholz device must be implanted and cannot function as an external monitor.
  • the Nappholz device is incapable of tracking the cardiovascular and cardiopulmonary consequences of any rhythm disorder.
  • physiological data could be telemetered signals data recorded either by an external or an implantable medical device or, alternatively, individual measures collected through manual means.
  • an approach would be capable of diagnosing both acute and chronic respiratory insufficiency conditions, as well as the symptoms of other lung disorders.
  • findings from individual, peer group, and general population patient care records could be integrated into continuous, on-going monitoring and analysis.
  • the present invention provides a system and method for diagnosing and monitoring the onset, progression, regression, and status quo of respiratory insufficiency using an automated collection and analysis patient care system.
  • Measures of patient cardiopulmonary information are either recorded by an external or implantable medical device, such as an IPG, cardiovascular or heart failure monitor, or respiratory diagnostic or therapeutic device, or manually through conventional patient-operable means.
  • the measures are collected on a regular, periodic basis for storage in a database along with other patient care records.
  • Derived measures are developed from the stored measures.
  • Select stored and derived measures are analyzed and changes in patient condition are logged. The logged changes are compared to quantified indicator thresholds to detect findings of respiratory distress or reduced exercise capacity indicative of the principal pathophysiological manifestations of respiratory insufficiency: elevated partial pressure of arterial carbon dioxide and reduced partial pressure of arterial oxygen.
  • An embodiment of the present invention is an automated system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof.
  • a plurality of monitoring sets is retrieved from a database.
  • Each of the monitoring sets include recorded measures relating to patient information recorded on a substantially continuous basis.
  • a patient status change is determined by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure. Both recorded measures relate to the same type of patient information.
  • Each patient status change is tested against an indicator threshold corresponding to the same type of patient information as the recorded measures that were compared.
  • the indicator threshold corresponds to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency.
  • a further embodiment is an automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof.
  • a plurality of monitoring sets is retrieved from a database.
  • Each monitoring set includes recorded measures that each relate to patient information and include either medical device measures or derived measures calculable therefrom.
  • the medical device measures are recorded on a substantially continuous basis.
  • a set of indicator thresholds is defined. Each indicator threshold corresponds to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency and relates to the same type of patient information as at least one of the recorded measures.
  • a respiratory insufficiency finding is diagnosed.
  • a change in patient status is determined by comparing at least one recorded measure to at least one other recorded measure with both recorded measures relating to the same type of patient information.
  • Each patient status change is compared to the indicator threshold corresponding to the same type of patient information as the recorded measures that were compared.
  • a further embodiment is an automated patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof.
  • Recorded measures organized into a monitoring set for an individual patient are stored into a database. Each recorded measure is recorded on a substantially continuous basis and relates to at least one aspect of monitoring reduced exercise capacity and/or respiratory distress.
  • a plurality of the monitoring sets is periodically retrieved from the database. At least one measure related to respiratory insufficiency onset, progression, regression, and status quo is evaluated.
  • a patient status change is determined by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to the same type of patient information.
  • Each patient status change is tested against an indicator threshold corresponding to the same type of patient information as the recorded measures that were compared.
  • the indicator threshold corresponds to a quantifiable physiological measure of a pathophysiology indicative of reduced exercise capacity and/or respiratory distress.
  • the present invention provides a capability to detect and track subtle trends and incremental changes in recorded patient cardiopulmonary information for diagnosing and monitoring respiratory insufficiency.
  • respiratory insufficiency detection, prevention and tracking regression from therapeutic maneuvers become feasible.
  • FIG. 1 is a block diagram showing an automated collection and analysis patient care system for diagnosing and monitoring respiratory insufficiency and outcomes thereof in accordance with the present invention
  • FIG. 2 is a database schema showing, by way of example, the organization of a device and derived measures set record for care of patients with respiratory insufficiency stored as part of a patient care record in the database of the system of FIG. 1;
  • FIG. 3 is a database schema showing, by way of example, the organization of a quality of life and symptom measures set record for care of patients with respiratory insufficiency stored as part of a patient care record in the database of the system of FIG. 1;
  • FIG. 4 is a database schema showing, by way of example, the organization of a combined measures set record for care of patients with respiratory insufficiency stored as part of a patient care record in the database of the system of FIG. 1;
  • FIG. 5 is a block diagram showing the software modules of the server system of the system of FIG. 1;
  • FIG. 6 is a record view showing, by way of example, a set of partial patient care records for care of patients with respiratory insufficiency stored in the database of the system of FIG. 1;
  • FIG. 7 is a Venn diagram showing, by way of example, peer group overlap between the partial patient care records of FIG. 6;
  • FIGS. 8 A- 8 B are flow diagrams showing a method for diagnosing and monitoring respiratory insufficiency and outcomes thereof using an automated collection and analysis patient care system in accordance with the present invention
  • FIG. 9 is a flow diagram showing the routine for retrieving reference baseline sets for use in the method of FIGS. 8 A- 8 B;
  • FIG. 10 is a flow diagram showing the routine for retrieving monitoring sets for use in the method of FIGS. 8 A- 8 B;
  • FIGS. 11 A- 11 F are flow diagrams showing the routine for testing threshold limits for use in the method of FIGS. 8 A- 8 B;
  • FIG. 12 is a flow diagram showing the routine for evaluating the onset, progression, regression, and status quo of respiratory insufficiency for use in the method of FIGS. 8 A- 8 B;
  • FIGS. 13 A- 13 C are flow diagrams showing the routine for determining an onset of respiratory insufficiency for use in the routine of FIG. 12;
  • FIGS. 14 A- 14 C are flow diagrams showing the routine for determining progression or worsening of respiratory insufficiency for use in the routine of FIG. 12;
  • FIGS. 15 A- 15 C are flow diagrams showing the routine for determining regression or improving of respiratory insufficiency for use in the routine of FIG. 12;
  • FIG. 16 is a flow diagram showing the routine for determining threshold stickiness (“hysteresis”) for use in the method of FIG. 12.
  • FIG. 1 is a block diagram showing an automated collection and analysis patient care system 10 for diagnosing and monitoring respiratory insufficiency in accordance with the present invention.
  • An exemplary automated collection and analysis patient care system suitable for use with the present invention is disclosed in the related, commonly assigned U.S. Pat. No. 6,312,378, issued Nov. 6, 2001, the disclosure of which is incorporated herein by reference.
  • an individual patient 11 is a recipient of an implantable medical device 12 , such as, by way of example, an IPG, cardiovascular, heart failure monitor, pulmonary monitor, or therapeutic device, with a set of leads extending into his or her heart and electrodes implanted throughout the cardiopulmonary system.
  • an implantable medical device 12 such as, by way of example, an IPG, cardiovascular, heart failure monitor, pulmonary monitor, or therapeutic device, with a set of leads extending into his or her heart and electrodes implanted throughout the cardiopulmonary system.
  • an external monitoring or therapeutic medical device 26 a subcutaneous monitor or device inserted into other organs, a cutaneous monitor, or even a manual physiological measurement device, such as an respiratory monitor, electrocardiogram or heart rate monitor, could be used.
  • the implantable medical device 12 and external medical device 26 include circuitry for recording into a short-term, volatile memory telemetered signals stored for later retrieval, which become part of a set of device and derived measures, such as described below, by way of example, with reference to FIG. 2.
  • Exemplary implantable medical devices suitable for use in the present invention include the Discovery line of pacemakers, manufactured by Guidant Corporation, Indianapolis, Ind., and the Gem line of ICDs, manufactured by Medtronic Corporation, Minneapolis, Minn.
  • the telemetered signals stored in the implantable medical device 12 are preferably retrieved upon the completion of an initial observation period and subsequently thereafter on a continuous, periodic (daily) basis, such as described in the related, commonly assigned U.S. Pat. No. 6,221,011, issued Apr. 24, 2001, the disclosure of which is incorporated herein by reference.
  • a programmer 14 , personal computer 18 , or similar device for communicating with an implantable medical device 12 can be used to retrieve the telemetered signals.
  • a magnetized reed switch (not shown) within the implantable medical device 12 closes in response to the placement of a wand 13 over the site of the implantable medical device 12 .
  • the programmer 14 sends programming or interrogating instructions to and retrieves stored telemetered signals from the implantable medical device 12 via RF signals exchanged through the wand 13 . Similar communication means are used for accessing the external medical device 26 . Once downloaded, the telemetered signals are sent via an internetwork 15 , such as the Internet, to a server system 16 which periodically receives and stores the telemetered signals as device measures in patient care records 23 in a database 17 , as further described below, by way of example, with reference to FIGS. 2 and 3.
  • An exemplary programmer 14 suitable for use in the present invention is the Model 2901 Programmer Recorder Monitor, manufactured by Guidant Corporation, Indianapolis, Ind.
  • the patient 11 is remotely monitored by the server system 16 via the internetwork 15 through the periodic receipt of the retrieved device measures from the implantable medical device 12 or external medical device 26 .
  • the patient care records 23 in the database 17 are organized into two identified sets of device measures: an optional reference baseline 26 recorded during an initial observation period and monitoring sets 27 recorded subsequently thereafter.
  • the device measures sets are periodically analyzed and compared by the server system 16 to indicator thresholds corresponding to quantifiable physiological measures of a pathophysiology indicative of respiratory insufficiency, as further described below with reference to FIG. 5. As necessary, feedback is provided to the patient 11 .
  • the feedback includes an electronic mail message automatically sent by the server system 16 over the internetwork 15 to a personal computer 18 (PC) situated for local access by the patient 11 .
  • the feedback can be sent through a telephone interface device 19 as an automated voice mail message to a telephone 21 or as an automated facsimile message to a facsimile machine 22 , both also situated for local access by the patient 11 .
  • simultaneous notifications can also be delivered to the patient's physician, hospital, or emergency medical services provider 29 using similar feedback means to deliver the information.
  • the server system 10 can consist of either a single computer system or a cooperatively networked or clustered set of computer systems.
  • Each computer system is a general purpose, programmed digital computing device consisting of a central processing unit (CPU), random access memory (RAM), non-volatile secondary storage, such as a hard drive or CD ROM drive, network interfaces, and peripheral devices, including user interfacing means, such as a keyboard and display.
  • Program code, including software programs, and data are loaded into the RAM for execution and processing by the CPU and results are generated for display, output, transmittal, or storage, as is known in the art.
  • the database 17 stores patient care records 23 for each individual patient to whom remote patient care is being provided.
  • Each patient care record 23 contains normal patient identification and treatment profile information, as well as medical history, medications taken, height and weight, and other pertinent data (not shown).
  • the patient care records 23 consist primarily of two sets of data: device and derived measures (D&DM) sets 24 a , 24 b and quality of life (QOL) sets 25 a , 25 b , the organization of which are further described below with respect to FIGS. 2 and 3, respectively.
  • D&DM device and derived measures
  • QOL quality of life
  • the device and derived measures sets 24 a , 24 b and quality of life and symptom measures sets 25 a , 25 b can be further logically categorized into two potentially overlapping sets.
  • the reference baseline 26 is a special set of device and derived reference measures sets 24 a and quality of life and symptom measures sets 25 a recorded and determined during an initial observation period.
  • Monitoring sets 27 are device and derived measures sets 24 b and quality of life and symptom measures sets 25 b recorded and determined thereafter on a regular, continuous basis. Other forms of database organization are feasible.
  • FIG. 2 is a database schema showing, by way of example, the organization of a device and derived measures set record 40 for patient care stored as part of a patient care record in the database 17 of the system of FIG. 1.
  • Each record 40 stores patient information which includes a snapshot of telemetered signals data which were recorded by the implantable medical device 12 or the external medical device 26 , for instance, on per heartbeat, binned average or derived bases; measures derived from the recorded device measures; and manually collected information, such as obtained through a patient medical history interview or questionnaire.
  • the following non-exclusive information can be recorded for a patient: atrial electrical activity 41 , ventricular electrical activity 42 , PR interval or AV interval 43 , QRS measures 44 , ST-T wave measures 45 , QT interval 46 , body temperature 47 , patient activity score 48 , posture 49 , cardiovascular pressures 50 , pulmonary artery systolic pressure measure 51 , pulmonary artery diastolic pressure measure 52 , respiratory rate 53 , ventilatory tidal volume 54 , minute ventilation 55 , transthoracic impedance 56 , cardiac output 57 , systemic blood pressure 58 , patient geographic location (altitude) 59 , mixed venous oxygen score 60 , arterial oxygen score 61 , arterial carbon dioxide score 62 , acidity (pH) level 63 , potassium [K+] level 64 , sodium [Na+] level 65 , glucose level 66 , blood urea nitrogen (BUN) and creatinine 67 , hematocrit 68 , hormonal levels 69
  • the implantable medical device or external medical device communicates device-specific information, including battery status, general device status and program settings 77 and the time of day 78 for the various recorded measures.
  • device-specific information including battery status, general device status and program settings 77 and the time of day 78 for the various recorded measures.
  • Other types of collected, recorded, combined, or derived measures are possible, as is known in the art.
  • the device and derived measures sets 24 a , 24 b (shown in FIG. 1), along with quality of life and symptom measures sets 25 a , 25 b , as further described below with reference to FIG. 3, are continuously and periodically received by the server system 16 as part of the on-going patient care monitoring and analysis function. These regularly collected data sets are collectively categorized as the monitoring sets 27 (shown in FIG. 1).
  • select device and derived measures sets 24 a and quality of life and symptom measures sets 25 a can be designated as a reference baseline 26 at the outset of patient care to improve the accuracy and meaningfulness of the serial monitoring sets 27 .
  • Select patient information is collected, recorded, and derived during an initial period of observation or patient care, such as described in the related, commonly assigned U.S. Pat. No. 6,221,011, issued Apr. 24, 2001, the disclosure of which is incorporated herein by reference.
  • quality of life and symptom measures sets 25 a can also be stored in the database 17 as part of the reference baseline 26 , if used, and the monitoring sets 27 .
  • a quality of life measure is a semi-quantitative self-assessment of an individual patient's physical and emotional well being and a record of symptoms, such as provided by the Duke Activities Status Indicator. These scoring systems can be provided for use by the patient 11 on the personal computer 18 (shown in FIG. 1) to record his or her quality of life scores for both initial and periodic download to the server system 16 .
  • FIG. 3 is a database schema showing, by way of example, the organization of a quality of life record 80 for use in the database 17 .
  • the following information is recorded for a patient: overall health wellness 81 , psychological state 82 , activities of daily living 83 , work status 84 , geographic location 85 , family status 86 , shortness of breath 87 , cough 88 , sputum production 89 , sputum color 90 , energy level 91 , exercise tolerance 92 , chest discomfort 93 , and time of day 94 , and other quality of life and symptom measures as would be known to one skilled in the art.
  • the patient may also add non-device quantitative measures, such as the six-minute walk distance, as complementary data to the device and derived measures sets 24 a , 24 b and the symptoms during the six-minute walk to quality of life and symptom measures sets 25 a , 25 b.
  • non-device quantitative measures such as the six-minute walk distance
  • FIG. 4 is a database schema showing, by way of example, the organization of a combined measures set record 95 for use in the database 17 .
  • Each record 95 stores patient information obtained or derived from the device and derived measures sets 24 a , 24 b and quality of life and symptom measures sets 25 a , 25 b as maintained in the reference baseline 26 , if used, and the monitoring sets 27 .
  • the combined measures set 95 represents those measures most (but not exhaustively or exclusively) relevant to a pathophysiology indicative of respiratory insufficiency and are determined as further described below with reference to FIGS. 8 A- 8 B.
  • the following information is stored for a patient: heart rate 96 , heart rhythm (e.g., normal sinus vs.
  • Atrial fibrillation 97
  • pacing modality 98 pulmonary artery systolic pressure measure 99
  • pulmonary artery diastolic pressure measure 100 cardiac output score 101
  • arterial oxygen score 102 mixed venous oxygen score 103
  • respiratory rate 104 tidal volume 105
  • transthoracic impedance 106 arterial carbon dioxide score 107
  • right ventricular peak systolic pressure 108 pulmonary artery end diastolic pressure 109
  • patient activity score 110 110
  • posture 111 exercise tolerance quality of life and symptom measures 112
  • respiratory distress quality of life and symptom measures 113 , cough 114 , sputum production 115
  • any interventions made to treat respiratory insufficiency 116 including treatment by medical device, via drug infusion administered by the patient or by a medical device, surgery, and any other form of medical intervention as is known in the art, the relative success of any such interventions made 117 , and time of day
  • each combined measures set 95 is sequentially retrieved from the database 17 and processed.
  • each combined measures set 95 could be stored within a dynamic data structure maintained transitorily in the random access memory of the server system 16 during the analysis and comparison operations.
  • FIG. 5 is a block diagram showing the software modules of the server system 16 of the system 10 of FIG. 1.
  • Each module is a computer program written as source code in a conventional programming language, such as the C or Java programming languages, and is presented for execution by the CPU of the server system 16 as object or byte code, as is known in the art.
  • the various implementations of the source code and object and byte codes can be held on a computer-readable storage medium or embodied on a transmission medium in a carrier wave.
  • the server system 16 includes three primary software modules, database module 125 , diagnostic module 126 , and feedback module 128 , which perform integrated functions as follows.
  • the database module 125 organizes the individual patient care records 23 stored in the database 17 (shown in FIG. 1) and efficiently stores and accesses the reference baseline 26 , monitoring sets 27 , and patient care data maintained in those records.
  • Any type of database organization could be utilized, including a flat file system, hierarchical database, relational database, or distributed database, such as provided by database vendors, such as Oracle Corporation, Redwood Shores, Calif.
  • the diagnostic module 126 makes findings of respiratory insufficiency based on the comparison and analysis of the data measures from the reference baseline 26 and monitoring sets 27 .
  • the diagnostic module includes three modules: comparison module 130 , analysis module 131 , and quality of life module 132 .
  • the comparison module 130 compares recorded and derived measures retrieved from the reference baseline 26 , if used, and monitoring sets 27 to indicator thresholds 129 .
  • the database 17 stores individual patient care records 23 for patients suffering from various health disorders and diseases for which they are receiving remote patient care. For purposes of comparison and analysis by the comparison module 130 , these records can be categorized into peer groups containing the records for those patients suffering from similar disorders, as well as being viewed in reference to the overall patient population.
  • FIG. 6 is a record view showing, by way of example, a set of partial patient care records for care of patients with respiratory insufficiency stored in the database 17 for three patients, Patient 1, Patient 2, and Patient 3.
  • three sets of peer measures, X, Y, and Z are shown.
  • Each of the measures, X, Y, and Z could be either collected or derived measures from the reference baseline 26 , if used, and monitoring sets 27 .
  • Measures representing different types of patient information are sibling measures. These are measures which are also measured over time, but which might have medically significant meaning when compared to each other within a set for an individual patient.
  • the comparison module 130 performs two basic forms of comparisons. First, individual measures for a given patient can be compared to other individual measures for that same patient (self-referencing). These comparisons might be peer-to-peer measures, that is, measures relating to a one specific type of patient information, projected over time, for instance, X n , X n ⁇ 1 , X n ⁇ 2 , . . .
  • X 0 or sibling-to-sibling measures, that is, measures relating to multiple types of patient information measured during the same time period, for a single snapshot, for instance, X n , Y n , and Z n , or projected over time, for instance, X n , Y n , Z n , X n ⁇ 1 , Y n ⁇ 1 , Z n ⁇ 1 , X n ⁇ 2 , Y n ⁇ 2 , Z n ⁇ 2 , . . . X 0 , Y 0 , Z 0 .
  • individual measures for a given patient can be compared to other individual measures for a group of other patients sharing the same disorder- or disease-specific characteristics (peer group referencing) or to the patient population in general (population referencing). Again, these comparisons might be peer-to-peer measures projected over time, for instance, X n , X n′ , X n′′ , X n ⁇ 1 , X n ⁇ 1′ , X n ⁇ 1′′ , X n ⁇ 2 , X n ⁇ 2′ , X n ⁇ 2′′ . . . X 0 , X 0′ , X 0′′ , or comparing the individual patient's measures to an average from the group.
  • these comparisons might be sibling-to-sibling measures for single snapshots, for instance, X n , X n′ , X n′′ , Y n , Y n′ , Y n′′ , and Z n , Z n′ , Z n′′ , or projected over time, for instance, X n , X n′ , X n′′ , Y n , Y n′ , Y n′′ , Z n , Z n′ , Z n′′ , X n ⁇ 1 , X n ⁇ 1′ , X n ⁇ 1′′ , Y n ⁇ 1 , Y n ⁇ 1′ , Y n ⁇ 1′′ , Z n ⁇ 1 , Z n ⁇ 1′ , Z n ⁇ 1′′ , X n ⁇ 2 , X n ⁇ 2′ , X n ⁇ 2′′ , Y n ⁇ 2′′
  • FIG. 7 is a Venn diagram showing, by way of example, peer group overlap between the partial patient care records 23 of FIG. 1.
  • Each patient care record 23 includes characteristics data 350 , 351 , 352 , including personal traits, demographics, medical history, and related personal data, for patients 1, 2 and 3, respectively.
  • the characteristics data 350 for patient 1 might personal traits which include gender and age, such as male and an age between 40-45; a demographic of resident of New York City; and a medical history consisting of chronic bronchitis, recurrent pneumonia, a history of an inferior myocardial infarction and diabetes.
  • the characteristics data 351 for patient 2 might include identical personal traits, thereby resulting in partial overlap 353 of characteristics data 350 and 351 .
  • Similar characteristics overlap 354 , 355 , 356 can exist between each respective patient.
  • the overall patient population 357 would include the universe of all characteristics data. As the monitoring population grows, the number of patients with personal traits matching those of the monitored patient will grow, increasing the value of peer group referencing. Large peer groups, well matched across all monitored measures, will result in a well known natural history of disease and will allow for more accurate prediction of the clinical course of the patient being monitored. If the population of patients is relatively small, only some traits 356 will be uniformly present in any particular peer group. Eventually, peer groups, for instance, composed of 100 or more patients each, would evolve under conditions in which there would be complete overlap of substantially all salient data, thereby forming a powerful core reference group for any new patient being monitored.
  • the analysis module 131 analyzes the results from the comparison module 130 , which are stored as a combined measures set 95 (not shown), to a set of indicator thresholds 129 , as further described below with reference to FIGS. 8 A- 8 B.
  • the quality of life module 132 compares quality of life and symptom measures 25 a , 25 b from the reference baseline 26 and monitoring sets 27 , the results of which are incorporated into the comparisons performed by the analysis module 131 , in part, to either refute or support the findings based on physiological “hard” data.
  • the feedback module 128 provides automated feedback to the individual patient based, in part, on the patient status indicator 127 generated by the diagnostic module 126 .
  • the feedback could be by electronic mail or by automated voice mail or facsimile.
  • the feedback can also include normalized voice feedback, such as described in the related, commonly assigned U.S. Pat. No. 6,203,495, issued Mar. 20, 2001, the disclosure of which is incorporated herein by reference.
  • the feedback module 128 determines whether any changes to interventive measures are appropriate based on threshold stickiness (“hysteresis”) 133 , as further described below with reference to FIG. 16.
  • the threshold stickiness 133 can prevent fickleness in the diagnostic routines resulting from transient, non-trending and non-significant fluctuations in the various collected and derived measures in favor of more certainty in diagnosis.
  • the feedback module 128 includes a patient query engine 134 that enables the individual patient 11 to interactively query the server system 16 regarding the diagnosis, therapeutic maneuvers, and treatment regimen.
  • the patient query engines 134 found in interactive expert systems for diagnosing medical conditions, can interactively query the patient.
  • the patient can have an interactive dialogue with the automated server system 16 , as well as human experts as necessary, to self assess his or her medical condition.
  • FIGS. 8 A- 8 B are flow diagrams showing a method for diagnosing and monitoring respiratory insufficiency and outcomes thereof 135 using an automated collection and analysis patient care system 10 in accordance with the present invention.
  • the indicator thresholds 129 (shown in FIG. 5) are set (block 136 ) by defining a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency and relating to the each type of patient information in the combined device and derived measures set 95 (shown in FIG. 4).
  • the actual values of each indicator threshold can be finite cutoff values, weighted values, or statistical ranges, as discussed below with reference to FIGS. 11 A- 11 F.
  • the reference baseline 26 (block 137 ) and monitoring sets 27 .
  • each measure in the combined device and derived measures set 95 is tested against the threshold limits defined for each indicator threshold 129 (block 139 ), as further described below with reference to FIGS. 11 A- 11 F.
  • the potential onset, progression, regression, or status quo of respiratory insufficiency is then evaluated (block 140 ) based upon the findings of the threshold limits tests (block 139 ), as further described below with reference to FIGS. 13 A- 13 C, 14 A- 14 C, 15 A- 15 C.
  • primary respiratory insufficiency is defined as the onset or progression of respiratory insufficiency without obvious inciting cause.
  • Secondary respiratory insufficiency is defined as the onset or progression of respiratory insufficiency (in a patient with or without pre-existing respiratory insufficiency) from another disease process, such as congestive heart failure, coronary insufficiency, atrial fibrillation, and so forth.
  • Other health disorders and diseases can potentially share the same forms of symptomatology as respiratory insufficiency, such as congestive heart failure, myocardial ischemia, pneumonia, exacerbation of chronic bronchitis, renal failure, sleep-apnea, stroke, anemia, atrial fibrillation, other cardiac arrhythmias, and so forth. If more than one abnormality is present, the relative sequence and magnitude of onset of abnormalities in the monitored measures becomes most important in sorting and prioritizing disease diagnosis and treatment.
  • respiratory insufficiency is due to an obvious inciting cause, i.e., secondary respiratory insufficiency, (block 143 )
  • an appropriate treatment regimen for respiratory insufficiency as exacerbated by other disorders is adopted that includes treatment of secondary disorders, e.g., congestive heart failure, myocardial ischemia, atrial fibrillation, and so forth (block 144 ) and a suitable patient status indicator 127 for respiratory insufficiency is provided (block 146 ) to the patient.
  • secondary disorders e.g., congestive heart failure, myocardial ischemia, atrial fibrillation, and so forth
  • a suitable patient status indicator 127 for respiratory insufficiency is provided (block 146 ) to the patient.
  • Suitable devices and approaches to diagnosing and treating congestive heart failure, myocardial infarction, and atrial fibrillation are described in related, commonly assigned U.S. Pat. No.
  • a primary treatment regimen is followed (block 145 ).
  • a patient status indicator 127 for respiratory insufficiency is provided (block 146 ) to the patient regarding physical well-being, disease prognosis, including any determinations of disease onset, progression, regression, or status quo, and other pertinent medical and general information of potential interest to the patient.
  • the patient query is interactively processed by the query engine (block 148 ).
  • the server query is interactively processed by the server query engine (block 150 ). The method then terminates if no further patient or server queries are submitted.
  • FIG. 9 is a flow diagram showing the routine for retrieving reference baseline sets 137 for use in the method of FIGS. 8 A- 8 B.
  • the purpose of this routine is to retrieve the appropriate reference baseline sets 26 , if used, from the database 17 based on the types of comparisons being performed. First, if the comparisons are self referencing with respect to the measures stored in the individual patient care record 23 (block 152 ), the reference device and derived measures set 24 a and reference quality of life and symptom measures set 25 a , if used, are retrieved for the individual patient from the database 17 (block 153 ).
  • the comparisons are peer group referencing with respect to measures stored in the patient care records 23 for a health disorder- or disease-specific peer group (block 154 )
  • the reference device and derived measures set 24 a and reference quality of life and symptom measures set 25 a are retrieved from each patient care record 23 for the peer group from the database 17 (block 155 ).
  • Data for each measure e.g., minimum, maximum, averaged, standard deviation (SD), and trending data
  • the reference device and derived measures set 24 a and reference quality of life and symptom measures set 25 a are retrieved from each patient care record 23 from the database 17 (block 158 ).
  • Minimum, maximum, averaged, standard deviation, and trending data and other numerical processes using the data, as is known in the art, for each measure from the reference baseline 26 for the peer group is then calculated (block 159 ). The routine then returns.
  • FIG. 10 is a flow diagram showing the routine for retrieving monitoring sets 138 for use in the method of FIGS. 8 A- 8 B.
  • the purpose of this routine is to retrieve the appropriate monitoring sets 27 from the database 17 on the types of comparisons being performed. First, if the comparisons are self referencing with respect to the measures stored in the individual patient care record 23 (block 160 ), the device and derived measures set 24 b and quality of life and symptom measures set 25 b , if used, are retrieved for the individual patient from the database 17 (block 161 ).
  • the device and derived measures set 24 b and quality of life and symptom measures set 25 b are retrieved from each patient care record 23 for the peer group from the database 17 (block 163 ).
  • Data for each measure e.g., minimum, maximum, averaged, standard deviation, and trending data
  • the monitoring sets 27 for the peer group is then calculated (block 164 ).
  • the device and derived measures set 24 b and quality of life and symptom measures set 25 b are retrieved from each patient care record 23 from the database 17 (block 166 ).
  • Minimum, maximum, averaged, standard deviation, and trending data and other numerical processes using the data, as is known in the art, for each measure from the monitoring sets 27 for the peer group is then calculated (block 167 ). The routine then returns.
  • FIGS. 11 A- 11 F are flow diagrams showing the routine for testing threshold limits 139 for use in the method of FIGS. 8A and 8B.
  • the purpose of this routine is to analyze, compare, and log any differences between the observed, objective measures stored in the reference baseline 26 , if used, and the monitoring sets 27 to the indicator thresholds 129 .
  • the routine consists of tests pertaining to each of the indicators relevant to diagnosing and monitoring respiratory insufficiency.
  • the threshold tests focus primarily on: (1) changes to and rates of change for the indicators themselves, as stored in the combined device and derived measures set 95 (shown in FIG. 4) or similar data structure; and (2) violations of absolute threshold limits which trigger an alert.
  • the timing and degree of change may vary with each measure and with the natural fluctuations noted in that measure during the reference baseline period. In the timing and degree of change might also vary with the individual and the natural history of a measure for that patient.
  • n is the total number of measures
  • x i is the time of day for measure i
  • y i is the value of measure i
  • ⁇ 1 is the slope
  • ⁇ 0 is they-intercept of the least squares error line.
  • a positive slope ⁇ 1 indicates an increasing trend
  • a negative slope ⁇ 1 indicates a decreasing trend
  • no slope indicates no change in patient condition for that particular measure.
  • a predicted measure value can be calculated and compared to the appropriate indicator threshold 129 for determining whether the particular measure has either exceeded an acceptable threshold rate of change of the absolute threshold limit.
  • each of these comparisons can include comparisons to individual measures stored in the pertinent reference baselines 24 .
  • the indicator thresholds 129 for detecting a trend indicating progression into a state of respiratory insufficiency or a state of imminent or likely respiratory insufficiency, for example, over a one week time period can be as follows:
  • Respiratory rate (block 170 ): If the respiratory rate has increased over 1.0 SD from the mean respiratory rate in the reference baseline 26 (block 171 ), the increased respiratory rate and time span over which it occurs are logged in the combined measures set 95 (block 172 ).
  • Heart rate (block 173 ): If the heart rate has increased over 1.0 SD from the mean heart rate in the reference baseline 26 (block 174 ), the increased heart rate and time span over which it occurs are logged in the combined measures set 95 (block 175 ).
  • Patient activity score (block 188 ): If the mean patient activity score has decreased over 1.0 SD from the mean patient activity score in the reference baseline 26 (block 189 ), the decreased patient activity score and time span are logged in the combined measures set 95 (block 190 ).
  • Respiratory distress quality of life (QOL) measures (block 203 ): If the respiratory distress QOL measure has deteriorated by more than 1.0 SD from the mean respiratory distress QOL measure in the reference baseline 26 (block 204 ), the increase in respiratory distress and the time span over which it occurs are logged in the combined measures set 95 (block 205 ).
  • Atrial fibrillation (block 212 ): The presence or absence of atrial fibrillation (AF) is determined and, if present (block 213 ), atrial fibrillation is logged (block 214 ).
  • Rhythm changes (block 215 ): The type and sequence of rhythm changes is significant and is determined (block 216 ) based on the timing of the relevant rhythm measure, such as sinus rhythm. For instance, a finding that a rhythm change to atrial fibrillation precipitated respiratory measures changes can indicate therapy directions against atrial fibrillation rather than the primary development of respiratory insufficiency. Thus, if there are rhythm changes (block 217 ), the sequence of the rhythm changes and time span are logged (block 211 ).
  • an inversion of the indicator thresholds 129 defined above could similarly be used for detecting a trend in disease regression.
  • these measures would vary based on whether or not they were recorded during rest or during activity and that the measured activity score can be used to indicate the degree of patient rest or activity.
  • the patient activity score can be determined via an implantable motion detector, for example, as described in U.S. Pat. No. 4,428,378, issued Jan. 31, 1984, to Anderson et al., the disclosure of which is incorporated herein by reference.
  • the indicator thresholds 129 for detecting a trend towards a state of respiratory insufficiency can also be used to declare, a priori, respiratory insufficiency present, regardless of pre-existing trend data when certain limits are established, such as:
  • An absolute limit of arterial oxygen (block 182 ) less than 85 mm Hg is an a priori definition of respiratory insufficiency from decreased oxygenation.
  • FIG. 12 is a flow diagram showing the routine for evaluating the onset, progression, regression and status quo of respiratory insufficiency 140 for use in the method of FIGS. 8A and 8B.
  • the purpose of this routine is to evaluate the presence of sufficient indicia to warrant a diagnosis of the onset, progression, regression, and status quo of respiratory insufficiency.
  • Quality of life and symptom measures 25 a , 25 b can be included in the evaluation (block 230 ) by determining whether any of the individual quality of life and symptom measures 25 a , 25 b have changed relative to the previously collected quality of life and symptom measures from the monitoring sets 27 and the reference baseline 26 , if used.
  • the routine returns upon either the determination of a finding or elimination of all factors as follows. If a finding of respiratory insufficiency was not previously diagnosed (block 232 ), a determination of disease onset is made (block 233 ), as further described below with reference to FIGS. 13 A- 13 C. Otherwise, if respiratory insufficiency was previously diagnosed (block 232 ), a further determination of either disease progression or worsening (block 234 ) or regression or improving (block 235 ) is made, as further described below with reference to FIGS. 14 A- 14 C and 15 A- 15 C, respectively.
  • FIGS. 13 A- 13 C are flow diagrams showing the routine for determining an onset of respiratory insufficiency 232 for use in the routine of FIG. 12.
  • Respiratory insufficiency is possible based on two general symptom categories: reduced exercise capacity (block 244 ) and respiratory distress (block 256 ).
  • An effort is made to diagnose respiratory insufficiency manifesting primarily as resulting in reduced exercise capacity (block 244 ) and/or increased respiratory distress (block 256 ).
  • Reduced exercise capacity and respiratory distress can generally serve as markers of low systemic arterial oxygenation.
  • the clinical aspects of respiratory insufficiency are described, by way of example, in A. S. Fauci et al. (Eds.), “Harrison's Principles of Internal Medicine,” pp. 1410-1419, McGraw-Hill, 14 th Ed. (1997), the disclosure of which is incorporated herein by reference.
  • Secondary disease considerations can be evaluated using the same indications (see, e.g., blocks 141 - 144 of FIGS. 8 A- 8 B), but with adjusted indicator thresholds 129 (shown in FIG. 5) triggered at a change of 0.5 SD, for example, instead of 1.0 SD.
  • the reduced exercise capacity and respiratory distress findings can be established by consolidating the individual indications (blocks 240 - 243 , 245 - 253 ) in several ways.
  • each individual indication (blocks 240 - 243 , 245 - 253 ) is assigned a scaled index value correlating with the relative severity of the indication.
  • decreased cardiac output (block 240 ) could be measured on a scale from ‘1’ to ‘5’ wherein a score of ‘1’ indicates no change in cardiac output from the reference point, a score of ‘2’ indicates a change exceeding 0.5 SD, a score of ‘3’ indicates a change exceeding 1.0 SD, a score of ‘4’ indicates a change exceeding 2.0 SD, and a score of ‘5’ indicates a change exceeding 3.0 SD.
  • the index value for each of the individual indications (blocks 240-243, 245253) can then either be aggregated or averaged with a result exceeding the aggregate or average maximum indicating an appropriate respiratory insufficiency finding.
  • all scores are weighted depending upon the assignments made from the measures in the reference baseline 26 .
  • arterial partial of oxygen 102 could be weighted more importantly than respiratory rate 104 if the respiratory rate in the reference baseline 26 is particularly high at the outset, making the detection of further disease progression from increases in respiratory rate, less sensitive.
  • arterial partial pressure of oxygen 102 receives the most weight in determining a reduced exercise capacity finding whereas arterial partial pressure of carbon dioxide 107 receives the most weight in determining a respiratory distress or dyspnea finding.
  • each of the individual indications (blocks 240 - 243 , 245 - 253 ) is either present or is not present. All or a majority of the individual indications (blocks 240 - 243 , 245 - 253 ) should be present for the relevant respiratory insufficiency finding to be affirmed.
  • FIGS. 14 A- 14 C are flow diagrams showing the routine for determining a progression or worsening of respiratory insufficiency 234 for use in the routine of FIG. 12.
  • the primary difference between the determinations of disease onset, as described with reference to FIGS. 13 A- 13 C, and disease progression is the evaluation of changes indicated in the same factors present in a disease onset finding.
  • a revised respiratory insufficiency finding is possible based on the same two general symptom categories: reduced exercise capacity (block 274 ) and respiratory distress (block 286 ).
  • reduced exercise capacity block 274
  • respiratory distress block 286
  • the same factors which need be indicated to warrant a diagnosis of respiratory insufficiency onset are evaluated to determine disease progression.
  • FIGS. 15 A- 15 C are flow diagrams showing the routine for determining a regression or improving of respiratory distress 235 for use in the routine of FIG. 12.
  • multiple individual indications (blocks 300 - 303 , 305 - 313 ) should be present for the two principal findings of respiratory insufficiency related reduced exercise capacity (block 304 ), or respiratory related respiratory distress (block 316 ), to indicate disease regression.
  • FIG. 16 is a flow diagram showing the routine for determining threshold stickiness (“hysteresis”) 231 for use in the method of FIG. 12.
  • Stickiness also known as hysteresis, is a medical practice doctrine whereby a diagnosis or therapy will not be changed based upon small or temporary changes in a patient reading, even though those changes might temporarily move into a new zone of concern. For example, if a patient measure can vary along a scale of ‘1’ to ‘10’ with ‘10’ being worse, a transient reading of ‘6,’ standing alone, on a patient who has consistently indicated a reading of ‘5’ for weeks will not warrant a change in diagnosis without a definitive prolonged deterioration first being indicated.
  • Stickiness dictates that small or temporary changes require more diagnostic certainty, as confirmed by the persistence of the changes, than large changes would require for any of the monitored (device) measures. Stickiness also makes reversal of important diagnostic decisions, particularly those regarding life-threatening disorders, more difficult than reversal of diagnoses of modest import.
  • automatic external defibrillators manufactured by Heartstream, a subsidiary of Agilent Technologies, Seattle, Wash., monitor heart rhythms and provide interventive shock treatment for the diagnosis of ventricular fibrillation. Once diagnosis of ventricular fibrillation and a decision to shock the patient has been made, a pattern of no ventricular fibrillation must be indicated for a relatively prolonged period before the AED changes to a “no-shock” decision.
  • stickiness mandates certainty before a decision to shock is disregarded. In practice, stickiness also dictates that acute deteriorations in disease state are treated aggressively while chronic, more slowly progressing disease states are treated in a more tempered fashion. However, in the case of some of the parameters being followed, such as activity and pulmonary artery systolic pressure, abrupt spikes in these measures can be indicative of coughing and therefore helpful in indicating the onset of a disorder that might lead to pulmonary insufficiency.
  • the routine returns. Otherwise, if the patient status indicates a change away from status quo (block 330 ), the relative quantum of change and the length of time over which the change has occurred is determinative. If the change of approximately 0.5 SD has occurred over the course of about one month (block 331 ), a gradually deteriorating condition exists (block 332 ) and a very tempered diagnostic, and if appropriate, treatment program is undertaken. If the change of approximately 1.0 SD has occurred over the course of about one week (block 333 ), a more rapidly deteriorating condition exists (block 334 ) and a slightly more aggressive diagnostic, and if appropriate, treatment program is undertaken.
  • the present invention provides several benefits.
  • One benefit is improved predictive accuracy from the outset of patient care when a reference baseline is incorporated into the automated diagnosis.
  • Another benefit is an expanded knowledge base created by expanding the methodologies applied to a single patient to include patient peer groups and the overall patient population. Collaterally, the information maintained in the database could also be utilized for the development of further predictive techniques and for medical research purposes.
  • Yet a further benefit is the ability to hone and improve the predictive techniques employed through a continual reassessment of patient therapy outcomes and morbidity rates.

Abstract

A system for diagnosing and monitoring respiratory insufficiency for automated remote patient care is presented. A database stores monitoring sets containing recorded measures relating to patient information recorded on a substantially continuous basis. A server retrieving and processing the monitoring sets includes a comparison module determining a patient status change by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to a same type of patient information; and an analysis module testing each patient status change against an indicator threshold corresponding to the same type of patient information as the recorded measures which were compared, the indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This patent application is a continuation of U.S. patent application Ser. No. 10/152,207, filed May 20, 2002, pending; which is a continuation of U.S. Pat. No. 6,398,728, issued Jun. 4, 2002, the disclosures of which are incorporated by reference.[0001]
  • FIELD OF THE INVENTION
  • The present invention relates in general to respiratory insufficiency diagnosis and analysis, and, in particular, to an automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof throughout disease onset, progression, regression, and status quo. [0002]
  • BACKGROUND OF THE INVENTION
  • Presently, respiratory insufficiency due to primary diseases of the lungs is one of the leading causes of acute and chronic illness in the world. Clinically, respiratory insufficiency involves either difficulty in ventilation or in oxygenation. The former is manifest by increases in the arterial partial pressure of carbon dioxide and the latter is manifest by decreases in arterial partial pressure of oxygen. For purposes of this invention, the term “respiratory insufficiency” will refer to ventilatory insufficiency and/or to problems in oxygenation due to diseases of the lung. Common causes of respiratory insufficiency include bronchitis, emphysema, pneumonia, pulmonary emboli, congestive heart failure, tumor infiltration of the lung and abnormalities of the interstitium of the lungs that may be infectious in origin, due to immunological abnormalities, or as a result of exposure to environmental pathogens. The effects of respiratory insufficiency range from cough to impairment during physical exertion to a complete failure of lung function and respiratory arrest at any level of activity. Clinical manifestations of respiratory insufficiency include respiratory distress, such as shortness of breath and fatigue, cough, and reduced exercise capacity or tolerance. [0003]
  • Several factors make the early diagnosis and prevention of respiratory insufficiency, as well as the monitoring of the progression of respiratory insufficiency, relatively difficult. First, the onset of respiratory insufficiency is generally subtle and erratic. Often, the symptoms are ignored and the patient compensates by changing his or her daily activities. This situation is especially true in chronic lung disorders where the onset of symptoms can be very gradual. As a result, many respiratory insufficiency conditions or deteriorations in respiratory insufficiency remain undiagnosed until more serious problems arise seriously limiting the activities of daily living. [0004]
  • The susceptibility to suffer from respiratory insufficiency depends upon the patient's age, sex, physical condition, and other factors, such as smoking history, occupation, diabetes, co-existing heart disease, immunodepression, the presence or absence of cancer, surgical history, kidney function, and extent of pre-existing lung disease. No one factor is dispositive. Finally, annual or even monthly lung checkups, including chest X-rays or other lung tests, provide, at best, a “snapshot” of patient wellness and the incremental and subtle clinicophysiological changes which portend the onset or progression of respiratory insufficiency often go unnoticed, even with regular health care. Documentation of subtle improvements following therapy that can guide and refine further evaluation and therapy can be equally elusive. [0005]
  • Nevertheless, taking advantage of frequently and regularly measured physiological measures, such as recorded manually by a patient, via an external monitoring or therapeutic device, or via implantable device technologies, can provide a degree of detection and prevention heretofore unknown. For instance, patients already suffering from some form of treatable heart disease often receive an implantable pulse generator (IPG), cardiovascular or heart failure monitor, therapeutic device, or similar external wearable device, with which rhythm and structural problems of the heart can be monitored and treated. These types of devices, although usually originally intended for use in treating some type of cardiac problem, can contain sufficient physiological data to allow accurate assessment of lung disorders. Such devices are useful for detecting physiological changes in patient conditions through the retrieval and analysis of telemetered signals stored in an on-board, volatile memory. Typically, these devices can store more than thirty minutes of per heartbeat and respiratory cycle data recorded on a per heartbeat, per respiration, binned average basis, or on a derived basis from, for example, atrial or ventricular electrical activity, minute ventilation, patient activity score, cardiac output score, arterial or mixed venous oxygen score, cardiopulmonary pressure measures, and the like. However, the proper analysis of retrieved telemetered signals requires detailed medical subspecialty knowledge, particularly by pulmonologists and cardiologists. [0006]
  • Alternatively, these telemetered signals can be remotely collected and analyzed using an automated patient care system. One such system is described in a related, commonly assigned U.S. Pat. No. 6,312,378, issued Nov. 6, 2001, the disclosure of which is incorporated herein by reference. A medical device adapted to be implanted in an individual patient records telemetered signals that are then retrieved on a regular, periodic basis using an interrogator or similar interfacing device. The telemetered signals are downloaded via an internetwork onto a network server on a regular, e.g., daily, basis and stored as sets of collected measures in a database along with other patient care records. The information is then analyzed in an automated fashion and feedback, which includes a patient status indicator, is provided to the patient. [0007]
  • While such an automated system can serve as a valuable tool in providing remote patient care, an approach to systematically correlating and analyzing the raw collected telemetered signals, as well as manually collected physiological measures, through applied pulmonary and cardiovascular medical knowledge to accurately diagnose the onset of a particular medical condition, such as respiratory insufficiency, is needed, especially in patients with co-existing heart disease. One automated patient care system directed to a patient-specific monitoring function is described in U.S. Pat. No. 5,113,869 ('869) to Nappholz et al. The '869 patent discloses an implantable, programmable electrocardiography (ECG) patient monitoring device that senses and analyzes ECG signals to detect ECG and physiological signal characteristics predictive of malignant cardiac arrhythmias. The monitoring device can communicate a warning signal to an external device when arrhythmias are predicted. However, the Nappholz device is limited to detecting tachycardias. Unlike requirements for automated respiratory insufficiency monitoring, the Nappholz device focuses on rudimentary ECG signals indicative of malignant cardiac tachycardias, an already well established technique that can be readily used with on-board signal detection techniques. Also, the Nappholz device is patient specific only and is unable to automatically take into consideration a broader patient or peer group history for reference to detect and consider the progression or improvement of lung disease. Moreover, the Nappholz device has a limited capability to automatically self-reference multiple data points in time and cannot detect disease regression even in the individual patient. Also, the Nappholz device must be implanted and cannot function as an external monitor. Finally, the Nappholz device is incapable of tracking the cardiovascular and cardiopulmonary consequences of any rhythm disorder. [0008]
  • Consequently, there is a need for a systematic approach to detecting trends in regularly collected physiological data indicative of the onset, progression, regression, or status quo of respiratory insufficiency diagnosed and monitored using an automated, remote patient care system. The physiological data could be telemetered signals data recorded either by an external or an implantable medical device or, alternatively, individual measures collected through manual means. Preferably, such an approach would be capable of diagnosing both acute and chronic respiratory insufficiency conditions, as well as the symptoms of other lung disorders. In addition, findings from individual, peer group, and general population patient care records could be integrated into continuous, on-going monitoring and analysis. [0009]
  • SUMMARY OF THE INVENTION
  • The present invention provides a system and method for diagnosing and monitoring the onset, progression, regression, and status quo of respiratory insufficiency using an automated collection and analysis patient care system. Measures of patient cardiopulmonary information are either recorded by an external or implantable medical device, such as an IPG, cardiovascular or heart failure monitor, or respiratory diagnostic or therapeutic device, or manually through conventional patient-operable means. The measures are collected on a regular, periodic basis for storage in a database along with other patient care records. Derived measures are developed from the stored measures. Select stored and derived measures are analyzed and changes in patient condition are logged. The logged changes are compared to quantified indicator thresholds to detect findings of respiratory distress or reduced exercise capacity indicative of the principal pathophysiological manifestations of respiratory insufficiency: elevated partial pressure of arterial carbon dioxide and reduced partial pressure of arterial oxygen. [0010]
  • An embodiment of the present invention is an automated system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof. A plurality of monitoring sets is retrieved from a database. Each of the monitoring sets include recorded measures relating to patient information recorded on a substantially continuous basis. A patient status change is determined by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure. Both recorded measures relate to the same type of patient information. Each patient status change is tested against an indicator threshold corresponding to the same type of patient information as the recorded measures that were compared. The indicator threshold corresponds to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency. [0011]
  • A further embodiment is an automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof. A plurality of monitoring sets is retrieved from a database. Each monitoring set includes recorded measures that each relate to patient information and include either medical device measures or derived measures calculable therefrom. The medical device measures are recorded on a substantially continuous basis. A set of indicator thresholds is defined. Each indicator threshold corresponds to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency and relates to the same type of patient information as at least one of the recorded measures. A respiratory insufficiency finding is diagnosed. A change in patient status is determined by comparing at least one recorded measure to at least one other recorded measure with both recorded measures relating to the same type of patient information. Each patient status change is compared to the indicator threshold corresponding to the same type of patient information as the recorded measures that were compared. [0012]
  • A further embodiment is an automated patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof. Recorded measures organized into a monitoring set for an individual patient are stored into a database. Each recorded measure is recorded on a substantially continuous basis and relates to at least one aspect of monitoring reduced exercise capacity and/or respiratory distress. A plurality of the monitoring sets is periodically retrieved from the database. At least one measure related to respiratory insufficiency onset, progression, regression, and status quo is evaluated. A patient status change is determined by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to the same type of patient information. Each patient status change is tested against an indicator threshold corresponding to the same type of patient information as the recorded measures that were compared. The indicator threshold corresponds to a quantifiable physiological measure of a pathophysiology indicative of reduced exercise capacity and/or respiratory distress. [0013]
  • The present invention provides a capability to detect and track subtle trends and incremental changes in recorded patient cardiopulmonary information for diagnosing and monitoring respiratory insufficiency. When coupled with an enrollment in a remote patient monitoring service having the capability to remotely and continuously collect and analyze external or implantable medical device measures, respiratory insufficiency detection, prevention and tracking regression from therapeutic maneuvers become feasible. [0014]
  • Still other embodiments of the present invention will become readily apparent to those skilled in the art from the following detailed description, wherein is described embodiments of the invention by way of illustrating the best mode contemplated for carrying out the invention. As will be realized, the invention is capable of other and different embodiments and its several details are capable of modifications in various obvious respects, all without departing from the spirit and the scope of the present invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not as restrictive.[0015]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a block diagram showing an automated collection and analysis patient care system for diagnosing and monitoring respiratory insufficiency and outcomes thereof in accordance with the present invention; [0016]
  • FIG. 2 is a database schema showing, by way of example, the organization of a device and derived measures set record for care of patients with respiratory insufficiency stored as part of a patient care record in the database of the system of FIG. 1; [0017]
  • FIG. 3 is a database schema showing, by way of example, the organization of a quality of life and symptom measures set record for care of patients with respiratory insufficiency stored as part of a patient care record in the database of the system of FIG. 1; [0018]
  • FIG. 4 is a database schema showing, by way of example, the organization of a combined measures set record for care of patients with respiratory insufficiency stored as part of a patient care record in the database of the system of FIG. 1; [0019]
  • FIG. 5 is a block diagram showing the software modules of the server system of the system of FIG. 1; [0020]
  • FIG. 6 is a record view showing, by way of example, a set of partial patient care records for care of patients with respiratory insufficiency stored in the database of the system of FIG. 1; [0021]
  • FIG. 7 is a Venn diagram showing, by way of example, peer group overlap between the partial patient care records of FIG. 6; [0022]
  • FIGS. [0023] 8A-8B are flow diagrams showing a method for diagnosing and monitoring respiratory insufficiency and outcomes thereof using an automated collection and analysis patient care system in accordance with the present invention;
  • FIG. 9 is a flow diagram showing the routine for retrieving reference baseline sets for use in the method of FIGS. [0024] 8A-8B;
  • FIG. 10 is a flow diagram showing the routine for retrieving monitoring sets for use in the method of FIGS. [0025] 8A-8B;
  • FIGS. [0026] 11A-11F are flow diagrams showing the routine for testing threshold limits for use in the method of FIGS. 8A-8B;
  • FIG. 12 is a flow diagram showing the routine for evaluating the onset, progression, regression, and status quo of respiratory insufficiency for use in the method of FIGS. [0027] 8A-8B;
  • FIGS. [0028] 13A-13C are flow diagrams showing the routine for determining an onset of respiratory insufficiency for use in the routine of FIG. 12;
  • FIGS. [0029] 14A-14C are flow diagrams showing the routine for determining progression or worsening of respiratory insufficiency for use in the routine of FIG. 12;
  • FIGS. [0030] 15A-15C are flow diagrams showing the routine for determining regression or improving of respiratory insufficiency for use in the routine of FIG. 12; and
  • FIG. 16 is a flow diagram showing the routine for determining threshold stickiness (“hysteresis”) for use in the method of FIG. 12.[0031]
  • DETAILED DESCRIPTION
  • FIG. 1 is a block diagram showing an automated collection and analysis [0032] patient care system 10 for diagnosing and monitoring respiratory insufficiency in accordance with the present invention. An exemplary automated collection and analysis patient care system suitable for use with the present invention is disclosed in the related, commonly assigned U.S. Pat. No. 6,312,378, issued Nov. 6, 2001, the disclosure of which is incorporated herein by reference. Preferably, an individual patient 11 is a recipient of an implantable medical device 12, such as, by way of example, an IPG, cardiovascular, heart failure monitor, pulmonary monitor, or therapeutic device, with a set of leads extending into his or her heart and electrodes implanted throughout the cardiopulmonary system. Alternatively, an external monitoring or therapeutic medical device 26, a subcutaneous monitor or device inserted into other organs, a cutaneous monitor, or even a manual physiological measurement device, such as an respiratory monitor, electrocardiogram or heart rate monitor, could be used. The implantable medical device 12 and external medical device 26 include circuitry for recording into a short-term, volatile memory telemetered signals stored for later retrieval, which become part of a set of device and derived measures, such as described below, by way of example, with reference to FIG. 2. Exemplary implantable medical devices suitable for use in the present invention include the Discovery line of pacemakers, manufactured by Guidant Corporation, Indianapolis, Ind., and the Gem line of ICDs, manufactured by Medtronic Corporation, Minneapolis, Minn.
  • The telemetered signals stored in the implantable [0033] medical device 12 are preferably retrieved upon the completion of an initial observation period and subsequently thereafter on a continuous, periodic (daily) basis, such as described in the related, commonly assigned U.S. Pat. No. 6,221,011, issued Apr. 24, 2001, the disclosure of which is incorporated herein by reference. A programmer 14, personal computer 18, or similar device for communicating with an implantable medical device 12 can be used to retrieve the telemetered signals. A magnetized reed switch (not shown) within the implantable medical device 12 closes in response to the placement of a wand 13 over the site of the implantable medical device 12. The programmer 14 sends programming or interrogating instructions to and retrieves stored telemetered signals from the implantable medical device 12 via RF signals exchanged through the wand 13. Similar communication means are used for accessing the external medical device 26. Once downloaded, the telemetered signals are sent via an internetwork 15, such as the Internet, to a server system 16 which periodically receives and stores the telemetered signals as device measures in patient care records 23 in a database 17, as further described below, by way of example, with reference to FIGS. 2 and 3. An exemplary programmer 14 suitable for use in the present invention is the Model 2901 Programmer Recorder Monitor, manufactured by Guidant Corporation, Indianapolis, Ind.
  • The [0034] patient 11 is remotely monitored by the server system 16 via the internetwork 15 through the periodic receipt of the retrieved device measures from the implantable medical device 12 or external medical device 26. The patient care records 23 in the database 17 are organized into two identified sets of device measures: an optional reference baseline 26 recorded during an initial observation period and monitoring sets 27 recorded subsequently thereafter. The device measures sets are periodically analyzed and compared by the server system 16 to indicator thresholds corresponding to quantifiable physiological measures of a pathophysiology indicative of respiratory insufficiency, as further described below with reference to FIG. 5. As necessary, feedback is provided to the patient 11. By way of example, the feedback includes an electronic mail message automatically sent by the server system 16 over the internetwork 15 to a personal computer 18 (PC) situated for local access by the patient 11. Alternatively, the feedback can be sent through a telephone interface device 19 as an automated voice mail message to a telephone 21 or as an automated facsimile message to a facsimile machine 22, both also situated for local access by the patient 11. Moreover, simultaneous notifications can also be delivered to the patient's physician, hospital, or emergency medical services provider 29 using similar feedback means to deliver the information.
  • The [0035] server system 10 can consist of either a single computer system or a cooperatively networked or clustered set of computer systems. Each computer system is a general purpose, programmed digital computing device consisting of a central processing unit (CPU), random access memory (RAM), non-volatile secondary storage, such as a hard drive or CD ROM drive, network interfaces, and peripheral devices, including user interfacing means, such as a keyboard and display. Program code, including software programs, and data are loaded into the RAM for execution and processing by the CPU and results are generated for display, output, transmittal, or storage, as is known in the art.
  • The [0036] database 17 stores patient care records 23 for each individual patient to whom remote patient care is being provided. Each patient care record 23 contains normal patient identification and treatment profile information, as well as medical history, medications taken, height and weight, and other pertinent data (not shown). The patient care records 23 consist primarily of two sets of data: device and derived measures (D&DM) sets 24 a, 24 b and quality of life (QOL) sets 25 a, 25 b, the organization of which are further described below with respect to FIGS. 2 and 3, respectively. The device and derived measures sets 24 a, 24 b and quality of life and symptom measures sets 25 a, 25 b can be further logically categorized into two potentially overlapping sets. The reference baseline 26 is a special set of device and derived reference measures sets 24 a and quality of life and symptom measures sets 25 a recorded and determined during an initial observation period. Monitoring sets 27 are device and derived measures sets 24 b and quality of life and symptom measures sets 25 b recorded and determined thereafter on a regular, continuous basis. Other forms of database organization are feasible.
  • The implantable [0037] medical device 12 and, in a more limited fashion, the external medical device 26, record patient information for care of patients with respiratory insufficiency on a regular basis. The recorded patient information is downloaded and stored in the database 17 as part of a patient care record 23. Further patient information can be derived from recorded data, as is known in the art. FIG. 2 is a database schema showing, by way of example, the organization of a device and derived measures set record 40 for patient care stored as part of a patient care record in the database 17 of the system of FIG. 1. Each record 40 stores patient information which includes a snapshot of telemetered signals data which were recorded by the implantable medical device 12 or the external medical device 26, for instance, on per heartbeat, binned average or derived bases; measures derived from the recorded device measures; and manually collected information, such as obtained through a patient medical history interview or questionnaire. The following non-exclusive information can be recorded for a patient: atrial electrical activity 41, ventricular electrical activity 42, PR interval or AV interval 43, QRS measures 44, ST-T wave measures 45, QT interval 46, body temperature 47, patient activity score 48, posture 49, cardiovascular pressures 50, pulmonary artery systolic pressure measure 51, pulmonary artery diastolic pressure measure 52, respiratory rate 53, ventilatory tidal volume 54, minute ventilation 55, transthoracic impedance 56, cardiac output 57, systemic blood pressure 58, patient geographic location (altitude) 59, mixed venous oxygen score 60, arterial oxygen score 61, arterial carbon dioxide score 62, acidity (pH) level 63, potassium [K+] level 64, sodium [Na+] level 65, glucose level 66, blood urea nitrogen (BUN) and creatinine 67, hematocrit 68, hormonal levels 69, lung injury chemical tests 70, cardiac injury chemical tests 71, myocardial blood flow 72, central nervous system (CNS) injury chemical tests 73, central nervous system blood flow 74, interventions made by the implantable medical device or external medical device 75, and the relative success of any interventions made 76. In addition, the implantable medical device or external medical device communicates device-specific information, including battery status, general device status and program settings 77 and the time of day 78 for the various recorded measures. Other types of collected, recorded, combined, or derived measures are possible, as is known in the art.
  • The device and derived measures sets [0038] 24 a, 24 b (shown in FIG. 1), along with quality of life and symptom measures sets 25 a, 25 b, as further described below with reference to FIG. 3, are continuously and periodically received by the server system 16 as part of the on-going patient care monitoring and analysis function. These regularly collected data sets are collectively categorized as the monitoring sets 27 (shown in FIG. 1). In addition, select device and derived measures sets 24 a and quality of life and symptom measures sets 25 a can be designated as a reference baseline 26 at the outset of patient care to improve the accuracy and meaningfulness of the serial monitoring sets 27. Select patient information is collected, recorded, and derived during an initial period of observation or patient care, such as described in the related, commonly assigned U.S. Pat. No. 6,221,011, issued Apr. 24, 2001, the disclosure of which is incorporated herein by reference.
  • As an adjunct to remote patient care through the monitoring of measured physiological data via the implantable [0039] medical device 12 or external medical device 26, quality of life and symptom measures sets 25 a can also be stored in the database 17 as part of the reference baseline 26, if used, and the monitoring sets 27. A quality of life measure is a semi-quantitative self-assessment of an individual patient's physical and emotional well being and a record of symptoms, such as provided by the Duke Activities Status Indicator. These scoring systems can be provided for use by the patient 11 on the personal computer 18 (shown in FIG. 1) to record his or her quality of life scores for both initial and periodic download to the server system 16. FIG. 3 is a database schema showing, by way of example, the organization of a quality of life record 80 for use in the database 17. The following information is recorded for a patient: overall health wellness 81, psychological state 82, activities of daily living 83, work status 84, geographic location 85, family status 86, shortness of breath 87, cough 88, sputum production 89, sputum color 90, energy level 91, exercise tolerance 92, chest discomfort 93, and time of day 94, and other quality of life and symptom measures as would be known to one skilled in the art.
  • The patient may also add non-device quantitative measures, such as the six-minute walk distance, as complementary data to the device and derived measures sets [0040] 24 a, 24 b and the symptoms during the six-minute walk to quality of life and symptom measures sets 25 a, 25 b.
  • Other types of quality of life and symptom measures are possible, such as those indicated by responses to the Minnesota Living with Heart Failure Questionnaire described in E. Braunwald, ed., “Heart Disease—A Textbook of Cardiovascular Medicine,” pp. 452-454, W. B. Saunders Co. (1997), the disclosure of which is incorporated herein by reference. Similarly, functional classifications based on the relationship between symptoms and the amount of effort required to provoke them can serve as quality of life and symptom measures, such as the New York Heart Association (NYHA) classifications I, II, III and IV, adapted for use for lung disease rather than heart disease, also described in Ibid. [0041]
  • On a periodic basis, the patient information stored in the [0042] database 17 is analyzed and compared to pre-determined cutoff levels, which, when exceeded, can provide etiological indications of respiratory insufficiency symptoms. FIG. 4 is a database schema showing, by way of example, the organization of a combined measures set record 95 for use in the database 17. Each record 95 stores patient information obtained or derived from the device and derived measures sets 24 a, 24 b and quality of life and symptom measures sets 25 a, 25 b as maintained in the reference baseline 26, if used, and the monitoring sets 27. The combined measures set 95 represents those measures most (but not exhaustively or exclusively) relevant to a pathophysiology indicative of respiratory insufficiency and are determined as further described below with reference to FIGS. 8A-8B. The following information is stored for a patient: heart rate 96, heart rhythm (e.g., normal sinus vs. atrial fibrillation) 97, pacing modality 98, pulmonary artery systolic pressure measure 99, pulmonary artery diastolic pressure measure 100, cardiac output score 101, arterial oxygen score 102, mixed venous oxygen score 103, respiratory rate 104, tidal volume 105, transthoracic impedance 106, arterial carbon dioxide score 107, right ventricular peak systolic pressure 108, pulmonary artery end diastolic pressure 109, patient activity score 110, posture 111, exercise tolerance quality of life and symptom measures 112, respiratory distress quality of life and symptom measures 113, cough 114, sputum production 115, any interventions made to treat respiratory insufficiency 116, including treatment by medical device, via drug infusion administered by the patient or by a medical device, surgery, and any other form of medical intervention as is known in the art, the relative success of any such interventions made 117, and time of day 118. Other types of comparison measures regarding respiratory insufficiency are possible as is known in the art. In the described embodiment, each combined measures set 95 is sequentially retrieved from the database 17 and processed. Alternatively, each combined measures set 95 could be stored within a dynamic data structure maintained transitorily in the random access memory of the server system 16 during the analysis and comparison operations.
  • FIG. 5 is a block diagram showing the software modules of the [0043] server system 16 of the system 10 of FIG. 1. Each module is a computer program written as source code in a conventional programming language, such as the C or Java programming languages, and is presented for execution by the CPU of the server system 16 as object or byte code, as is known in the art. The various implementations of the source code and object and byte codes can be held on a computer-readable storage medium or embodied on a transmission medium in a carrier wave. The server system 16 includes three primary software modules, database module 125, diagnostic module 126, and feedback module 128, which perform integrated functions as follows.
  • First, the [0044] database module 125 organizes the individual patient care records 23 stored in the database 17 (shown in FIG. 1) and efficiently stores and accesses the reference baseline 26, monitoring sets 27, and patient care data maintained in those records. Any type of database organization could be utilized, including a flat file system, hierarchical database, relational database, or distributed database, such as provided by database vendors, such as Oracle Corporation, Redwood Shores, Calif.
  • Next, the [0045] diagnostic module 126 makes findings of respiratory insufficiency based on the comparison and analysis of the data measures from the reference baseline 26 and monitoring sets 27. The diagnostic module includes three modules: comparison module 130, analysis module 131, and quality of life module 132. The comparison module 130 compares recorded and derived measures retrieved from the reference baseline 26, if used, and monitoring sets 27 to indicator thresholds 129. The database 17 stores individual patient care records 23 for patients suffering from various health disorders and diseases for which they are receiving remote patient care. For purposes of comparison and analysis by the comparison module 130, these records can be categorized into peer groups containing the records for those patients suffering from similar disorders, as well as being viewed in reference to the overall patient population. The definition of the peer group can be progressively refined as the overall patient population grows. To illustrate, FIG. 6 is a record view showing, by way of example, a set of partial patient care records for care of patients with respiratory insufficiency stored in the database 17 for three patients, Patient 1, Patient 2, and Patient 3. For each patient, three sets of peer measures, X, Y, and Z are shown. Each of the measures, X, Y, and Z could be either collected or derived measures from the reference baseline 26, if used, and monitoring sets 27.
  • The same measures are organized into time-based sets with [0046] Set 0 representing sibling measures made at a reference time t=0. Similarly, Set n−2, Set n−1 and Set n each represent sibling measures made at later reference times t=n−2, t=n−1 and t=n, respectively. Thus, for a given patient, such as Patient 1, serial peer measures, such as peer measure X0 through Xn, represent the same type of patient information monitored over time. The combined peer measures for all patients can be categorized into a health disorder- or disease-matched peer group. The definition of disease-matched peer group is a progressive definition, refined over time as the number of monitored patients grows. Measures representing different types of patient information, such as measures X0, Y0, and Z0, are sibling measures. These are measures which are also measured over time, but which might have medically significant meaning when compared to each other within a set for an individual patient.
  • The [0047] comparison module 130 performs two basic forms of comparisons. First, individual measures for a given patient can be compared to other individual measures for that same patient (self-referencing). These comparisons might be peer-to-peer measures, that is, measures relating to a one specific type of patient information, projected over time, for instance, Xn, Xn−1, Xn−2, . . . X0, or sibling-to-sibling measures, that is, measures relating to multiple types of patient information measured during the same time period, for a single snapshot, for instance, Xn, Yn, and Zn, or projected over time, for instance, Xn, Yn, Zn, Xn−1, Yn−1, Zn−1, Xn−2, Yn−2, Zn−2, . . . X0, Y0, Z0. Second, individual measures for a given patient can be compared to other individual measures for a group of other patients sharing the same disorder- or disease-specific characteristics (peer group referencing) or to the patient population in general (population referencing). Again, these comparisons might be peer-to-peer measures projected over time, for instance, Xn, Xn′, Xn″, Xn−1, Xn−1′, Xn−1″, Xn−2, Xn−2′, Xn−2″ . . . X0, X0′, X0″, or comparing the individual patient's measures to an average from the group. Similarly, these comparisons might be sibling-to-sibling measures for single snapshots, for instance, Xn, Xn′, Xn″, Yn, Yn′, Yn″, and Zn, Zn′, Zn″, or projected over time, for instance, Xn, Xn′, Xn″, Yn, Yn′, Yn″, Zn, Zn′, Zn″, Xn−1, Xn−1′, Xn−1″, Yn−1, Yn−1′, Yn−1″, Zn−1, Zn−1′, Zn−1″, Xn−2, Xn−2′, Xn−2″, Yn−2, Yn−2′, Yn−2″, Zn−2, Zn−2′, Zn−2″ . . . X0, X0′, X0″, Y0, Y0′, Y0″, and Z0, Z0′, Z0″. Other forms of comparisons are feasible, including multiple disease diagnoses for diseases exhibiting similar abnormalities in physiological measures that result from a second disease but manifest in different combinations or onset in different temporal sequences.
  • FIG. 7 is a Venn diagram showing, by way of example, peer group overlap between the partial [0048] patient care records 23 of FIG. 1. Each patient care record 23 includes characteristics data 350, 351, 352, including personal traits, demographics, medical history, and related personal data, for patients 1, 2 and 3, respectively. For example, the characteristics data 350 for patient 1 might personal traits which include gender and age, such as male and an age between 40-45; a demographic of resident of New York City; and a medical history consisting of chronic bronchitis, recurrent pneumonia, a history of an inferior myocardial infarction and diabetes. Similarly, the characteristics data 351 for patient 2 might include identical personal traits, thereby resulting in partial overlap 353 of characteristics data 350 and 351. Similar characteristics overlap 354, 355, 356 can exist between each respective patient. The overall patient population 357 would include the universe of all characteristics data. As the monitoring population grows, the number of patients with personal traits matching those of the monitored patient will grow, increasing the value of peer group referencing. Large peer groups, well matched across all monitored measures, will result in a well known natural history of disease and will allow for more accurate prediction of the clinical course of the patient being monitored. If the population of patients is relatively small, only some traits 356 will be uniformly present in any particular peer group. Eventually, peer groups, for instance, composed of 100 or more patients each, would evolve under conditions in which there would be complete overlap of substantially all salient data, thereby forming a powerful core reference group for any new patient being monitored.
  • Referring back to FIG. 5, the [0049] analysis module 131 analyzes the results from the comparison module 130, which are stored as a combined measures set 95 (not shown), to a set of indicator thresholds 129, as further described below with reference to FIGS. 8A-8B. Similarly, the quality of life module 132 compares quality of life and symptom measures 25 a, 25 b from the reference baseline 26 and monitoring sets 27, the results of which are incorporated into the comparisons performed by the analysis module 131, in part, to either refute or support the findings based on physiological “hard” data. Finally, the feedback module 128 provides automated feedback to the individual patient based, in part, on the patient status indicator 127 generated by the diagnostic module 126. As described above, the feedback could be by electronic mail or by automated voice mail or facsimile. The feedback can also include normalized voice feedback, such as described in the related, commonly assigned U.S. Pat. No. 6,203,495, issued Mar. 20, 2001, the disclosure of which is incorporated herein by reference. In addition, the feedback module 128 determines whether any changes to interventive measures are appropriate based on threshold stickiness (“hysteresis”) 133, as further described below with reference to FIG. 16. The threshold stickiness 133 can prevent fickleness in the diagnostic routines resulting from transient, non-trending and non-significant fluctuations in the various collected and derived measures in favor of more certainty in diagnosis. However, in the case of some of the parameters being followed, such as activity and pulmonary artery systolic and diastolic pressures, abrupt spikes in these measures can be indicative of coughing and therefore helpful in indicating the onset of pulmonary insufficiency. In a further embodiment of the present invention, the feedback module 128 includes a patient query engine 134 that enables the individual patient 11 to interactively query the server system 16 regarding the diagnosis, therapeutic maneuvers, and treatment regimen. Conversely, the patient query engines 134, found in interactive expert systems for diagnosing medical conditions, can interactively query the patient. Using the personal computer 18 (shown in FIG. 1), the patient can have an interactive dialogue with the automated server system 16, as well as human experts as necessary, to self assess his or her medical condition. Such expert systems are well known in the art, an example of which is the MYCIN expert system developed at Stanford University and described in Buchanan, B. & Shortlife, E., “RULE-BASED EXPERT SYSTEMS. The MYCIN Experiments of the Stanford Heuristic Programming Project,” Addison-Wesley (1984). The various forms of feedback described above help to increase the accuracy and specificity of the reporting of the quality of life and symptomatic measures.
  • FIGS. [0050] 8A-8B are flow diagrams showing a method for diagnosing and monitoring respiratory insufficiency and outcomes thereof 135 using an automated collection and analysis patient care system 10 in accordance with the present invention. First, the indicator thresholds 129 (shown in FIG. 5) are set (block 136) by defining a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency and relating to the each type of patient information in the combined device and derived measures set 95 (shown in FIG. 4). The actual values of each indicator threshold can be finite cutoff values, weighted values, or statistical ranges, as discussed below with reference to FIGS. 11A-11F. Next, the reference baseline 26 (block 137) and monitoring sets 27. (block 138) are retrieved from the database 17, as further described below with reference to FIGS. 9 and 10, respectively. Each measure in the combined device and derived measures set 95 is tested against the threshold limits defined for each indicator threshold 129 (block 139), as further described below with reference to FIGS. 11A-11F. The potential onset, progression, regression, or status quo of respiratory insufficiency is then evaluated (block 140) based upon the findings of the threshold limits tests (block 139), as further described below with reference to FIGS. 13A-13C, 14A-14C, 15A-15C.
  • In a further embodiment, multiple near-simultaneous disorders are considered in addition to primary respiratory insufficiency. Primary respiratory insufficiency is defined as the onset or progression of respiratory insufficiency without obvious inciting cause. Secondary respiratory insufficiency is defined as the onset or progression of respiratory insufficiency (in a patient with or without pre-existing respiratory insufficiency) from another disease process, such as congestive heart failure, coronary insufficiency, atrial fibrillation, and so forth. Other health disorders and diseases can potentially share the same forms of symptomatology as respiratory insufficiency, such as congestive heart failure, myocardial ischemia, pneumonia, exacerbation of chronic bronchitis, renal failure, sleep-apnea, stroke, anemia, atrial fibrillation, other cardiac arrhythmias, and so forth. If more than one abnormality is present, the relative sequence and magnitude of onset of abnormalities in the monitored measures becomes most important in sorting and prioritizing disease diagnosis and treatment. [0051]
  • Thus, if other disorders or diseases are being cross-referenced and diagnosed (block [0052] 141), their status is determined (block 142). In the described embodiment, the operations of ordering and prioritizing multiple near-simultaneous disorders (box 151) by the testing of threshold limits and analysis in a manner similar to congestive heart failure as described above, preferably in parallel to the present determination, is described in the related, commonly assigned U.S. Pat. No. 6,440,066, entitled “Automated Collection And Analysis Patient Care System And Method For Ordering And Prioritizing Multiple Health Disorders To Identify An Index Disorder,” issued Aug. 27, 2002, the disclosure of which is incorporated herein by reference. If respiratory insufficiency is due to an obvious inciting cause, i.e., secondary respiratory insufficiency, (block 143), an appropriate treatment regimen for respiratory insufficiency as exacerbated by other disorders is adopted that includes treatment of secondary disorders, e.g., congestive heart failure, myocardial ischemia, atrial fibrillation, and so forth (block 144) and a suitable patient status indicator 127 for respiratory insufficiency is provided (block 146) to the patient. Suitable devices and approaches to diagnosing and treating congestive heart failure, myocardial infarction, and atrial fibrillation are described in related, commonly assigned U.S. Pat. No. 6,336,903, entitled “Automated Collection And Analysis Patient Care System And Method For Diagnosing And Monitoring Congestive Heart Failure And Outcomes Thereof,” issued Jan. 8, 2002; U.S. Pat. No. 6,368,284, entitled “Automated Collection And Analysis Patient Care System And Method For Diagnosing And Monitoring Myocardial Ischemia And Outcomes Thereof,” issued Apr. 9, 2002; and U.S. Pat. No. 6,411,840, entitled “Automated Collection And Analysis Patient Care System And Method For Diagnosing And Monitoring The Outcomes Of Atrial Fibrillation,” Jun. 15, 2002, the disclosures of which are incorporated herein by reference.
  • Otherwise, if primary respiratory insufficiency is indicated (block [0053] 143), a primary treatment regimen is followed (block 145). A patient status indicator 127 for respiratory insufficiency is provided (block 146) to the patient regarding physical well-being, disease prognosis, including any determinations of disease onset, progression, regression, or status quo, and other pertinent medical and general information of potential interest to the patient.
  • Finally, in a further embodiment, if the patient submits a query to the server system [0054] 16 (block 147), the patient query is interactively processed by the query engine (block 148). Similarly, if the server elects to query the patient (block 149), the server query is interactively processed by the server query engine (block 150). The method then terminates if no further patient or server queries are submitted.
  • FIG. 9 is a flow diagram showing the routine for retrieving reference baseline sets [0055] 137 for use in the method of FIGS. 8A-8B. The purpose of this routine is to retrieve the appropriate reference baseline sets 26, if used, from the database 17 based on the types of comparisons being performed. First, if the comparisons are self referencing with respect to the measures stored in the individual patient care record 23 (block 152), the reference device and derived measures set 24 a and reference quality of life and symptom measures set 25 a, if used, are retrieved for the individual patient from the database 17 (block 153). Next, if the comparisons are peer group referencing with respect to measures stored in the patient care records 23 for a health disorder- or disease-specific peer group (block 154), the reference device and derived measures set 24 a and reference quality of life and symptom measures set 25 a, if used, are retrieved from each patient care record 23 for the peer group from the database 17 (block 155). Data for each measure (e.g., minimum, maximum, averaged, standard deviation (SD), and trending data) from the reference baseline 26 for the peer group is then calculated (block 156). Finally, if the comparisons are population referencing with respect to measures stored in the patient care records 23 for the overall patient population (block 157), the reference device and derived measures set 24 a and reference quality of life and symptom measures set 25 a, if used, are retrieved from each patient care record 23 from the database 17 (block 158). Minimum, maximum, averaged, standard deviation, and trending data and other numerical processes using the data, as is known in the art, for each measure from the reference baseline 26 for the peer group is then calculated (block 159). The routine then returns.
  • FIG. 10 is a flow diagram showing the routine for retrieving monitoring sets [0056] 138 for use in the method of FIGS. 8A-8B. The purpose of this routine is to retrieve the appropriate monitoring sets 27 from the database 17 on the types of comparisons being performed. First, if the comparisons are self referencing with respect to the measures stored in the individual patient care record 23 (block 160), the device and derived measures set 24 b and quality of life and symptom measures set 25 b, if used, are retrieved for the individual patient from the database 17 (block 161). Next, if the comparisons are peer group referencing with respect to measures stored in the patient care records 23 for a health disorder- or disease-specific peer group (block 162), the device and derived measures set 24 b and quality of life and symptom measures set 25 b, if used, are retrieved from each patient care record 23 for the peer group from the database 17 (block 163). Data for each measure (e.g., minimum, maximum, averaged, standard deviation, and trending data) from the monitoring sets 27 for the peer group is then calculated (block 164). Finally, if the comparisons are population referencing with respect to measures stored in the patient care records 23 for the overall patient population (block 165), the device and derived measures set 24 b and quality of life and symptom measures set 25 b, if used, are retrieved from each patient care record 23 from the database 17 (block 166). Minimum, maximum, averaged, standard deviation, and trending data and other numerical processes using the data, as is known in the art, for each measure from the monitoring sets 27 for the peer group is then calculated (block 167). The routine then returns.
  • FIGS. [0057] 11A-11F are flow diagrams showing the routine for testing threshold limits 139 for use in the method of FIGS. 8A and 8B. The purpose of this routine is to analyze, compare, and log any differences between the observed, objective measures stored in the reference baseline 26, if used, and the monitoring sets 27 to the indicator thresholds 129. Briefly, the routine consists of tests pertaining to each of the indicators relevant to diagnosing and monitoring respiratory insufficiency. The threshold tests focus primarily on: (1) changes to and rates of change for the indicators themselves, as stored in the combined device and derived measures set 95 (shown in FIG. 4) or similar data structure; and (2) violations of absolute threshold limits which trigger an alert. The timing and degree of change may vary with each measure and with the natural fluctuations noted in that measure during the reference baseline period. In the timing and degree of change might also vary with the individual and the natural history of a measure for that patient.
  • One suitable approach to performing the threshold tests uses a standard statistical linear regression technique using a least squares error fit. The least squares error fit can be calculated as follows: [0058] y = β 0 + β 1 x ( 1 ) β = SS x y SS xx ( 2 ) SS x y = i = 1 n x i y i - ( i = 1 n x i ) ( i = 1 n y i ) n ( 3 ) SS xx = i = 1 n x i 2 - ( i = 1 n x i ) 2 n ( 4 )
    Figure US20040039263A1-20040226-M00001
  • where n is the total number of measures, x[0059] i is the time of day for measure i, and yi is the value of measure i, β1 is the slope, and β0 is they-intercept of the least squares error line. A positive slope β1 indicates an increasing trend, a negative slope β1 indicates a decreasing trend, and no slope indicates no change in patient condition for that particular measure. A predicted measure value can be calculated and compared to the appropriate indicator threshold 129 for determining whether the particular measure has either exceeded an acceptable threshold rate of change of the absolute threshold limit.
  • For any given patient, three basic types of comparisons between individual measures stored in the monitoring sets [0060] 27 are possible: self referencing, peer group, and general population, as explained above with reference to FIG. 6. In addition, each of these comparisons can include comparisons to individual measures stored in the pertinent reference baselines 24.
  • The [0061] indicator thresholds 129 for detecting a trend indicating progression into a state of respiratory insufficiency or a state of imminent or likely respiratory insufficiency, for example, over a one week time period, can be as follows:
  • (1) Respiratory rate (block [0062] 170): If the respiratory rate has increased over 1.0 SD from the mean respiratory rate in the reference baseline 26 (block 171), the increased respiratory rate and time span over which it occurs are logged in the combined measures set 95 (block 172).
  • (2) Heart rate (block [0063] 173): If the heart rate has increased over 1.0 SD from the mean heart rate in the reference baseline 26 (block 174), the increased heart rate and time span over which it occurs are logged in the combined measures set 95 (block 175).
  • (3) Transthoracic impedance (block [0064] 176): If the transthoracic impedance has increased over 1.0 SD from the mean transthoracic impedance in the reference baseline 26 (block 177), the increased transthoracic impedance and time span are logged in the combined measures set 95 (block 178).
  • (4) The ventilatory tidal volume (block [0065] 179): If the tidal volume has increased over 1.0 SD from the tidal volume score in the reference baseline 26 (block 180), the increased tidal volume score and time span are logged in the combined measures set 95 (block 181).
  • (5) Arterial oxygen score (block [0066] 182): If the arterial oxygen score has decreased over 1.0 SD from the arterial oxygen score in the reference baseline 26 (block 183), the decreased arterial oxygen score and time span are logged in the combined measures set 95 (block 184).
  • (6) Arterial carbon dioxide score (block [0067] 185): If the arterial carbon dioxide score has decreased over 1.0 SD from the arterial carbon dioxide score in the reference baseline 26 (block 186), the decreased arterial carbon dioxide score and time span are logged in the combined measures set 95 (block 187).
  • (7) Patient activity score (block [0068] 188): If the mean patient activity score has decreased over 1.0 SD from the mean patient activity score in the reference baseline 26 (block 189), the decreased patient activity score and time span are logged in the combined measures set 95 (block 190).
  • (8) Temperature (block [0069] 191): If the patient temperature score has increased over 1.0 SD from the mean patient temperature score in the reference baseline 26 (block 192), the increased patient temperature score and the time span are logged in the combined measures set 95 (block 193).
  • (9) Spikes in patient activity (block [0070] 194): If short-lived spikes in the patient activity score occur over time periods under 5 minutes compared to the reference baseline 26 (block 195), the spike in patient activity score and time span are logged in the combined measures set 95 (block 196).
  • (10) Spikes in pulmonary arterial pressure (PAP) (block [0071] 197): If short-lived spikes in the pulmonary arterial pressure score occur over time periods under 5 minutes compared to the reference baseline 26 (block 198), the spike in the pulmonary arterial pressure score and time span are logged in the combined measures set 95 (block 199). In the described embodiment, the mean arterial pressure on any spike in the arterial pressure tracing could be utilized.
  • (11) Exercise tolerance quality of life (QOL) measures (block [0072] 200): If the exercise tolerance QOL has decreased over 1.0 SD from the mean exercise tolerance in the reference baseline 26 (block 201), the decrease in exercise tolerance and the time span over which it occurs are logged in the combined measures set 95 (block 202).
  • (12) Respiratory distress quality of life (QOL) measures (block [0073] 203): If the respiratory distress QOL measure has deteriorated by more than 1.0 SD from the mean respiratory distress QOL measure in the reference baseline 26 (block 204), the increase in respiratory distress and the time span over which it occurs are logged in the combined measures set 95 (block 205).
  • (13) Spikes in right ventricular (RV) pressure (block [0074] 206): If short-lived spikes in the right ventricular pressure occur over time periods under 5 minutes compared to the reference baseline 26 (block 207), the spike in the right ventricular pressure and time span are logged in the combined measures set 95 (block 208).
  • (14) Spikes in transthoracic impedance (TTZ) (block [0075] 209): If short-lived spikes in the transthoracic impedance occur over time periods under 5 minutes compared to the reference baseline 26 (block 210), the spike in the transthoracic impedance and time span are logged in the combined measures set 95 (block 211).
  • (15) Atrial fibrillation (block [0076] 212): The presence or absence of atrial fibrillation (AF) is determined and, if present (block 213), atrial fibrillation is logged (block 214).
  • (16) Rhythm changes (block [0077] 215): The type and sequence of rhythm changes is significant and is determined (block 216) based on the timing of the relevant rhythm measure, such as sinus rhythm. For instance, a finding that a rhythm change to atrial fibrillation precipitated respiratory measures changes can indicate therapy directions against atrial fibrillation rather than the primary development of respiratory insufficiency. Thus, if there are rhythm changes (block 217), the sequence of the rhythm changes and time span are logged (block 211).
  • Note also that an inversion of the [0078] indicator thresholds 129 defined above could similarly be used for detecting a trend in disease regression. One skilled in the art would recognize that these measures would vary based on whether or not they were recorded during rest or during activity and that the measured activity score can be used to indicate the degree of patient rest or activity. The patient activity score can be determined via an implantable motion detector, for example, as described in U.S. Pat. No. 4,428,378, issued Jan. 31, 1984, to Anderson et al., the disclosure of which is incorporated herein by reference.
  • The [0079] indicator thresholds 129 for detecting a trend towards a state of respiratory insufficiency can also be used to declare, a priori, respiratory insufficiency present, regardless of pre-existing trend data when certain limits are established, such as:
  • (1) An absolute limit of arterial oxygen (block [0080] 182) less than 85 mm Hg is an a priori definition of respiratory insufficiency from decreased oxygenation.
  • (2) An absolute limit of arterial carbon dioxide (block [0081] 185) falling below 25 mm Hg (in the absence of marked exercise) or greater than 50 mm Hg are both a priori definitions of respiratory insufficiency as indicated by hyperventilation and hypoventilation, respectively.
  • FIG. 12 is a flow diagram showing the routine for evaluating the onset, progression, regression and status quo of [0082] respiratory insufficiency 140 for use in the method of FIGS. 8A and 8B. The purpose of this routine is to evaluate the presence of sufficient indicia to warrant a diagnosis of the onset, progression, regression, and status quo of respiratory insufficiency. Quality of life and symptom measures 25 a, 25 b can be included in the evaluation (block 230) by determining whether any of the individual quality of life and symptom measures 25 a, 25 b have changed relative to the previously collected quality of life and symptom measures from the monitoring sets 27 and the reference baseline 26, if used. For example, an increase in the shortness of breath measure 87 and exercise tolerance measure 92 would corroborate a finding of respiratory insufficiency. Similarly, a transition from NYHA Class II to NYHA Class III would indicate a deterioration or, conversely, a transition from NYHA Class III to NYHA Class II status would indicate improvement or progress when adapting the NYHA classifications for their parallel in lung disorders. Incorporating the quality of life and symptom measures 25 a, 25 b into the evaluation can help, in part, to refute or support findings based on physiological data. Next, a determination as to whether any changes to interventive measures are appropriate based on threshold stickiness (“hysteresis”) is made (block 231), as further described below with reference to FIG. 16.
  • The routine returns upon either the determination of a finding or elimination of all factors as follows. If a finding of respiratory insufficiency was not previously diagnosed (block [0083] 232), a determination of disease onset is made (block 233), as further described below with reference to FIGS. 13A-13C. Otherwise, if respiratory insufficiency was previously diagnosed (block 232), a further determination of either disease progression or worsening (block 234) or regression or improving (block 235) is made, as further described below with reference to FIGS. 14A-14C and 15A-15C, respectively. If, upon evaluation, neither disease onset (block 233), worsening (block 234) or improving (block 235) is indicated, a finding of status quo is appropriate (block 236) and noted (block 237). Otherwise, respiratory insufficiency and the related outcomes are actively managed (block 238) through the administration of, non-exclusively, antibiotic and antiviral therapies, bronchodilator therapies, oxygen therapies, antiinflammation therapies, electrical therapies, mechanical therapies, and other therapies as are known in the art. The management of respiratory insufficiency is described, by way of example, in A. S. Fauci et al. (Eds.), “Harrison's Principles of Internal Medicine,” pp. 1407-1491, McGraw-Hill, 14th Ed. (1997), the disclosure of which is incorporated herein by reference. The routine then returns.
  • FIGS. [0084] 13A-13C are flow diagrams showing the routine for determining an onset of respiratory insufficiency 232 for use in the routine of FIG. 12. Respiratory insufficiency is possible based on two general symptom categories: reduced exercise capacity (block 244) and respiratory distress (block 256). An effort is made to diagnose respiratory insufficiency manifesting primarily as resulting in reduced exercise capacity (block 244) and/or increased respiratory distress (block 256). Reduced exercise capacity and respiratory distress can generally serve as markers of low systemic arterial oxygenation. The clinical aspects of respiratory insufficiency are described, by way of example, in A. S. Fauci et al. (Eds.), “Harrison's Principles of Internal Medicine,” pp. 1410-1419, McGraw-Hill, 14th Ed. (1997), the disclosure of which is incorporated herein by reference.
  • As primary pulmonary disease considerations, multiple individual indications (blocks [0085] 240-243, 245-253) should be present for the two principal findings of respiratory insufficiency related reduced exercise capacity (block 244), or respiratory insufficiency related respiratory distress (block 256), to be indicated, both for disease onset or progression. The presence of primary key findings alone can be sufficient to indicate an onset of respiratory insufficiency and secondary key findings serve to corroborate disease onset. Note the presence of any abnormality can trigger an analysis for the presence or absence of secondary disease processes, such as the presence of atrial fibrillation or congestive heart failure. Secondary disease considerations can be evaluated using the same indications (see, e.g., blocks 141-144 of FIGS. 8A-8B), but with adjusted indicator thresholds 129 (shown in FIG. 5) triggered at a change of 0.5 SD, for example, instead of 1.0 SD.
  • In the described embodiment, the reduced exercise capacity and respiratory distress findings ([0086] blocks 244, 251) can be established by consolidating the individual indications (blocks 240-243, 245-253) in several ways. First, in a preferred embodiment, each individual indication (blocks 240-243, 245-253) is assigned a scaled index value correlating with the relative severity of the indication. For example, decreased cardiac output (block 240) could be measured on a scale from ‘1’ to ‘5’ wherein a score of ‘1’ indicates no change in cardiac output from the reference point, a score of ‘2’ indicates a change exceeding 0.5 SD, a score of ‘3’ indicates a change exceeding 1.0 SD, a score of ‘4’ indicates a change exceeding 2.0 SD, and a score of ‘5’ indicates a change exceeding 3.0 SD. The index value for each of the individual indications (blocks 240-243, 245253) can then either be aggregated or averaged with a result exceeding the aggregate or average maximum indicating an appropriate respiratory insufficiency finding.
  • Preferably, all scores are weighted depending upon the assignments made from the measures in the [0087] reference baseline 26. For instance, arterial partial of oxygen 102 could be weighted more importantly than respiratory rate 104 if the respiratory rate in the reference baseline 26 is particularly high at the outset, making the detection of further disease progression from increases in respiratory rate, less sensitive. In the described embodiment, arterial partial pressure of oxygen 102 receives the most weight in determining a reduced exercise capacity finding whereas arterial partial pressure of carbon dioxide 107 receives the most weight in determining a respiratory distress or dyspnea finding.
  • Alternatively, a simple binary decision tree can be utilized wherein each of the individual indications (blocks [0088] 240-243, 245-253) is either present or is not present. All or a majority of the individual indications (blocks 240-243, 245-253) should be present for the relevant respiratory insufficiency finding to be affirmed.
  • Other forms of consolidating the individual indications (blocks [0089] 240-243, 245-253) are feasible.
  • FIGS. [0090] 14A-14C are flow diagrams showing the routine for determining a progression or worsening of respiratory insufficiency 234 for use in the routine of FIG. 12. The primary difference between the determinations of disease onset, as described with reference to FIGS. 13A-13C, and disease progression is the evaluation of changes indicated in the same factors present in a disease onset finding. Thus, a revised respiratory insufficiency finding is possible based on the same two general symptom categories: reduced exercise capacity (block 274) and respiratory distress (block 286). The same factors which need be indicated to warrant a diagnosis of respiratory insufficiency onset are evaluated to determine disease progression.
  • Similarly, FIGS. [0091] 15A-15C are flow diagrams showing the routine for determining a regression or improving of respiratory distress 235 for use in the routine of FIG. 12. The same factors as described above with reference to FIGS. 13A-13C and 14A-14C, trending in opposite directions from disease onset or progression, are evaluated to determine disease regression. As primary cardiac disease considerations, multiple individual indications (blocks 300-303, 305-313) should be present for the two principal findings of respiratory insufficiency related reduced exercise capacity (block 304), or respiratory related respiratory distress (block 316), to indicate disease regression.
  • FIG. 16 is a flow diagram showing the routine for determining threshold stickiness (“hysteresis”) [0092] 231 for use in the method of FIG. 12. Stickiness, also known as hysteresis, is a medical practice doctrine whereby a diagnosis or therapy will not be changed based upon small or temporary changes in a patient reading, even though those changes might temporarily move into a new zone of concern. For example, if a patient measure can vary along a scale of ‘1’ to ‘10’ with ‘10’ being worse, a transient reading of ‘6,’ standing alone, on a patient who has consistently indicated a reading of ‘5’ for weeks will not warrant a change in diagnosis without a definitive prolonged deterioration first being indicated. Stickiness dictates that small or temporary changes require more diagnostic certainty, as confirmed by the persistence of the changes, than large changes would require for any of the monitored (device) measures. Stickiness also makes reversal of important diagnostic decisions, particularly those regarding life-threatening disorders, more difficult than reversal of diagnoses of modest import. As an example, automatic external defibrillators (AEDs) manufactured by Heartstream, a subsidiary of Agilent Technologies, Seattle, Wash., monitor heart rhythms and provide interventive shock treatment for the diagnosis of ventricular fibrillation. Once diagnosis of ventricular fibrillation and a decision to shock the patient has been made, a pattern of no ventricular fibrillation must be indicated for a relatively prolonged period before the AED changes to a “no-shock” decision. As implemented in this AED example, stickiness mandates certainty before a decision to shock is disregarded. In practice, stickiness also dictates that acute deteriorations in disease state are treated aggressively while chronic, more slowly progressing disease states are treated in a more tempered fashion. However, in the case of some of the parameters being followed, such as activity and pulmonary artery systolic pressure, abrupt spikes in these measures can be indicative of coughing and therefore helpful in indicating the onset of a disorder that might lead to pulmonary insufficiency.
  • Thus, if the patient status indicates a status quo (block [0093] 330), no changes in treatment or diagnosis are indicated and the routine returns. Otherwise, if the patient status indicates a change away from status quo (block 330), the relative quantum of change and the length of time over which the change has occurred is determinative. If the change of approximately 0.5 SD has occurred over the course of about one month (block 331), a gradually deteriorating condition exists (block 332) and a very tempered diagnostic, and if appropriate, treatment program is undertaken. If the change of approximately 1.0 SD has occurred over the course of about one week (block 333), a more rapidly deteriorating condition exists (block 334) and a slightly more aggressive diagnostic, and if appropriate, treatment program is undertaken. If the change of approximately 2.0 SD has occurred over the course of about one day (block 335), an urgently deteriorating condition exists (block 336) and a moderately aggressive diagnostic, and if appropriate, treatment program is undertaken. If the change of approximately 3.0 SD has occurred over the course of about one hour (block 337), an emergency condition exists (block 338) and an immediate diagnostic, and if appropriate, treatment program is undertaken as is practical. Finally, if the change and duration fall outside the aforementioned ranges (blocks 331-338), an exceptional condition exists (block 339) and the changes are reviewed manually, if necessary. The routine then returns. These threshold limits and time ranges may then be adapted depending upon patient history and peer-group guidelines.
  • The present invention provides several benefits. One benefit is improved predictive accuracy from the outset of patient care when a reference baseline is incorporated into the automated diagnosis. Another benefit is an expanded knowledge base created by expanding the methodologies applied to a single patient to include patient peer groups and the overall patient population. Collaterally, the information maintained in the database could also be utilized for the development of further predictive techniques and for medical research purposes. Yet a further benefit is the ability to hone and improve the predictive techniques employed through a continual reassessment of patient therapy outcomes and morbidity rates. [0094]
  • Other benefits include an automated, expert system approach to the cross-referral, consideration, and potential finding or elimination of other diseases and health disorders with similar or related etiological indicators and for those other disorders that may have an impact on respiratory insufficiency. Although disease specific markers will prove very useful in discriminating the underlying cause of symptoms, many diseases, other than respiratory insufficiency, will alter some of the same physiological measures indicative of respiratory insufficiency. Consequently, an important aspect of considering the potential impact of other disorders will be, not only the monitoring of disease specific markers, but the sequencing of change and the temporal evolution of more general physiological measures, for example respiratory rate, pulmonary artery diastolic pressure, and cardiac output, to reflect disease onset, progression or regression in more than one type of disease process, especially congestive heart failure from whatever cause. [0095]
  • While the invention has been particularly shown and described as referenced to the embodiments thereof, those skilled in the art will understand that the foregoing and other changes in form and detail may be made therein without departing from the spirit and scope of the invention. [0096]

Claims (81)

What is claimed is:
1. A system for diagnosing and monitoring respiratory insufficiency for automated remote patient care, comprising:
a database storing a plurality of monitoring sets which each comprise recorded measures relating to patient information recorded on a substantially continuous basis;
a server retrieving and processing a plurality of the monitoring sets, comprising:
a comparison module determining a patient status change by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to a same type of patient information; and
an analysis module testing each patient status change against an indicator threshold corresponding to the same type of patient information as the recorded measures which were compared, the indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency.
2. A system according to claim 1, further comprising:
the analysis module managing the respiratory insufficiency and outcomes thereof through administration of at least one of antibiotic and antiviral therapies, bronchodilator therapies, oxygen therapies, anti inflammation therapies, electrical therapies, and mechanical therapies.
3. A system according to claim 1, further comprising:
a database module periodically receiving a monitoring set for an individual patient, each recorded measure in the monitoring set having been recorded by at least one of a medical device adapted to be implanted in an individual patient and an external medical device proximal to the individual patient when the device measures are recorded and storing the received set in the database as part of a patient care record for the individual patient.
4. A system according to claim 3, further comprising:
a set of further indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure used to detect a pathophysiology indicative of diseases other than respiratory insufficiency;
the comparison module comparing each patient status change to each such further indicator threshold corresponding to the same type of patient information as the at least one recorded measure and the at least one other recorded measure; and
the analysis module testing each patient status change against each such further indicator threshold corresponding to the same type of patient information as the recorded measures which were compared.
5. A system according to claim 1, further comprising:
the comparison determining a change in patient status by comparing at least one recorded quality of life measure to at least one other corresponding recorded quality of life measure.
6. A system according to claim 1, further comprising:
a set of stickiness indicators for each type of patient information, each stickiness indicator corresponding to a temporal limit related to a program of patient diagnosis or treatment;
the comparison module comparing a time span occurring between each patient status change for each recorded measure to the stickiness indicator relating to the same type of patient information as the recorded measure being compared; and
the analysis module determining a revised program of patient diagnosis or treatment responsive to each patient status change occurring subsequent to a time span exceeding the stickiness indicator.
7. A system according to claim 1, further comprising:
a database module retrieving the plurality of monitoring sets from one of a patient care record for an individual patient, a peer group, and a overall patient population.
8. A system according to claim 1, further comprising:
the database further storing a reference baseline comprising recorded measures which each relate to patient information recorded during an initial time period and comprise either medical device measures or derived measures calculable therefrom; and
a database module obtaining at least one of the at least one recorded measure and the at least one other recorded measure from the retrieved reference baseline.
9. A system according to claim 1, wherein the indicator thresholds relate to at least one of a finding of reduced exercise capacity and respiratory distress.
10. A system according to claim 9, wherein the indicator thresholds relating to the finding of reduced exercise capacity are selected from the group comprising decreased cardiac output, decreased mixed venous oxygen score, decreased patient activity score and decreased exercise tolerance.
11. A system according to claim 9, wherein the indicator thresholds relating to the finding of respiratory distress are selected from the group comprising a spike in patient activity score, a spike in pulmonary artery pressure, a spike in right ventricular pressure, a spike in transthoracic impedance, increased respiratory rate, increased minute ventilation, increased temperature, decreased QT interval, decreased arterial oxygen and decreased arterial carbon dioxide.
12. A method for diagnosing and monitoring respiratory insufficiency for automated remote patient care, comprising:
storing a plurality of monitoring sets which each comprise recorded measures relating to patient information recorded on a substantially continuous basis in a database;
retrieving a plurality of the monitoring sets from the database;
determining a patient status change by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to a same type of patient information; and
testing each patient status change against an indicator threshold corresponding to the same type of patient information as the recorded measures which were compared, the indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency.
13. A method according to claim 12, further comprising:
managing the respiratory insufficiency and outcomes thereof through administration of at least one of antibiotic and antiviral therapies, bronchodilator therapies, oxygen therapies, anti inflammation therapies, electrical therapies, and mechanical therapies.
14. A method according to claim 12, further comprising:
periodically receiving a monitoring set for an individual patient, each recorded measure in the monitoring set having been recorded by at least one of a medical device adapted to be implanted in an individual patient and an external medical device proximal to the individual patient when the device measures are recorded; and
storing the received monitoring set in the database as part of a patient care record for the individual patient.
15. A method according to claim 14, further comprising:
defining a set of further indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure used to detect a pathophysiology indicative of diseases other than respiratory insufficiency;
comparing each patient status change to each such further indicator threshold corresponding to the same type of patient information as the at least one recorded measure and the at least one other recorded measure; and
testing each patient status change against each such further indicator threshold corresponding to the same type of patient information as the recorded measures which were compared.
16. A method according to claim 12, further comprising:
determining a change in patient status by comparing at least one recorded quality of life measure to at least one other corresponding recorded quality of life measure.
17. A method according to claim 12, further comprising:
defining a set of stickiness indicators for each type of patient information, each stickiness indicator corresponding to a temporal limit related to a program of patient diagnosis or treatment;
comparing a time span occurring between each patient status change for each recorded measure to the stickiness indicator relating to the same type of patient information as the recorded measure being compared; and
determining a revised program of patient diagnosis or treatment responsive to each patient status change occurring subsequent to a time span exceeding the stickiness indicator.
18. A method according to claim 12, further comprising:
retrieving the plurality of monitoring sets from one of a patient care record for an individual patient, a peer group, and a overall patient population.
19. A method according to claim 12, further comprising:
retrieving a reference baseline comprising recorded measures which each relate to patient information recorded during an initial time period and comprise either medical device measures or derived measures calculable therefrom; and
obtaining at least one of the at least one recorded measure and the at least one other recorded measure from the retrieved reference baseline.
20. A method according to claim 12, wherein the indicator thresholds relate to at least one of a finding of reduced exercise capacity and respiratory distress.
21. A method according to claim 20, wherein the indicator thresholds relating to the finding of reduced exercise capacity are selected from the group comprising decreased cardiac output, decreased mixed venous oxygen score, decreased patient activity score and decreased exercise tolerance.
22. A method according to claim 20, wherein the indicator thresholds relating to the finding of respiratory distress are selected from the group comprising a spike in patient activity score, a spike in pulmonary artery pressure, a spike in right ventricular pressure, a spike in transthoracic impedance, increased respiratory rate, increased minute ventilation, increased temperature, decreased QT interval, decreased arterial oxygen and decreased arterial carbon dioxide.
23. A computer-readable storage medium holding code for diagnosing and monitoring respiratory insufficiency for automated remote patient care, comprising:
code for storing a plurality of monitoring sets from a database which each comprise recorded measures relating to patient information recorded on a substantially continuous basis;
code for retrieving a plurality of the monitoring sets from the database;
code for determining a patient status change by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to a same type of patient information; and
code for testing each patient status change against an indicator threshold corresponding to the same type of patient information as the recorded measures which were compared, the indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency.
24. A storage medium according to claim 23, further comprising:
code for managing the respiratory insufficiency and outcomes thereof through administration of at least one of antibiotic and antiviral therapies, bronchodilator therapies, oxygen therapies, anti inflammation therapies, electrical therapies, and mechanical therapies.
25. A storage medium according to claim 23, further comprising:
code for periodically receiving a monitoring set for an individual patient, each recorded measure in the monitoring set having been recorded by at least one of a medical device adapted to be implanted in an individual patient and an external medical device proximal to the individual patient when the device measures are recorded; and
code for storing the received monitoring set in the database as part of a patient care record for the individual patient.
26. A storage medium according to claim 25, further comprising:
code for defining a set of further indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure used to detect a pathophysiology indicative of diseases other than respiratory insufficiency;
code for comparing each patient status change to each such further indicator threshold corresponding to the same type of patient information as the at least one recorded measure and the at least one other recorded measure; and
code for testing each patient status change against each such further indicator threshold corresponding to the same type of patient information as the recorded measures which were compared.
27. A storage medium according to claim 23, further comprising:
code for determining a change in patient status by comparing at least one recorded quality of life measure to at least one other corresponding recorded quality of life measure.
28. A storage medium according to claim 23, further comprising:
code for defining a set of stickiness indicators for each type of patient information, each stickiness indicator corresponding to a temporal limit related to a program of patient diagnosis or treatment;
code for comparing a time span occurring between each patient status change for each recorded measure to the stickiness indicator relating to the same type of patient information as the recorded measure being compared; and
code for determining a revised program of patient diagnosis or treatment responsive to each patient status change occurring subsequent to a time span exceeding the stickiness indicator.
29. A storage medium according to claim 23, further comprising:
code for retrieving the plurality of monitoring sets from one of a patient care record for an individual patient, a peer group, and a overall patient population.
30. A storage medium according to claim 23, further comprising:
code for retrieving a reference baseline comprising recorded measures which each relate to patient information recorded during an initial time period and comprise either medical device measures or derived measures calculable therefrom; and
code for obtaining at least one of the at least one recorded measure and the at least one other recorded measure from the retrieved reference baseline.
31. An automated collection and analysis patient care system for diagnosing and monitoring respiratory insufficiency and outcomes thereof, comprising:
a database storing patient monitoring information, comprising:
a plurality of monitoring sets, each monitoring set comprising recorded measures which each relate to patient information and comprise either medical device measures or derived measures calculable therefrom, the medical device measures having been recorded on a substantially continuous basis;
a set of stored indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency and relating to a same type of patient information as at least one of the recorded measures;
a server diagnosing a respiratory insufficiency finding, comprising:
an analysis module determining a change in patient status by comparing at least one recorded measure to at least one other recorded measure with both recorded measures relating to the same type of patient information; and
a comparison module comparing each patient status change to the indicator threshold corresponding to the same type of patient information as the recorded measures which were compared.
32. A system according to claim 31, wherein the device measures are recorded by at least one of a medical device adapted to be implanted in an individual patient and an external medical device proximal to the individual patient when the device measures are recorded.
33. A system according to claim 31, wherein each of the monitoring sets comprises recorded measures relating to patient information solely for the individual patient, further comprising:
a database module retrieving each monitoring set from a patient care record for the individual patient and obtaining the at least one recorded measure and the at least one other recorded measure from the retrieved monitoring sets.
34. A system according to claim 31, wherein each of the monitoring sets comprises recorded measures relating to patient information for a peer group of patients to which the individual patient belongs, further comprising:
a database module retrieving at least one monitoring set from a patient care record for the individual patient, retrieving at least one other monitoring set from a patient care record in the same patient peer group, and obtaining the at least one recorded measure from the at least one monitoring set and the at least one other recorded measure from the at least one other monitoring set.
35. A system according to claim 31, wherein each of the monitoring sets comprises recorded measures relating to patient information for the general population of patients, further comprising:
a database module retrieving at least one monitoring set from a patient care record for the individual patient, retrieving at least one other monitoring set from a patient care record in the overall patient population, and obtaining the at least one recorded measure from the at least one monitoring set and the at least one other recorded measure from the at least one other monitoring set.
36. A system according to claim 31, further comprising:
the database further storing a reference baseline comprising recorded measures which each relate to patient information recorded by the medical device adapted to be implanted during an initial time period and comprise either device measures recorded by the medical device adapted to be implanted or derived measures calculable therefrom; and
a database module obtaining at least one of the at least one recorded measure and the at least one other recorded measure from the retrieved reference baseline.
37. A system according to claim 36, wherein the reference baseline comprises recorded measures relating to patient information for one of the individual patients solely, a peer group of patients to which the individual patient belongs, and a general population of patients.
38. A system according to claim 31, wherein the indicator thresholds relate to reduced exercise capacity selected from the group comprising decreased cardiac output, decreased mixed venous oxygen score, decreased patient activity score and decreased exercise tolerance.
39. A system according to claim 31, wherein the indicator thresholds relate to respiratory distress selected from the group comprising a spike in patient activity score, a spike in pulmonary artery pressure, a spike in right ventricular pressure, a spike in transthoracic impedance, increased respiratory rate, increased minute ventilation, increased temperature, decreased QT interval, decreased arterial oxygen and decreased arterial carbon dioxide.
40. A system according to claim 31, the comparison module further comprising:
a module grading the comparisons between each patient status change and corresponding indicator threshold on a fixed scale based on a degree of deviation from the indicator threshold; and
the comparison module determining an overall patient status change by performing a summation over the individual graded comparisons.
41. A system according to claim 31, the comparison module further comprising:
a module determining probabilistic weightings of the comparisons between each patient status change and corresponding indicator threshold based on a statistical deviation and trends via linear fits from the indicator threshold; and
the comparison module determining an overall patient status change by performing a summation over the individual graded comparisons.
42. A system according to claim 31, wherein each monitoring set further comprises quality of life and symptom measures recorded by the individual patient, the server further comprising:
a quality of life module determining a change in patient status by comparing at least one recorded quality of life measure to at least one other corresponding recorded quality of life measure; and
the server incorporating each patient status change in quality of life into the respiratory insufficiency finding to either refute or support the diagnosis.
43. A system according to claim 31, further comprising:
a set of stored further indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure used to detect a pathophysiology indicative of diseases other than respiratory insufficiency of disease; and
the server diagnosing a finding of a disease other than respiratory insufficiency, the comparison module further comprising comparing each patient status change to each such further indicator threshold corresponding to the same type of patient information as the at least one recorded measure and the at least one other recorded measure.
44. A system according to claim 31, further comprising:
a set of stickiness indicators, each indicator threshold corresponding to a temporal limit related to a course of patient care; and
a feedback module comparing a time span between each patient status change for each recorded measure to the stickiness indicator corresponding to the same type of patient information as the recorded measure being compared.
45. A system according to claim 31, further comprising:
a feedback module providing automated feedback to the individual patient when a respiratory insufficiency finding is indicated.
46. A system according to claim 45, further comprising:
the feedback module performing an interactive dialogue between the individual patient and the patient care system regarding a medical condition of the individual patient.
47. A method for diagnosing and monitoring respiratory insufficiency using an automated collection and analysis patient care system, comprising:
storing a plurality of monitoring sets from a database, each monitoring set comprising recorded measures which each relate to patient information and comprise either medical device measures or derived measures calculable therefrom, the medical device measures having been recorded on a substantially continuous basis;
retrieving a plurality of the monitoring sets from the database;
defining a set of indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency and relating to a same type of patient information as at least one of the recorded measures; and
diagnosing a respiratory insufficiency finding, comprising:
determining a change in patient status by comparing at least one recorded measure to at least one other recorded measure with both recorded measures relating to the same type of patient information; and
comparing each patient status change to the indicator threshold corresponding to the same type of patient information as the recorded measures which were compared.
48. A method according to claim 47, wherein the device measures are recorded by at least one of a medical device adapted to be implanted in an individual patient and an external medical device proximal to the individual patient when the device measures are recorded.
49. A method according to claim 47, wherein each of the monitoring sets comprises recorded measures relating to patient information solely for the individual patient, further comprising:
retrieving each monitoring set from a patient care record for the individual patient; and
obtaining the at least one recorded measure and the at least one other recorded measure from the retrieved monitoring sets.
50. A method according to claim 47, wherein each of the monitoring sets comprises recorded measures relating to patient information for a peer group of patients to which the individual patient belongs, further comprising:
retrieving at least one monitoring set from a patient care record for the individual patient;
retrieving at least one other monitoring set from a patient care record in the same patient peer group; and
obtaining the at least one recorded measure from the at least one monitoring set and the at least one other recorded measure from the at least one other monitoring set.
51. A method according to claim 47, wherein each of the monitoring sets comprises recorded measures relating to patient information for the general population of patients, further comprising:
retrieving at least one monitoring set from a patient care record for the individual patient;
retrieving at least one other monitoring set from a patient care record in the overall patient population; and
obtaining the at least one recorded measure from the at least one monitoring set and the at least one other recorded measure from the at least one other monitoring set.
52. A method according to claim 47, further comprising:
retrieving a reference baseline comprising recorded measures which each relate to patient information recorded by the medical device adapted to be implanted during an initial time period and comprise either device measures recorded by the medical device adapted to be implanted or derived measures calculable therefrom; and
obtaining at least one of the at least one recorded measure and the at least one other recorded measure from the retrieved reference baseline.
53. A method according to claim 52, wherein the reference baseline comprises recorded measures relating to patient information for one of the individual patients solely, a peer group of patients to which the individual patient belongs, and a general population of patients.
54. A method according to claim 47, wherein the indicator thresholds relate to reduced exercise capacity selected from the group comprising decreased cardiac output, decreased mixed venous oxygen score, decreased patient activity score and decreased exercise tolerance.
55. A method according to claim 47, wherein the indicator thresholds relate to respiratory distress selected from the group comprising a spike in patient activity score, a spike in pulmonary artery pressure, a spike in right ventricular pressure, a spike in transthoracic impedance, increased respiratory rate, increased minute ventilation, increased temperature, decreased QT interval, decreased arterial oxygen and decreased arterial carbon dioxide.
56. A method according to claim 47, the operation of comparing each patient status change further comprising:
grading the comparisons between each patient status change and corresponding indicator threshold on a fixed scale based on a degree of deviation from the indicator threshold; and
determining an overall patient status change by performing a summation over the individual graded comparisons.
57. A method according to claim 47, the operation of comparing each patient status change further comprising:
determining probabilistic weightings of the comparisons between each patient status change and corresponding indicator threshold based on a statistical deviation and trends via linear fits from the indicator threshold; and
determining an overall patient status change by performing a summation over the individual graded comparisons.
58. A method according to claim 47, wherein each monitoring set further comprises quality of life and symptom measures recorded by the individual patient, the operation of diagnosing a respiratory insufficiency finding further comprising:
determining a change in patient status by comparing at least one recorded quality of life measure to at least one other corresponding recorded quality of life measure; and
incorporating each patient status change in quality of life into the respiratory insufficiency finding to either refute or support the diagnosis.
59. A method according to claim 47, further comprising:
defining a set of further indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure used to detect a pathophysiology indicative of diseases other than respiratory insufficiency; and
diagnosing a finding of the disease other than respiratory insufficiency, comprising comparing each patient status change to each such further indicator threshold corresponding to the same type of patient information as the at least one recorded measure and the at least one other recorded measure.
60. A method according to claim 47, further comprising:
defining a set of stickiness indicators, each indicator threshold corresponding to a temporal limit related to a course of patient care; and
comparing a time span between each patient status change for each recorded measure to the stickiness indicator corresponding to the same type of patient information as the recorded measure being compared.
61. A method according to claim 47, further comprising:
providing automated feedback to the individual patient when a respiratory insufficiency finding is indicated.
62. A method according to claim 61, further comprising:
performing an interactive dialogue between the individual patient and the patient care system regarding a medical condition of the individual patient.
63. A computer-readable storage medium holding code for diagnosing and monitoring respiratory insufficiency using an automated collection and analysis patient care system, comprising:
code for storing a plurality of monitoring sets from a database, each monitoring set comprising recorded measures which each relate to patient information and comprise either medical device measures or derived measures calculable therefrom, the medical device measures having been recorded on a substantially continuous basis;
code for retrieving a plurality of the monitoring sets from the database;
code for defining a set of indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of respiratory insufficiency and relating to a same type of patient information as at least one of the recorded measures; and
code for diagnosing a respiratory insufficiency finding, comprising:
code for determining a change in patient status by comparing at least one recorded measure to at least one other recorded measure with both recorded measures relating to the same type of patient information; and
code for comparing each patient status change to the indicator threshold corresponding to the same type of patient information as the recorded measures which were compared.
64. A storage medium according to claim 63, wherein each of the monitoring sets comprises recorded measures relating to patient information solely for the individual patient, further comprising:
code for retrieving each monitoring set from a patient care record for the individual patient; and
code for obtaining the at least one recorded measure and the at least one other recorded measure from the retrieved monitoring sets.
65. A storage medium according to claim 63, wherein each of the monitoring sets comprises recorded measures relating to patient information for a peer group of patients to which the individual patient belongs, further comprising:
code for retrieving at least one monitoring set from a patient care record for the individual patient;
code for retrieving at least one other monitoring set from a patient care record in the same patient peer group; and
code for obtaining the at least one recorded measure from the at least one monitoring set and the at least one other recorded measure from the at least one other monitoring set.
66. A storage medium according to claim 63, wherein each of the monitoring sets comprises recorded measures relating to patient information for the general population of patients, further comprising:
code for retrieving at least one monitoring set from a patient care record for the individual patient;
code for retrieving at least one other monitoring set from a patient care record in the overall patient population; and
code for obtaining the at least one recorded measure from the at least one monitoring set and the at least one other recorded measure from the at least one other monitoring set.
67. A storage medium according to claim 63, further comprising:
code for retrieving a reference baseline comprising recorded measures which each relate to patient information recorded by the medical device adapted to be implanted during an initial time period and comprise either device measures recorded by the medical device adapted to be implanted or derived measures calculable therefrom; and
code for obtaining at least one of the at least one recorded measure and the at least one other recorded measure from the retrieved reference baseline.
68. A storage medium according to claim 63, the operation of comparing each patient status change further comprising:
code for grading the comparisons between each patient status change and corresponding indicator threshold on a fixed scale based on a degree of deviation from the indicator threshold; and
code for determining an overall patient status change by performing a summation over the individual graded comparisons.
69. A storage medium according to claim 63, the operation of comparing each patient status change further comprising:
code for determining probabilistic weightings of the comparisons between each patient status change and corresponding indicator threshold based on a statistical deviation and trends via linear fits from the indicator threshold; and
code for determining an overall patient status change by performing a summation over the individual graded comparisons.
70. A storage medium according to claim 63, wherein each monitoring set further comprises quality of life and symptom measures recorded by the individual patient, the operation of diagnosing a respiratory insufficiency finding further comprising:
code for determining a change in patient status by comparing at least one recorded quality of life measure to at least one other corresponding recorded quality of life measure; and
code for incorporating each patient status change in quality of life into the respiratory insufficiency finding to either refute or support the diagnosis.
71. A storage medium according to claim 63, further comprising:
code for defining a set of further indicator thresholds, each indicator threshold corresponding to a quantifiable physiological measure used to detect a pathophysiology indicative of diseases other than respiratory insufficiency; and
code for diagnosing a finding of the disease other than respiratory insufficiency, comprising comparing each patient status change to each such further indicator threshold corresponding to the same type of patient information as the at least one recorded measure and the at least one other recorded measure.
72. A storage medium according to claim 63, further comprising:
code for defining a set of stickiness indicators, each indicator threshold corresponding to a temporal limit related to a course of patient care; and
code for comparing a time span between each patient status change for each recorded measure to the stickiness indicator corresponding to the same type of patient information as the recorded measure being compared.
73. A storage medium according to claim 63, further comprising:
code for providing automated feedback to the individual patient when a respiratory insufficiency finding is indicated.
74. A storage medium according to claim 73, further comprising:
code for performing an interactive dialogue between the individual patient and the patient care system regarding a medical condition of the individual patient.
75. An automated patient care system for diagnosing and monitoring respiratory insufficiency, comprising:
a medical device regularly recording measures relating to at least one of monitoring reduced exercise capacity and respiratory distress;
a database maintaining information for an individual patient, comprising organizing a plurality of monitoring sets in a database, and storing the recorded measures for the individual patient on a substantially continuous basis into a monitoring set in the database;
a server evaluating at least one of respiratory insufficiency onset, progression, regression, and status quo, comprising:
a comparison module determining a patient status change by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to a same type of patient information; and
an analysis module testing each patient status change against an indicator threshold corresponding to the same type of patient information as the recorded measures which were compared, the indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of reduced exercise capacity and respiratory distress.
76. A system according to claim 75, wherein the indicator thresholds relating to reduced exercise capacity selected from the group comprising decreased cardiac output, decreased mixed venous oxygen score, decreased patient activity score and decreased exercise tolerance.
77. A system according to claim 75, wherein the indicator thresholds relating to respiratory distress selected from the group comprising a spike in patient activity score, a spike in pulmonary artery pressure, a spike in right ventricular pressure, a spike in transthoracic impedance, increased respiratory rate, increased minute ventilation, increased temperature, decreased QT interval, decreased arterial oxygen and decreased arterial carbon dioxide.
78. A method for diagnosing and monitoring respiratory insufficiency in an automated patient care system, comprising:
regularly recording measures relating to at least one of monitoring reduced exercise capacity and respiratory distress;
maintaining information for an individual patient, comprising:
organizing a plurality of monitoring sets in a database;
storing the recorded measures for the individual patient on a substantially continuous basis into a monitoring set in the database;
periodically retrieving a plurality of the monitoring sets from the database;
evaluating at least one of respiratory insufficiency onset, progression, regression, and status quo, comprising:
determining a patient status change by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to a same type of patient information; and
testing each patient status change against an indicator threshold corresponding to the same type of patient information as the recorded measures which were compared, the indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of reduced exercise capacity and respiratory distress.
79. A method according to claim 78, wherein the indicator thresholds relating to reduced exercise capacity selected from the group comprising decreased cardiac output, decreased mixed venous oxygen score, decreased patient activity score and decreased exercise tolerance.
80. A method according to claim 78, wherein the indicator thresholds relating to respiratory distress selected from the group comprising a spike in patient activity score, a spike in pulmonary artery pressure, a spike in right ventricular pressure, a spike in transthoracic impedance, increased respiratory rate, increased minute ventilation, increased temperature, decreased QT interval, decreased arterial oxygen and decreased arterial carbon dioxide.
81. A computer-readable storage medium holding code for diagnosing and monitoring respiratory insufficiency in an automated patient care system, comprising:
code for regularly recording measures relating to at least one of monitoring reduced exercise capacity and respiratory distress;
code for maintaining information for an individual patient, comprising:
code for organizing a plurality of monitoring sets in a database;
code for storing the recorded measures for the individual patient on a substantially continuous basis into a monitoring set in the database;
code for periodically retrieving a plurality of the monitoring sets from the database;
code for evaluating at least one of respiratory insufficiency onset, progression, regression, and status quo, comprising:
code for determining a patient status change by comparing at least one recorded measure from each of the monitoring sets to at least one other recorded measure with both recorded measures relating to a same type of patient information; and
code for testing each patient status change against an indicator threshold corresponding to the same type of patient information as the recorded measures which were compared, the indicator threshold corresponding to a quantifiable physiological measure of a pathophysiology indicative of reduced exercise capacity and respiratory distress.
US10/646,243 1999-11-16 2003-08-22 System and method for diagnosing and monitoring respiratory insufficiency for automated remote patient care Expired - Lifetime US7258670B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/646,243 US7258670B2 (en) 1999-11-16 2003-08-22 System and method for diagnosing and monitoring respiratory insufficiency for automated remote patient care
US11/879,654 US8231539B2 (en) 1999-11-16 2007-07-17 Automated patient care system and method for diagnosing and monitoring respiratory insufficiency
US11/894,302 US8231540B2 (en) 1999-11-16 2007-08-20 System and method for managing respiratory insufficiency in conjunction with heart failure assessment

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/442,125 US6398728B1 (en) 1999-11-16 1999-11-16 Automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof
US10/152,207 US7207945B2 (en) 1999-11-16 2002-05-20 System and method for providing diagnosis and monitoring of respiratory insufficiency for use in automated patient care
US10/646,243 US7258670B2 (en) 1999-11-16 2003-08-22 System and method for diagnosing and monitoring respiratory insufficiency for automated remote patient care

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/152,207 Continuation US7207945B2 (en) 1999-11-16 2002-05-20 System and method for providing diagnosis and monitoring of respiratory insufficiency for use in automated patient care

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/879,654 Division US8231539B2 (en) 1999-11-16 2007-07-17 Automated patient care system and method for diagnosing and monitoring respiratory insufficiency
US11/894,302 Continuation US8231540B2 (en) 1999-11-16 2007-08-20 System and method for managing respiratory insufficiency in conjunction with heart failure assessment

Publications (2)

Publication Number Publication Date
US20040039263A1 true US20040039263A1 (en) 2004-02-26
US7258670B2 US7258670B2 (en) 2007-08-21

Family

ID=23755639

Family Applications (8)

Application Number Title Priority Date Filing Date
US09/442,125 Expired - Lifetime US6398728B1 (en) 1999-11-16 1999-11-16 Automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof
US10/152,207 Expired - Fee Related US7207945B2 (en) 1999-11-16 2002-05-20 System and method for providing diagnosis and monitoring of respiratory insufficiency for use in automated patient care
US10/646,243 Expired - Lifetime US7258670B2 (en) 1999-11-16 2003-08-22 System and method for diagnosing and monitoring respiratory insufficiency for automated remote patient care
US11/691,414 Expired - Fee Related US7959574B2 (en) 1999-11-16 2007-03-26 System and method for analyzing a patient status for respiratory insufficiency for use in automated patient care
US11/789,387 Expired - Lifetime US8747329B2 (en) 1999-11-16 2007-04-23 System and method for managing respiratory insufficiency through remote patient care
US11/789,388 Abandoned US20070203415A1 (en) 1999-11-16 2007-04-23 System and method for determining edema through remote patient monitoring
US11/879,654 Expired - Fee Related US8231539B2 (en) 1999-11-16 2007-07-17 Automated patient care system and method for diagnosing and monitoring respiratory insufficiency
US11/894,302 Expired - Fee Related US8231540B2 (en) 1999-11-16 2007-08-20 System and method for managing respiratory insufficiency in conjunction with heart failure assessment

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/442,125 Expired - Lifetime US6398728B1 (en) 1999-11-16 1999-11-16 Automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof
US10/152,207 Expired - Fee Related US7207945B2 (en) 1999-11-16 2002-05-20 System and method for providing diagnosis and monitoring of respiratory insufficiency for use in automated patient care

Family Applications After (5)

Application Number Title Priority Date Filing Date
US11/691,414 Expired - Fee Related US7959574B2 (en) 1999-11-16 2007-03-26 System and method for analyzing a patient status for respiratory insufficiency for use in automated patient care
US11/789,387 Expired - Lifetime US8747329B2 (en) 1999-11-16 2007-04-23 System and method for managing respiratory insufficiency through remote patient care
US11/789,388 Abandoned US20070203415A1 (en) 1999-11-16 2007-04-23 System and method for determining edema through remote patient monitoring
US11/879,654 Expired - Fee Related US8231539B2 (en) 1999-11-16 2007-07-17 Automated patient care system and method for diagnosing and monitoring respiratory insufficiency
US11/894,302 Expired - Fee Related US8231540B2 (en) 1999-11-16 2007-08-20 System and method for managing respiratory insufficiency in conjunction with heart failure assessment

Country Status (4)

Country Link
US (8) US6398728B1 (en)
EP (1) EP1102198A3 (en)
AU (1) AU751511B2 (en)
CA (1) CA2325655A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040073093A1 (en) * 2002-10-11 2004-04-15 Cardiac Pacemakers, Inc. Methods and devices for detection of context when addressing a medical condition of a patient
US20050242942A1 (en) * 2004-04-29 2005-11-03 Zoe Medical Incorporated Audible alarm enhancement for monitoring systems
US20060031094A1 (en) * 2004-08-06 2006-02-09 Medtronic Minimed, Inc. Medical data management system and process
US20060200007A1 (en) * 2005-03-03 2006-09-07 Cardiac Pacemakers, Inc. Automatic etiology sequencing system
US20070073171A1 (en) * 2005-09-28 2007-03-29 Cho Yong K Methods for detecting and monitoring sleep disordered breathing using an implantable medical device
US20070129641A1 (en) * 2005-12-01 2007-06-07 Sweeney Robert J Posture estimation at transitions between states
WO2008064725A1 (en) * 2006-12-01 2008-06-05 Dräger Medical AG & Co. KG Medical system
WO2011137019A1 (en) * 2010-04-30 2011-11-03 Nellcor Puritan Bennett Llc Method for respiration rate and blood pressure alarm management
US20120110054A1 (en) * 2009-04-17 2012-05-03 Arkray, Inc. Information Provision System, Information Provision Method, Program, and Server Device
US8870791B2 (en) 2006-03-23 2014-10-28 Michael E. Sabatino Apparatus for acquiring, processing and transmitting physiological sounds
US20150148698A1 (en) * 2008-09-12 2015-05-28 Paul LeLorier Method of detecting and predicting neurocardiogenic syncope
USRE49122E1 (en) * 2008-09-12 2022-07-05 Physiovoyance, Llc Method of detecting and predicting neurocardiogenic syncope

Families Citing this family (530)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020173643A1 (en) * 1995-04-14 2002-11-21 Kappes John C. Fusion protein delivery system and uses thereof
USD386557S (en) * 1996-06-10 1997-11-18 David Thompson Fishing rod holder
WO1998029790A2 (en) 1996-12-30 1998-07-09 Imd Soft Ltd. Medical information system
US7429243B2 (en) * 1999-06-03 2008-09-30 Cardiac Intelligence Corporation System and method for transacting an automated patient communications session
US7134996B2 (en) * 1999-06-03 2006-11-14 Cardiac Intelligence Corporation System and method for collection and analysis of patient information for automated remote patient care
US6270457B1 (en) * 1999-06-03 2001-08-07 Cardiac Intelligence Corp. System and method for automated collection and analysis of regularly retrieved patient information for remote patient care
US6312378B1 (en) * 1999-06-03 2001-11-06 Cardiac Intelligence Corporation System and method for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care
US7467094B2 (en) * 1999-06-23 2008-12-16 Visicu, Inc. System and method for accounting and billing patients in a hospital environment
US7650291B2 (en) * 1999-06-23 2010-01-19 Koninklijke Philips Electronics N.V. Video visitation system and method for a health care location
US8175895B2 (en) * 1999-06-23 2012-05-08 Koninklijke Philips Electronics N.V. Remote command center for patient monitoring
US7395216B2 (en) 1999-06-23 2008-07-01 Visicu, Inc. Using predictive models to continuously update a treatment plan for a patient in a health care location
US7411509B2 (en) * 1999-06-23 2008-08-12 Visicu, Inc. System and method for observing patients in geographically dispersed health care locations
US7315825B2 (en) * 1999-06-23 2008-01-01 Visicu, Inc. Rules-based patient care system for use in healthcare locations
US7475019B2 (en) * 1999-11-18 2009-01-06 Visicu, Inc. System and method for physician note creation and management
US7454359B2 (en) * 1999-06-23 2008-11-18 Visicu, Inc. System and method for displaying a health status of hospitalized patients
US7256708B2 (en) * 1999-06-23 2007-08-14 Visicu, Inc. Telecommunications network for remote patient monitoring
US7433827B2 (en) 1999-06-23 2008-10-07 Visicu, Inc. System and method for displaying a health status of hospitalized patients
US7321862B2 (en) * 1999-06-23 2008-01-22 Visicu, Inc. System and method for patient-worn monitoring of patients in geographically dispersed health care locations
US7454360B2 (en) * 1999-06-23 2008-11-18 Visicu, Inc. Order evaluation system for use in a healthcare location
US7991625B2 (en) * 1999-06-23 2011-08-02 Koninklijke Philips Electronics N.V. System for providing expert care to a basic care medical facility from a remote location
CA2314513A1 (en) * 1999-07-26 2001-01-26 Gust H. Bardy System and method for providing normalized voice feedback from an individual patient in an automated collection and analysis patient care system
US6221011B1 (en) * 1999-07-26 2001-04-24 Cardiac Intelligence Corporation System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system
CA2314517A1 (en) * 1999-07-26 2001-01-26 Gust H. Bardy System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system
US6398728B1 (en) * 1999-11-16 2002-06-04 Cardiac Intelligence Corporation Automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof
US6440066B1 (en) * 1999-11-16 2002-08-27 Cardiac Intelligence Corporation Automated collection and analysis patient care system and method for ordering and prioritizing multiple health disorders to identify an index disorder
US6336903B1 (en) * 1999-11-16 2002-01-08 Cardiac Intelligence Corp. Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof
US6411840B1 (en) * 1999-11-16 2002-06-25 Cardiac Intelligence Corporation Automated collection and analysis patient care system and method for diagnosing and monitoring the outcomes of atrial fibrillation
US8369937B2 (en) 1999-11-16 2013-02-05 Cardiac Pacemakers, Inc. System and method for prioritizing medical conditions
US6400986B1 (en) * 2000-04-10 2002-06-04 Cardiac Pacemakers, Inc. Adaptive anti-tachycardia therapy apparatus and method
WO2001086575A2 (en) 2000-05-05 2001-11-15 Hill-Rom Services, Inc. Patient point of care computer system
CA2408258A1 (en) 2000-05-05 2001-11-15 Hill Rom Services, Inc. Hospital monitoring and control system and method
US6847892B2 (en) * 2001-10-29 2005-01-25 Digital Angel Corporation System for localizing and sensing objects and providing alerts
US7198603B2 (en) * 2003-04-14 2007-04-03 Remon Medical Technologies, Inc. Apparatus and methods using acoustic telemetry for intrabody communications
US20020116221A1 (en) * 2000-10-26 2002-08-22 Fields Martin J. Chronic illness treatment system and method
US8147419B2 (en) 2000-12-07 2012-04-03 Baruch Shlomo Krauss Automated interpretive medical care system and methodology
CA2430775A1 (en) 2000-12-11 2002-06-20 Resmed Ltd. Method and apparatus for stroke patient treatment
EP1374194A2 (en) 2001-03-30 2004-01-02 Hill-Rom Services, Inc. Hospital bed and network system
US7526112B2 (en) * 2001-04-30 2009-04-28 Chase Medical, L.P. System and method for facilitating cardiac intervention
US7327862B2 (en) * 2001-04-30 2008-02-05 Chase Medical, L.P. System and method for facilitating cardiac intervention
AU2002312565A1 (en) * 2001-06-19 2003-01-02 University Of Southern California Therapeutic decisions systems and method using stochastic techniques
EP1271384A1 (en) * 2001-06-28 2003-01-02 Boehringer Ingelheim International GmbH System and method for assisting in diagnosis, therapy and/or monitoring of a funtional lung disease
US7340303B2 (en) * 2001-09-25 2008-03-04 Cardiac Pacemakers, Inc. Evoked response sensing for ischemia detection
US7383088B2 (en) * 2001-11-07 2008-06-03 Cardiac Pacemakers, Inc. Centralized management system for programmable medical devices
US6909916B2 (en) * 2001-12-20 2005-06-21 Cardiac Pacemakers, Inc. Cardiac rhythm management system with arrhythmia classification and electrode selection
US6666826B2 (en) * 2002-01-04 2003-12-23 Cardiac Pacemakers, Inc. Method and apparatus for measuring left ventricular pressure
US20050144042A1 (en) * 2002-02-19 2005-06-30 David Joffe Associated systems and methods for managing biological data and providing data interpretation tools
US8043213B2 (en) * 2002-12-18 2011-10-25 Cardiac Pacemakers, Inc. Advanced patient management for triaging health-related data using color codes
US8391989B2 (en) 2002-12-18 2013-03-05 Cardiac Pacemakers, Inc. Advanced patient management for defining, identifying and using predetermined health-related events
US7468032B2 (en) * 2002-12-18 2008-12-23 Cardiac Pacemakers, Inc. Advanced patient management for identifying, displaying and assisting with correlating health-related data
US7043305B2 (en) 2002-03-06 2006-05-09 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
US7983759B2 (en) * 2002-12-18 2011-07-19 Cardiac Pacemakers, Inc. Advanced patient management for reporting multiple health-related parameters
US20040122487A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management with composite parameter indices
US20040122294A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management with environmental data
US20040122486A1 (en) * 2002-12-18 2004-06-24 Stahmann Jeffrey E. Advanced patient management for acquiring, trending and displaying health-related parameters
US7113825B2 (en) 2002-05-03 2006-09-26 Cardiac Pacemakers, Inc. Method and apparatus for detecting acoustic oscillations in cardiac rhythm
US20040030581A1 (en) * 2002-06-12 2004-02-12 Samuel Leven Heart monitoring device
AU2003298552B2 (en) * 2002-08-19 2010-02-18 Stout Solutions, Llc. Bio-surveillance system
US7072711B2 (en) * 2002-11-12 2006-07-04 Cardiac Pacemakers, Inc. Implantable device for delivering cardiac drug therapy
US20040103001A1 (en) * 2002-11-26 2004-05-27 Mazar Scott Thomas System and method for automatic diagnosis of patient health
US7189204B2 (en) 2002-12-04 2007-03-13 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
US7252640B2 (en) * 2002-12-04 2007-08-07 Cardiac Pacemakers, Inc. Detection of disordered breathing
US20050080348A1 (en) * 2003-09-18 2005-04-14 Stahmann Jeffrey E. Medical event logbook system and method
US6949075B2 (en) * 2002-12-27 2005-09-27 Cardiac Pacemakers, Inc. Apparatus and method for detecting lung sounds using an implanted device
US20040133079A1 (en) * 2003-01-02 2004-07-08 Mazar Scott Thomas System and method for predicting patient health within a patient management system
WO2004068406A2 (en) 2003-01-30 2004-08-12 Chase Medical, L.P. A method and system for image processing and contour assessment
US8620678B2 (en) * 2003-01-31 2013-12-31 Imd Soft Ltd. Medical information query system
US7848935B2 (en) * 2003-01-31 2010-12-07 I.M.D. Soft Ltd. Medical information event manager
MXPA05008845A (en) * 2003-02-20 2006-02-17 Pneumoflex Systems Llc Apparatus for evaluating a patient's laryngeal cough reflex and associated methods.
US7979122B2 (en) * 2003-04-11 2011-07-12 Cardiac Pacemakers, Inc. Implantable sudden cardiac death prevention device with reduced programmable feature set
US20040215240A1 (en) * 2003-04-11 2004-10-28 Lovett Eric G. Reconfigurable subcutaneous cardiac device
US20040230282A1 (en) * 2003-04-11 2004-11-18 Cates Adam W. Acute and chronic fixation for subcutaneous electrodes
US20040230230A1 (en) * 2003-04-11 2004-11-18 Lindstrom Curtis Charles Methods and systems involving subcutaneous electrode positioning relative to a heart
US7218966B2 (en) * 2003-04-11 2007-05-15 Cardiac Pacemakers, Inc. Multi-parameter arrhythmia discrimination
US7389138B2 (en) * 2003-04-11 2008-06-17 Cardiac Pacemakers, Inc. Electrode placement determination for subcutaneous cardiac monitoring and therapy
US7555335B2 (en) * 2003-04-11 2009-06-30 Cardiac Pacemakers, Inc. Biopotential signal source separation using source impedances
US7570997B2 (en) * 2003-04-11 2009-08-04 Cardiac Pacemakers, Inc. Subcutaneous cardiac rhythm management with asystole prevention therapy
US20050004615A1 (en) * 2003-04-11 2005-01-06 Sanders Richard S. Reconfigurable implantable cardiac monitoring and therapy delivery device
US7493175B2 (en) * 2003-04-11 2009-02-17 Cardiac Pacemakers, Inc. Subcutaneous lead with tined fixation
US7236819B2 (en) 2003-04-11 2007-06-26 Cardiac Pacemakers, Inc. Separation of a subcutaneous cardiac signal from a plurality of composite signals
US20040230229A1 (en) * 2003-04-11 2004-11-18 Lovett Eric G. Hybrid transthoracic/intrathoracic cardiac stimulation devices and methods
US7865233B2 (en) * 2003-04-11 2011-01-04 Cardiac Pacemakers, Inc. Subcutaneous cardiac signal discrimination employing non-electrophysiologic signal
US7349742B2 (en) * 2003-04-11 2008-03-25 Cardiac Pacemakers, Inc. Expandable fixation elements for subcutaneous electrodes
US7302294B2 (en) * 2003-04-11 2007-11-27 Cardiac Pacemakers, Inc. Subcutaneous cardiac sensing and stimulation system employing blood sensor
US7499758B2 (en) 2003-04-11 2009-03-03 Cardiac Pacemakers, Inc. Helical fixation elements for subcutaneous electrodes
US20040230456A1 (en) * 2003-05-14 2004-11-18 Lozier Luke R. System for identifying candidates for ICD implantation
JP2007516011A (en) * 2003-05-16 2007-06-21 シャピロ、マーク Data entry system for endoscopy
US7477932B2 (en) 2003-05-28 2009-01-13 Cardiac Pacemakers, Inc. Cardiac waveform template creation, maintenance and use
US7539803B2 (en) * 2003-06-13 2009-05-26 Agere Systems Inc. Bi-directional interface for low data rate application
US7289761B2 (en) * 2003-06-23 2007-10-30 Cardiac Pacemakers, Inc. Systems, devices, and methods for selectively preventing data transfer from a medical device
US7468040B2 (en) * 2003-09-18 2008-12-23 Cardiac Pacemakers, Inc. Methods and systems for implantably monitoring external breathing therapy
US20050142070A1 (en) * 2003-09-18 2005-06-30 Hartley Jesse W. Methods and systems for assessing pulmonary disease with drug therapy control
EP2008581B1 (en) 2003-08-18 2011-08-17 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
US7967756B2 (en) 2003-09-18 2011-06-28 Cardiac Pacemakers, Inc. Respiratory therapy control based on cardiac cycle
US20050107838A1 (en) * 2003-09-18 2005-05-19 Lovett Eric G. Subcutaneous cardiac rhythm management with disordered breathing detection and treatment
US7616988B2 (en) * 2003-09-18 2009-11-10 Cardiac Pacemakers, Inc. System and method for detecting an involuntary muscle movement disorder
US8251061B2 (en) 2003-09-18 2012-08-28 Cardiac Pacemakers, Inc. Methods and systems for control of gas therapy
US7678061B2 (en) 2003-09-18 2010-03-16 Cardiac Pacemakers, Inc. System and method for characterizing patient respiration
US8606356B2 (en) 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
US7336996B2 (en) * 2003-09-18 2008-02-26 Cardiac Pacemakers, Inc. Rate regularization of cardiac pacing for disordered breathing therapy
US7887493B2 (en) 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US7396333B2 (en) * 2003-08-18 2008-07-08 Cardiac Pacemakers, Inc. Prediction of disordered breathing
US7970470B2 (en) * 2003-09-18 2011-06-28 Cardiac Pacemakers, Inc. Diagnosis and/or therapy using blood chemistry/expired gas parameter analysis
US7572225B2 (en) * 2003-09-18 2009-08-11 Cardiac Pacemakers, Inc. Sleep logbook
US7532934B2 (en) * 2003-09-18 2009-05-12 Cardiac Pacemakers, Inc. Snoring detection system and method
US7720541B2 (en) * 2003-08-18 2010-05-18 Cardiac Pacemakers, Inc. Adaptive therapy for disordered breathing
US7668591B2 (en) 2003-09-18 2010-02-23 Cardiac Pacemakers, Inc. Automatic activation of medical processes
US8002553B2 (en) * 2003-08-18 2011-08-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
US7664546B2 (en) * 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Posture detection system and method
US7680537B2 (en) * 2003-08-18 2010-03-16 Cardiac Pacemakers, Inc. Therapy triggered by prediction of disordered breathing
US7510531B2 (en) * 2003-09-18 2009-03-31 Cardiac Pacemakers, Inc. System and method for discrimination of central and obstructive disordered breathing events
US8192376B2 (en) 2003-08-18 2012-06-05 Cardiac Pacemakers, Inc. Sleep state classification
US7591265B2 (en) 2003-09-18 2009-09-22 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US7469697B2 (en) * 2003-09-18 2008-12-30 Cardiac Pacemakers, Inc. Feedback system and method for sleep disordered breathing therapy
US7757690B2 (en) * 2003-09-18 2010-07-20 Cardiac Pacemakers, Inc. System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
US7662101B2 (en) 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
US7364547B2 (en) * 2003-09-18 2008-04-29 Cardiac Pacemakers, Inc. Use of external respiratory therapy device to detect cardiac electrical activity
WO2005022692A2 (en) 2003-08-21 2005-03-10 Hill-Rom Services, Inc. Plug and receptacle having wired and wireless coupling
US7320675B2 (en) 2003-08-21 2008-01-22 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure
US7252090B2 (en) * 2003-09-15 2007-08-07 Medtronic, Inc. Selection of neurostimulator parameter configurations using neural network
US7239926B2 (en) * 2003-09-15 2007-07-03 Medtronic, Inc. Selection of neurostimulator parameter configurations using genetic algorithms
US7617002B2 (en) * 2003-09-15 2009-11-10 Medtronic, Inc. Selection of neurostimulator parameter configurations using decision trees
US7184837B2 (en) * 2003-09-15 2007-02-27 Medtronic, Inc. Selection of neurostimulator parameter configurations using bayesian networks
US20050075832A1 (en) * 2003-09-22 2005-04-07 Ikeguchi Edward F. System and method for continuous data analysis of an ongoing clinical trial
US20060247693A1 (en) 2005-04-28 2006-11-02 Yanting Dong Non-captured intrinsic discrimination in cardiac pacing response classification
US7319900B2 (en) 2003-12-11 2008-01-15 Cardiac Pacemakers, Inc. Cardiac response classification using multiple classification windows
US8521284B2 (en) 2003-12-12 2013-08-27 Cardiac Pacemakers, Inc. Cardiac response classification using multisite sensing and pacing
US7774064B2 (en) 2003-12-12 2010-08-10 Cardiac Pacemakers, Inc. Cardiac response classification using retriggerable classification windows
WO2005067375A2 (en) * 2004-01-09 2005-07-28 Imd-Soft, Ltd. Clinical data database system and method for a critical care and/or hospital environment
US7333643B2 (en) * 2004-01-30 2008-02-19 Chase Medical, L.P. System and method for facilitating cardiac intervention
US8403865B2 (en) 2004-02-05 2013-03-26 Earlysense Ltd. Prediction and monitoring of clinical episodes
US8942779B2 (en) 2004-02-05 2015-01-27 Early Sense Ltd. Monitoring a condition of a subject
US8491492B2 (en) 2004-02-05 2013-07-23 Earlysense Ltd. Monitoring a condition of a subject
US7077810B2 (en) 2004-02-05 2006-07-18 Earlysense Ltd. Techniques for prediction and monitoring of respiration-manifested clinical episodes
US7333845B2 (en) * 2004-02-06 2008-02-19 Wake Forest University Health Sciences Non-invasive imaging for determination of global tissue characteristics
US7747308B2 (en) * 2004-02-06 2010-06-29 Wake Forest University Health Sciences Non-invasive systems and methods for the determination of cardiac injury using a characterizing portion of a voxel histogram
US7726306B2 (en) * 2004-02-20 2010-06-01 Pneumoflex Systems, Llc Intra-oral nebulizer with rainfall chamber
US7712466B2 (en) * 2004-02-20 2010-05-11 Pneumoflex Systems, Llc Intra-oral nebulizer
US8109266B2 (en) 2004-02-20 2012-02-07 Pneumoflex Systems, Llc Nebulizer having flow meter function
US9022027B2 (en) 2004-02-20 2015-05-05 Pneumoflex Systems, Llc Nebulizer with intra-oral vibrating mesh
US20050192838A1 (en) * 2004-02-27 2005-09-01 Cardiac Pacemakers, Inc. Systems and methods for accessing and distributing medical information
US20050215884A1 (en) * 2004-02-27 2005-09-29 Greicius Michael D Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI
US20050192843A1 (en) * 2004-02-27 2005-09-01 Cardiac Pacemakers, Inc. Systems and methods for validating patient and medical devices information
US20050192649A1 (en) * 2004-02-27 2005-09-01 Cardiac Pacemakers, Inc. Systems and methods for providing variable medical information
US20050192837A1 (en) * 2004-02-27 2005-09-01 Cardiac Pacemakers, Inc. Systems and methods for uploading and distributing medical data sets
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7751894B1 (en) 2004-03-04 2010-07-06 Cardiac Pacemakers, Inc. Systems and methods for indicating aberrant behavior detected by an implanted medical device
US20050197588A1 (en) * 2004-03-04 2005-09-08 Scott Freeberg Sleep disordered breathing alert system
JP2005275890A (en) * 2004-03-25 2005-10-06 Nec Corp Presence information issuing device, system and program
US7801611B2 (en) * 2004-06-03 2010-09-21 Cardiac Pacemakers, Inc. System and method for providing communications between a physically secure programmer and an external device using a cellular network
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7596413B2 (en) * 2004-06-08 2009-09-29 Cardiac Pacemakers, Inc. Coordinated therapy for disordered breathing including baroreflex modulation
US7747323B2 (en) 2004-06-08 2010-06-29 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
US7706866B2 (en) 2004-06-24 2010-04-27 Cardiac Pacemakers, Inc. Automatic orientation determination for ECG measurements using multiple electrodes
US7319386B2 (en) 2004-08-02 2008-01-15 Hill-Rom Services, Inc. Configurable system for alerting caregivers
US7743151B2 (en) * 2004-08-05 2010-06-22 Cardiac Pacemakers, Inc. System and method for providing digital data communications over a wireless intra-body network
US7567841B2 (en) * 2004-08-20 2009-07-28 Cardiac Pacemakers, Inc. Method and apparatus for delivering combined electrical and drug therapies
US7647108B2 (en) * 2004-09-30 2010-01-12 Cardiac Pacemakers, Inc. Methods and systems for selection of cardiac pacing electrode configurations
US7228173B2 (en) * 2004-11-23 2007-06-05 Cardiac Pacemakers, Inc. Cardiac tachyarrhythmia therapy selection based on patient response information
US7277747B2 (en) * 2004-11-23 2007-10-02 Cardiac Pacemakers, Inc. Arrhythmia memory for tachyarrhythmia discrimination
US7917196B2 (en) * 2005-05-09 2011-03-29 Cardiac Pacemakers, Inc. Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes
US7933651B2 (en) * 2004-11-23 2011-04-26 Cardiac Pacemakers, Inc. Cardiac template generation based on patient response information
US7797036B2 (en) 2004-11-30 2010-09-14 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring for ischemia detection
US7894893B2 (en) * 2004-09-30 2011-02-22 Cardiac Pacemakers, Inc. Arrhythmia classification and therapy selection
US7509170B2 (en) 2005-05-09 2009-03-24 Cardiac Pacemakers, Inc. Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes
US7890159B2 (en) * 2004-09-30 2011-02-15 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring and tracking
US7457664B2 (en) 2005-05-09 2008-11-25 Cardiac Pacemakers, Inc. Closed loop cardiac resynchronization therapy using cardiac activation sequence information
US7805185B2 (en) * 2005-05-09 2010-09-28 Cardiac Pacemakers, In. Posture monitoring using cardiac activation sequences
US8150509B2 (en) * 2004-10-21 2012-04-03 Cardiac Pacemakers, Inc. Systems and methods for drug therapy enhancement using expected pharmacodynamic models
US20060089856A1 (en) * 2004-10-21 2006-04-27 Cardiac Pacemakers Integrated pharmaceutical dispensing and patient management monitoring
US20060094028A1 (en) * 2004-11-04 2006-05-04 Welch Allyn, Inc. Rapid diagnostic assay
US7418293B2 (en) * 2004-11-09 2008-08-26 Cardiac Pacemakers, Inc. Multiple pulse defibrillation for subcutaneous implantable cardiac devices
US7761162B2 (en) * 2004-12-13 2010-07-20 Cardiac Pacemakers, Inc. Capture verification with intrinsic response discrimination
US8229561B2 (en) * 2004-12-15 2012-07-24 Cardiac Pacemakers, Inc. Atrial retrograde management
US7908006B2 (en) * 2004-12-15 2011-03-15 Cardiac Pacemakers, Inc. Cardiac pacing response classification using an adaptable classification interval
US7587240B2 (en) 2004-12-15 2009-09-08 Cardiac Pacemakers, Inc. Atrial capture verification
US7930029B2 (en) 2004-12-15 2011-04-19 Cardiac Pacemakers, Inc. Template initialization for evoked response detection
US8818504B2 (en) 2004-12-16 2014-08-26 Cardiac Pacemakers Inc Leadless cardiac stimulation device employing distributed logic
US8204771B1 (en) 2004-12-16 2012-06-19 Cerner Innovation, Inc. Computerized method and system for updating a task list from an action item documentation view
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
SG123633A1 (en) * 2004-12-20 2006-07-26 Nanyang Polytechnic System and method for detecting of pulmonary diseases
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US7996072B2 (en) * 2004-12-21 2011-08-09 Cardiac Pacemakers, Inc. Positionally adaptable implantable cardiac device
JP2006185060A (en) * 2004-12-27 2006-07-13 Fujitsu Ltd Method for inputting password
US8273018B1 (en) 2004-12-28 2012-09-25 Cerner Innovation, Inc. Computerized method for establishing a communication between a bedside care location and a remote care location
US7612679B1 (en) 2004-12-28 2009-11-03 Cerner Innovation, Inc. Computerized method and system for providing alerts from a multi-patient display
US7680534B2 (en) 2005-02-28 2010-03-16 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US8652039B2 (en) * 2005-03-02 2014-02-18 Siemens Medical Solutions Usa, Inc. Guiding differential diagnosis through information maximization
US7761159B2 (en) * 2005-03-17 2010-07-20 Cardiac Pacemakers, Inc. Cardiac rhythm pacing rate selection for automatic capture threshold testing
US7818056B2 (en) * 2005-03-24 2010-10-19 Cardiac Pacemakers, Inc. Blending cardiac rhythm detection processes
EP1875248A2 (en) * 2005-03-29 2008-01-09 Inverness Medical Switzerland GmbH Device and method of monitoring a patient
US20090048500A1 (en) * 2005-04-20 2009-02-19 Respimetrix, Inc. Method for using a non-invasive cardiac and respiratory monitoring system
US7270633B1 (en) * 2005-04-22 2007-09-18 Cardiac Pacemakers, Inc. Ambulatory repeater for use in automated patient care and method thereof
US7392086B2 (en) 2005-04-26 2008-06-24 Cardiac Pacemakers, Inc. Implantable cardiac device and method for reduced phrenic nerve stimulation
US7337000B2 (en) 2005-04-28 2008-02-26 Cardiac Pacemakers Inc. Selection of cardiac signal features detected in multiple classification intervals for cardiac pacing response classification
US7499751B2 (en) * 2005-04-28 2009-03-03 Cardiac Pacemakers, Inc. Cardiac signal template generation using waveform clustering
US7574260B2 (en) 2005-04-28 2009-08-11 Cardiac Pacemakers, Inc. Adaptive windowing for cardiac waveform discrimination
US7392088B2 (en) * 2005-04-28 2008-06-24 Cardiac Pacemakers, Inc. Capture detection for multi-chamber pacing
US7316846B2 (en) * 2005-04-28 2008-01-08 Ppg Industries Ohio, Inc. Hard coat compositions with acid functional organosiloxane polyol
US20100063840A1 (en) * 2005-05-03 2010-03-11 Hoyme Kenneth P System and method for managing coordination of collected patient data in an automated patient management system
US20060253300A1 (en) * 2005-05-03 2006-11-09 Somberg Benjamin L System and method for managing patient triage in an automated patient management system
US7630755B2 (en) * 2005-05-04 2009-12-08 Cardiac Pacemakers Inc. Syncope logbook and method of using same
US8391990B2 (en) 2005-05-18 2013-03-05 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
US7457666B2 (en) * 2005-05-25 2008-11-25 Cardiac Pacemakers, Inc. Retrograde atrial sensing for identifying sub-threshold atrial pacing
US7922669B2 (en) 2005-06-08 2011-04-12 Cardiac Pacemakers, Inc. Ischemia detection using a heart sound sensor
US9265949B2 (en) * 2005-06-28 2016-02-23 Cardiac Pacemakers, Inc. Method and apparatus for controlling cardiac therapy based on electromechanical timing
US7529578B2 (en) * 2005-07-12 2009-05-05 Cardiac Pacemakers, Inc. Multi channel approach to capture verification
US7471983B2 (en) 2005-07-19 2008-12-30 Cardiac Pacemakers, Inc. Pacing output determination based on selected capture threshold values
US7908001B2 (en) * 2005-08-23 2011-03-15 Cardiac Pacemakers, Inc. Automatic multi-level therapy based on morphologic organization of an arrhythmia
US20070055115A1 (en) * 2005-09-08 2007-03-08 Jonathan Kwok Characterization of sleep disorders using composite patient data
US7927284B2 (en) * 2005-09-16 2011-04-19 Cardiac Pacemakers, Inc. Quantifying hemodynamic response to drug therapy using implantable sensor
US7775983B2 (en) * 2005-09-16 2010-08-17 Cardiac Pacemakers, Inc. Rapid shallow breathing detection for use in congestive heart failure status determination
US7731663B2 (en) * 2005-09-16 2010-06-08 Cardiac Pacemakers, Inc. System and method for generating a trend parameter based on respiration rate distribution
US8364264B2 (en) * 2005-10-03 2013-01-29 Cardiac Pacemakers, Inc. Pacing interval adjustment for cardiac pacing response determination
US20070118180A1 (en) * 2005-11-18 2007-05-24 Quan Ni Cardiac resynchronization therapy for improved hemodynamics based on disordered breathing detection
US8108034B2 (en) 2005-11-28 2012-01-31 Cardiac Pacemakers, Inc. Systems and methods for valvular regurgitation detection
US7766840B2 (en) * 2005-12-01 2010-08-03 Cardiac Pacemakers, Inc. Method and system for heart failure status evaluation based on a disordered breathing index
US7479114B2 (en) * 2005-12-01 2009-01-20 Cardiac Pacemakers, Inc. Determining blood gas saturation based on measured parameter of respiration
US20070135847A1 (en) * 2005-12-12 2007-06-14 Kenknight Bruce H Subcutaneous defibrillation system and method using same
US20070135855A1 (en) 2005-12-13 2007-06-14 Foshee Phillip D Patient management device for portably interfacing with a plurality of implantable medical devices and method thereof
US7662105B2 (en) * 2005-12-14 2010-02-16 Cardiac Pacemakers, Inc. Systems and methods for determining respiration metrics
US20070137648A1 (en) * 2005-12-16 2007-06-21 Pneumoflex Systems, Llc Intraoral Nebulizer Providing Air Curtains
US7653431B2 (en) * 2005-12-20 2010-01-26 Cardiac Pacemakers, Inc. Arrhythmia discrimination based on determination of rate dependency
US8532762B2 (en) * 2005-12-20 2013-09-10 Cardiac Pacemakers, Inc. Discriminating polymorphic and monomorphic cardiac rhythms using template generation
US7761158B2 (en) * 2005-12-20 2010-07-20 Cardiac Pacemakers, Inc. Detection of heart failure decompensation based on cumulative changes in sensor signals
US8204585B2 (en) 2005-12-20 2012-06-19 Cardiac Pacemakers, Inc. Bio-impedance sensor and sensing method
US9155896B2 (en) * 2005-12-22 2015-10-13 Cardiac Pacemakers, Inc. Method and apparatus for improving cardiac efficiency based on myocardial oxygen consumption
JP5085561B2 (en) 2006-01-09 2012-11-28 カーディアック ペースメイカーズ, インコーポレイテッド Remote programming of patient medical devices
US20070168222A1 (en) * 2006-01-19 2007-07-19 Hoyme Kenneth P System and method for providing hierarchical medical device control for automated patient management
WO2007092159A2 (en) 2006-02-02 2007-08-16 Wake Forest University Health Sciences Cardiac visualization systems for displaying 3-d images of cardiac voxel intensity distributions with optional physician interactive boundary tracing tools
TW200730134A (en) * 2006-02-14 2007-08-16 Univ Yuan Ze Sleep quality monitor system, and physiological signal monitor process
US20070197881A1 (en) * 2006-02-22 2007-08-23 Wolf James L Wireless Health Monitor Device and System with Cognition
US7780606B2 (en) 2006-03-29 2010-08-24 Cardiac Pacemakers, Inc. Hemodynamic stability assessment based on heart sounds
US7819816B2 (en) * 2006-03-29 2010-10-26 Cardiac Pacemakers, Inc. Periodic disordered breathing detection
US7801612B2 (en) * 2006-06-05 2010-09-21 Cardiac Pacemakers, Inc. System and method for managing locally-initiated medical device interrogation
US7649449B2 (en) * 2006-06-05 2010-01-19 Cardiac Pacemakers, Inc. System and method for providing synergistic alert condition processing in an automated patient management system
US20070299317A1 (en) * 2006-06-13 2007-12-27 Hoyme Kenneth P System and method for programming customized data collection for an autonomous medical device
US7599741B2 (en) 2006-06-29 2009-10-06 Cardiac Pacemakers, Inc. Systems and methods for improving heart rate kinetics in heart failure patients
US8527048B2 (en) 2006-06-29 2013-09-03 Cardiac Pacemakers, Inc. Local and non-local sensing for cardiac pacing
US8620430B2 (en) 2006-06-30 2013-12-31 Cardiac Pacemakers, Inc. Selection of pacing sites to enhance cardiac performance
US7908334B2 (en) * 2006-07-21 2011-03-15 Cardiac Pacemakers, Inc. System and method for addressing implantable devices
US7738950B2 (en) * 2006-09-13 2010-06-15 Cardiac Pacemakers, Inc. Method and apparatus for identifying potentially misclassified arrhythmic episodes
US8948867B2 (en) 2006-09-14 2015-02-03 Cardiac Pacemakers, Inc. Capture detection with cross chamber backup pacing
US8209013B2 (en) 2006-09-14 2012-06-26 Cardiac Pacemakers, Inc. Therapeutic electrical stimulation that avoids undesirable activation
US20120179066A1 (en) * 2006-10-18 2012-07-12 Yuan Ze University Sleeping quality monitor system and a method for monitoring a physiological signal
US7801610B2 (en) * 2006-11-17 2010-09-21 Cardiac Pacemakers, Inc. Methods and systems for management of atrial retrograde conduction and pacemaker mediated tachyarrhythmia
US8725255B2 (en) * 2006-11-17 2014-05-13 Cardiac Pacemakers, Inc. Cardiac resynchronization therapy optimization using cardiac activation sequence information
US8290590B2 (en) * 2006-11-17 2012-10-16 Cardiac Pacemakers, Inc. Dynamic morphology based atrial automatic threshold
US20080126124A1 (en) * 2006-11-28 2008-05-29 Schechter Alan M Quantitative assessment, evaluation and triage of the health status of an individual
US7890172B2 (en) * 2007-01-18 2011-02-15 Cardiac Pacemakers, Inc. Pacing output configuration selection for cardiac resynchronization therapy patients
US8052611B2 (en) 2007-03-14 2011-11-08 Cardiac Pacemakers, Inc. Method and apparatus for management of heart failure hospitalization
US20080228040A1 (en) * 2007-03-16 2008-09-18 Arthur Solomon Thompson International medical expert diagnosis
WO2008118042A1 (en) * 2007-03-23 2008-10-02 St. Jude Medical Ab Implantable medical device
US20080243007A1 (en) * 2007-03-28 2008-10-02 Cardiac Pacemakers, Inc. Pulmonary Artery Pressure Signals And Methods of Using
US8347365B2 (en) 2007-03-29 2013-01-01 Cardiac Pacemakers, Inc. System and method for confirming identity and authority by a patient medical device
US8229557B2 (en) 2007-03-29 2012-07-24 Cardiac Pacemakers, Inc. Estimating acute response to cardiac resynchronization therapy
US7844336B2 (en) 2007-04-10 2010-11-30 Cardiac Pacemakers, Inc. Implantable medical device configured as a pedometer
WO2009138976A2 (en) 2008-05-12 2009-11-19 Earlysense Ltd Monitoring, predicting and treating clinical episodes
US8585607B2 (en) 2007-05-02 2013-11-19 Earlysense Ltd. Monitoring, predicting and treating clinical episodes
US8103343B2 (en) * 2007-05-03 2012-01-24 Cardiac Pacemakers, Inc. Automatic modulation of pacing timing intervals using beat to beat measures
US8271080B2 (en) 2007-05-23 2012-09-18 Cardiac Pacemakers, Inc. Decongestive therapy titration for heart failure patients using implantable sensor
US20090030945A1 (en) * 2007-07-26 2009-01-29 Diagnosisplus Llc Method and system for collecting and analyzing medical patient data
US9037239B2 (en) 2007-08-07 2015-05-19 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US8265736B2 (en) 2007-08-07 2012-09-11 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US20090048644A1 (en) * 2007-08-14 2009-02-19 Stahmann Jeffrey E System and method for providing intrabody data security on an active implantable medical device
US7904156B2 (en) * 2007-08-20 2011-03-08 Cardiac Pacemakers, Inc. Modulation of AV delay to control ventricular interval variability
US7957802B2 (en) * 2007-08-20 2011-06-07 Cardiac Pacemakers, Inc. Method, apparatus, and system to optimize cardiac preload based on measured pulmonary artery pressure
US9848058B2 (en) 2007-08-31 2017-12-19 Cardiac Pacemakers, Inc. Medical data transport over wireless life critical network employing dynamic communication link mapping
US8515547B2 (en) 2007-08-31 2013-08-20 Cardiac Pacemakers, Inc. Wireless patient communicator for use in a life critical network
US20090088651A1 (en) * 2007-09-28 2009-04-02 Allan Charles Shuros Method and apparatus to perform transvascular hemodynamic sensing
EP2210226A4 (en) * 2007-10-12 2013-11-06 Patientslikeme Inc Self-improving method of using online communities to predict health-related outcomes
US8082160B2 (en) * 2007-10-26 2011-12-20 Hill-Rom Services, Inc. System and method for collection and communication of data from multiple patient care devices
US8229556B2 (en) * 2007-11-21 2012-07-24 Cardiac Pacemakers, Inc. Tachycardia hemodynamics detection based on cardiac mechanical sensor signal regularity
US8838240B2 (en) * 2007-11-21 2014-09-16 Cardiac Pacemakers Inc. Hemodynamic status assessment during tachycardia
US20090149719A1 (en) * 2007-12-05 2009-06-11 Cardiac Pacemakers, Inc. System And Method For Performing Remote Patient Risk Assessment Through A Visual Analog Scale
FR2924847B1 (en) * 2007-12-06 2014-08-29 Vigilio METHOD AND EQUIPMENT FOR DETECTING CRITICAL SITUATION OF A SUBJECT
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090163774A1 (en) * 2007-12-20 2009-06-25 Sudeesh Thatha Managment and Diagnostic System for Patient Monitoring and Symptom Analysis
US8041431B2 (en) * 2008-01-07 2011-10-18 Cardiac Pacemakers, Inc. System and method for in situ trimming of oscillators in a pair of implantable medical devices
AU2009206541B2 (en) * 2008-01-22 2012-02-09 Cardiac Pacemakers, Inc. Respiration as a trigger for therapy optimization
US20090192362A1 (en) * 2008-01-24 2009-07-30 Sweeney Robert J System And Method For Corroborating Transitory Changes In Wellness Status Against A Patient Population
US8301262B2 (en) * 2008-02-06 2012-10-30 Cardiac Pacemakers, Inc. Direct inductive/acoustic converter for implantable medical device
EP2254661B1 (en) 2008-02-14 2015-10-07 Cardiac Pacemakers, Inc. Apparatus for phrenic stimulation detection
WO2009108791A1 (en) * 2008-02-26 2009-09-03 The Regents Of The University Of California Diagnostic skin mapping by mrs, mri and other methods
US8768443B2 (en) * 2008-03-03 2014-07-01 Cardiac Pacemakers, Inc. System and method for determining atrial arrhythmia burden
WO2009110996A1 (en) * 2008-03-05 2009-09-11 Cardiac Pacemakers, Inc. Automated heart function classification to standardized classes
US8640700B2 (en) * 2008-03-27 2014-02-04 Covidien Lp Method for selecting target settings in a medical device
US8402467B2 (en) * 2008-04-04 2013-03-19 Cardiac Pacemakers, Inc. System and method for providing fault resilient processing in an implantable medical device
US9883809B2 (en) 2008-05-01 2018-02-06 Earlysense Ltd. Monitoring, predicting and treating clinical episodes
US8882684B2 (en) 2008-05-12 2014-11-11 Earlysense Ltd. Monitoring, predicting and treating clinical episodes
US8362903B2 (en) * 2008-05-07 2013-01-29 Cardiac Pacemakers, Inc. System and method for providing enhanced weight alert notification during automated patient management
WO2009137189A1 (en) * 2008-05-07 2009-11-12 Cardiac Pacemakers, Inc. System and method for detection of pulmonary embolism
US8103346B2 (en) * 2008-05-22 2012-01-24 Cardiac Pacemakers, Inc. Regulatory compliant transmission of medical data employing a patient implantable medical device and a generic network access device
US8165840B2 (en) * 2008-06-12 2012-04-24 Cardiac Pacemakers, Inc. Posture sensor automatic calibration
US20090326339A1 (en) * 2008-06-26 2009-12-31 Microsoft Corporation Connected healthcare devices with real-time and proactive capture and relay of contextual information
US8712509B2 (en) * 2008-07-25 2014-04-29 Medtronic, Inc. Virtual physician acute myocardial infarction detection system and method
US9713701B2 (en) * 2008-07-31 2017-07-25 Medtronic, Inc. Using multiple diagnostic parameters for predicting heart failure events
US8126566B2 (en) * 2008-08-14 2012-02-28 Cardiac Pacemakers, Inc. Performance assessment and adaptation of an acoustic communication link
US8600777B2 (en) * 2008-08-28 2013-12-03 I.M.D. Soft Ltd. Monitoring patient conditions
US8347149B2 (en) * 2008-10-01 2013-01-01 Cardiac Pacemakers, Inc. System and method for providing fault tolerant processing in an implantable medical device
JP5364167B2 (en) * 2008-10-03 2013-12-11 カーディアック ペースメイカーズ, インコーポレイテッド Method and apparatus for cardiac resynchronization therapy mode selection based on intrinsic conduction
CN102187343B (en) * 2008-10-15 2016-08-03 皇家飞利浦电子股份有限公司 For detecting the system and method for respiratory insufficiency in subject breathed
US11478190B2 (en) 2008-10-29 2022-10-25 Flashback Technologies, Inc. Noninvasive hydration monitoring
EP2356579B1 (en) * 2008-10-29 2015-05-20 The Regents of the University of Colorado, a body corporate Long term active learning from large continually changing data sets
US11406269B2 (en) 2008-10-29 2022-08-09 Flashback Technologies, Inc. Rapid detection of bleeding following injury
US11382571B2 (en) 2008-10-29 2022-07-12 Flashback Technologies, Inc. Noninvasive predictive and/or estimative blood pressure monitoring
US11857293B2 (en) 2008-10-29 2024-01-02 Flashback Technologies, Inc. Rapid detection of bleeding before, during, and after fluid resuscitation
US11395634B2 (en) 2008-10-29 2022-07-26 Flashback Technologies, Inc. Estimating physiological states based on changes in CRI
US11395594B2 (en) 2008-10-29 2022-07-26 Flashback Technologies, Inc. Noninvasive monitoring for fluid resuscitation
US8512260B2 (en) 2008-10-29 2013-08-20 The Regents Of The University Of Colorado, A Body Corporate Statistical, noninvasive measurement of intracranial pressure
US9727139B2 (en) 2008-12-12 2017-08-08 Immersion Corporation Method and apparatus for providing a haptic monitoring system using multiple sensors
US20100152620A1 (en) * 2008-12-12 2010-06-17 Immersion Corporation Method and Apparatus for Providing A Haptic Monitoring System Using Multiple Sensors
US8632473B2 (en) 2009-01-30 2014-01-21 Medtronic, Inc. Detecting worsening heart failure based on fluid accumulation with respiratory confirmation
EP2401718A4 (en) * 2009-02-26 2014-03-12 I M D Soft Ltd Decision support
US8319631B2 (en) 2009-03-04 2012-11-27 Cardiac Pacemakers, Inc. Modular patient portable communicator for use in life critical network
US8812841B2 (en) 2009-03-04 2014-08-19 Cardiac Pacemakers, Inc. Communications hub for use in life critical network
US8401639B2 (en) * 2009-04-13 2013-03-19 Cardiac Pacemakers, Inc. Anodal stimulation detection and avoidance
AU2010201032B2 (en) 2009-04-29 2014-11-20 Resmed Limited Methods and Apparatus for Detecting and Treating Respiratory Insufficiency
CA2758481C (en) 2009-04-30 2018-03-20 Patientslikeme, Inc. Systems and methods for encouragement of data submission in online communities
US8452405B2 (en) * 2009-05-05 2013-05-28 Cardiac Pacemakers, Inc. Methods and systems for mitigating the occurrence of arrhythmia during atrial pacing
US8634915B2 (en) 2009-05-27 2014-01-21 Cardiac Pacemakers, Inc. Activity sensor processing for phrenic nerve activation detection
US9149642B2 (en) * 2009-05-27 2015-10-06 Cardiac Pacemakers, Inc. Method and apparatus for phrenic nerve activation detection with respiration cross-checking
EP2659931B1 (en) 2009-05-27 2017-07-19 Cardiac Pacemakers, Inc. Phrenic nerve activation detection
US8626292B2 (en) 2009-05-27 2014-01-07 Cardiac Pacemakers, Inc. Respiration sensor processing for phrenic nerve activation detection
US20110009760A1 (en) * 2009-07-10 2011-01-13 Yi Zhang Hospital Readmission Alert for Heart Failure Patients
US8483808B2 (en) 2009-09-25 2013-07-09 Yanting Dong Methods and systems for characterizing cardiac signal morphology using K-fit analysis
US8271072B2 (en) * 2009-10-30 2012-09-18 Medtronic, Inc. Detecting worsening heart failure
US9119925B2 (en) 2009-12-04 2015-09-01 Covidien Lp Quick initiation of respiratory support via a ventilator user interface
WO2011080602A2 (en) * 2009-12-28 2011-07-07 Koninklijke Philips Electronics N.V. Early exacerbation detection using differential temperature monitoring
US8638200B2 (en) 2010-05-07 2014-01-28 Covidien Lp Ventilator-initiated prompt regarding Auto-PEEP detection during volume ventilation of non-triggering patient
US20110313504A1 (en) * 2010-06-02 2011-12-22 Golding Arthur L Device and method to prevent or treat outflow vein stenosis of an arteriovenous fistula constructed with a synthetic vascular graft
US8607789B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of non-triggering patient exhibiting obstructive component
US8607791B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation
US8607790B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation of patient exhibiting obstructive component
US8607788B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of triggering patient exhibiting obstructive component
US9017255B2 (en) 2010-07-27 2015-04-28 Carefusion 303, Inc. System and method for saving battery power in a patient monitoring system
US9585620B2 (en) 2010-07-27 2017-03-07 Carefusion 303, Inc. Vital-signs patch having a flexible attachment to electrodes
US9055925B2 (en) * 2010-07-27 2015-06-16 Carefusion 303, Inc. System and method for reducing false alarms associated with vital-signs monitoring
US20120029300A1 (en) * 2010-07-27 2012-02-02 Carefusion 303, Inc. System and method for reducing false alarms and false negatives based on motion and position sensing
US9420952B2 (en) 2010-07-27 2016-08-23 Carefusion 303, Inc. Temperature probe suitable for axillary reading
US9357929B2 (en) 2010-07-27 2016-06-07 Carefusion 303, Inc. System and method for monitoring body temperature of a person
US9615792B2 (en) 2010-07-27 2017-04-11 Carefusion 303, Inc. System and method for conserving battery power in a patient monitoring system
US8814792B2 (en) 2010-07-27 2014-08-26 Carefusion 303, Inc. System and method for storing and forwarding data from a vital-signs monitor
US9037477B2 (en) 2010-10-08 2015-05-19 Cardiac Science Corporation Computer-implemented system and method for evaluating ambulatory electrocardiographic monitoring of cardiac rhythm disorders
US20120089000A1 (en) 2010-10-08 2012-04-12 Jon Mikalson Bishay Ambulatory Electrocardiographic Monitor For Providing Ease Of Use In Women And Method Of Use
US8239012B2 (en) 2010-10-08 2012-08-07 Cardiac Science Corporation Microcontrolled electrocardiographic monitoring circuit with differential voltage encoding
US8613708B2 (en) 2010-10-08 2013-12-24 Cardiac Science Corporation Ambulatory electrocardiographic monitor with jumpered sensing electrode
CN107007253B (en) * 2010-11-11 2020-09-01 卓尔医学产品公司 Medical system
US8757153B2 (en) 2010-11-29 2014-06-24 Covidien Lp Ventilator-initiated prompt regarding detection of double triggering during ventilation
US8757152B2 (en) 2010-11-29 2014-06-24 Covidien Lp Ventilator-initiated prompt regarding detection of double triggering during a volume-control breath type
US8595639B2 (en) 2010-11-29 2013-11-26 Covidien Lp Ventilator-initiated prompt regarding detection of fluctuations in resistance
US10292625B2 (en) 2010-12-07 2019-05-21 Earlysense Ltd. Monitoring a sleeping subject
US20140202457A1 (en) 2011-01-20 2014-07-24 Pneumoflex Systems, Llc Metered dose nebulizer
US9452270B2 (en) 2011-01-20 2016-09-27 Pneumoflex Systems, Llc Nebulizer having replaceable nozzle assembly and suction line
US8671934B2 (en) 2011-01-20 2014-03-18 Pneumoflex Systems, Llc Nebulizer that is activated by negative inspiratory pressure
WO2012103526A2 (en) 2011-01-28 2012-08-02 Carefusion 207, Inc. Pressure relief device and system
US10098584B2 (en) 2011-02-08 2018-10-16 Cardiac Pacemakers, Inc. Patient health improvement monitor
EP2680742A2 (en) 2011-03-01 2014-01-08 Koninklijke Philips N.V. Patient deterioration detection
US9038633B2 (en) 2011-03-02 2015-05-26 Covidien Lp Ventilator-initiated prompt regarding high delivered tidal volume
US9986918B2 (en) 2011-03-14 2018-06-05 Cardiac Pacemakers, Inc. Systems and methods to indicate heart failure co-morbidity
EP3432174A1 (en) * 2011-06-30 2019-01-23 University of Pittsburgh - Of the Commonwealth System of Higher Education System and method of determining a susceptibility to cardiorespiratory insufficiency
WO2013005228A2 (en) * 2011-07-04 2013-01-10 Amin Ketan Subhaschandra A device for measuring, processing and evaluating medical parameters relating to human body
WO2013016212A1 (en) 2011-07-22 2013-01-31 Flashback Technologies, Inc. Hemodynamic reserve monitor and hemodialysis control
US8437840B2 (en) 2011-09-26 2013-05-07 Medtronic, Inc. Episode classifier algorithm
US8774909B2 (en) 2011-09-26 2014-07-08 Medtronic, Inc. Episode classifier algorithm
US9067036B2 (en) 2011-09-30 2015-06-30 Carefusion 207, Inc. Removing condensation from a breathing circuit
US10168046B2 (en) 2011-09-30 2019-01-01 Carefusion 207, Inc. Non-metallic humidification component
US9289572B2 (en) 2011-09-30 2016-03-22 Carefusion 207, Inc. Humidifying gas for respiratory therapy
US9212673B2 (en) 2011-09-30 2015-12-15 Carefusion 207, Inc. Maintaining a water level in a humidification component
US8733348B2 (en) 2011-09-30 2014-05-27 Carefusion 207, Inc. Humidifying respiratory gases
US9597468B2 (en) 2011-11-07 2017-03-21 Redmed Limited Methods and apparatus for providing ventilation to a patient
US8801678B2 (en) 2012-01-20 2014-08-12 Carefusion 303, Inc. Piston for a needleless valve system
US9272113B2 (en) 2012-03-30 2016-03-01 Carefusion 207, Inc. Transporting liquid in a respiratory component
US9259548B2 (en) 2012-04-30 2016-02-16 Carefusion 207, Inc. Patient nasal interface for use with a nasal airway pressure system
EP3639733B1 (en) 2012-05-30 2022-10-26 ResMed Sensor Technologies Limited Apparatus for monitoring cardio-pulmonary health
JP6305994B2 (en) * 2012-06-08 2018-04-04 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Method and system for monitoring pulmonary function of a patient
US10525219B2 (en) 2012-06-26 2020-01-07 Resmed Sensor Technologies Limited Methods and apparatus for monitoring and treating respiratory insufficiency
US9022023B2 (en) 2012-06-29 2015-05-05 Carefusion 207, Inc. Breath actuated nebulizer having a pressurized gas diverter with a diverter orifice
US9027552B2 (en) 2012-07-31 2015-05-12 Covidien Lp Ventilator-initiated prompt or setting regarding detection of asynchrony during ventilation
EP2919646B8 (en) 2012-11-14 2019-06-12 Vectorious Medical Technologies Ltd. Drift compensation for implanted capacitance-based pressure transducer
US10709341B2 (en) 2012-11-21 2020-07-14 St. Jude Medical Luxembourg Holdings II S.a.r.l. Devices, systems, and methods for pulmonary arterial hypertension (PAH) assessment and treatment
US9539407B2 (en) 2012-12-19 2017-01-10 Vyaire Medical Consumables Llc Adjustable nebulizer dispenser
WO2014145712A1 (en) 2013-03-15 2014-09-18 Cardiomems, Inc. Methods for the treatment of cardiovascular conditions
CN103142399B (en) * 2013-03-18 2015-05-27 嘉兴泰信医疗电子有限公司 Intelligent judgment type sputum draining machine
WO2017115112A1 (en) 2015-12-30 2017-07-06 Vectorious Medical Technologies Ltd. Power-efficient pressure-sensor implant
EP2986252B1 (en) 2013-04-18 2018-07-25 Vectorious Medical Technologies Ltd. Remotely powered sensory implant
US10205488B2 (en) 2013-04-18 2019-02-12 Vectorious Medical Technologies Ltd. Low-power high-accuracy clock harvesting in inductive coupling systems
WO2015005958A1 (en) * 2013-07-09 2015-01-15 Pulmone Advanced Medical Devices, Ltd. Determining respiratory parameters
US9743889B2 (en) 2013-08-05 2017-08-29 Cardiac Pacemakers, Inc. System and method for detecting worsening of heart failure based on rapid shallow breathing index
US9504423B1 (en) 2015-10-05 2016-11-29 Bardy Diagnostics, Inc. Method for addressing medical conditions through a wearable health monitor with the aid of a digital computer
US10433748B2 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. Extended wear electrocardiography and physiological sensor monitor
US10165946B2 (en) 2013-09-25 2019-01-01 Bardy Diagnostics, Inc. Computer-implemented system and method for providing a personal mobile device-triggered medical intervention
US9364155B2 (en) 2013-09-25 2016-06-14 Bardy Diagnostics, Inc. Self-contained personal air flow sensing monitor
US9433380B1 (en) 2013-09-25 2016-09-06 Bardy Diagnostics, Inc. Extended wear electrocardiography patch
US10463269B2 (en) 2013-09-25 2019-11-05 Bardy Diagnostics, Inc. System and method for machine-learning-based atrial fibrillation detection
US9615763B2 (en) 2013-09-25 2017-04-11 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitor recorder optimized for capturing low amplitude cardiac action potential propagation
US9545204B2 (en) 2013-09-25 2017-01-17 Bardy Diagnostics, Inc. Extended wear electrocardiography patch
US9700227B2 (en) 2013-09-25 2017-07-11 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation
US11213237B2 (en) 2013-09-25 2022-01-04 Bardy Diagnostics, Inc. System and method for secure cloud-based physiological data processing and delivery
US9717432B2 (en) 2013-09-25 2017-08-01 Bardy Diagnostics, Inc. Extended wear electrocardiography patch using interlaced wire electrodes
US20190167139A1 (en) 2017-12-05 2019-06-06 Gust H. Bardy Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring
US10736531B2 (en) 2013-09-25 2020-08-11 Bardy Diagnostics, Inc. Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection
US10251576B2 (en) 2013-09-25 2019-04-09 Bardy Diagnostics, Inc. System and method for ECG data classification for use in facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US9345414B1 (en) 2013-09-25 2016-05-24 Bardy Diagnostics, Inc. Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer
US10820801B2 (en) 2013-09-25 2020-11-03 Bardy Diagnostics, Inc. Electrocardiography monitor configured for self-optimizing ECG data compression
US10667711B1 (en) 2013-09-25 2020-06-02 Bardy Diagnostics, Inc. Contact-activated extended wear electrocardiography and physiological sensor monitor recorder
US9655537B2 (en) 2013-09-25 2017-05-23 Bardy Diagnostics, Inc. Wearable electrocardiography and physiology monitoring ensemble
US9717433B2 (en) 2013-09-25 2017-08-01 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation
US9408551B2 (en) 2013-11-14 2016-08-09 Bardy Diagnostics, Inc. System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US11723575B2 (en) 2013-09-25 2023-08-15 Bardy Diagnostics, Inc. Electrocardiography patch
US9655538B2 (en) 2013-09-25 2017-05-23 Bardy Diagnostics, Inc. Self-authenticating electrocardiography monitoring circuit
US9737224B2 (en) 2013-09-25 2017-08-22 Bardy Diagnostics, Inc. Event alerting through actigraphy embedded within electrocardiographic data
US10624551B2 (en) 2013-09-25 2020-04-21 Bardy Diagnostics, Inc. Insertable cardiac monitor for use in performing long term electrocardiographic monitoring
US10736529B2 (en) 2013-09-25 2020-08-11 Bardy Diagnostics, Inc. Subcutaneous insertable electrocardiography monitor
US9433367B2 (en) 2013-09-25 2016-09-06 Bardy Diagnostics, Inc. Remote interfacing of extended wear electrocardiography and physiological sensor monitor
US10806360B2 (en) 2013-09-25 2020-10-20 Bardy Diagnostics, Inc. Extended wear ambulatory electrocardiography and physiological sensor monitor
US10433751B2 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data
US10799137B2 (en) 2013-09-25 2020-10-13 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US9775536B2 (en) 2013-09-25 2017-10-03 Bardy Diagnostics, Inc. Method for constructing a stress-pliant physiological electrode assembly
US10888239B2 (en) 2013-09-25 2021-01-12 Bardy Diagnostics, Inc. Remote interfacing electrocardiography patch
WO2015048194A1 (en) 2013-09-25 2015-04-02 Bardy Diagnostics, Inc. Self-contained personal air flow sensing monitor
US9619660B1 (en) 2013-09-25 2017-04-11 Bardy Diagnostics, Inc. Computer-implemented system for secure physiological data collection and processing
US9408545B2 (en) 2013-09-25 2016-08-09 Bardy Diagnostics, Inc. Method for efficiently encoding and compressing ECG data optimized for use in an ambulatory ECG monitor
USD793566S1 (en) 2015-09-10 2017-08-01 Bardy Diagnostics, Inc. Extended wear electrode patch
USD744659S1 (en) 2013-11-07 2015-12-01 Bardy Diagnostics, Inc. Extended wear electrode patch
USD801528S1 (en) 2013-11-07 2017-10-31 Bardy Diagnostics, Inc. Electrocardiography monitor
USD831833S1 (en) 2013-11-07 2018-10-23 Bardy Diagnostics, Inc. Extended wear electrode patch
USD892340S1 (en) 2013-11-07 2020-08-04 Bardy Diagnostics, Inc. Extended wear electrode patch
USD717955S1 (en) 2013-11-07 2014-11-18 Bardy Diagnostics, Inc. Electrocardiography monitor
AU2015204701B2 (en) 2014-01-10 2018-03-15 Cardiac Pacemakers, Inc. Systems and methods for detecting cardiac arrhythmias
EP3092038B1 (en) 2014-01-10 2017-12-27 Cardiac Pacemakers, Inc. Methods and systems for improved communication between medical devices
US9804768B1 (en) * 2014-06-25 2017-10-31 ABCDisability, Inc. Method and system for generating an examination report
CN107073275B (en) 2014-08-28 2020-09-01 心脏起搏器股份公司 Medical device with triggered blanking period
EP3827877A1 (en) 2015-02-06 2021-06-02 Cardiac Pacemakers, Inc. Systems for treating cardiac arrhythmias
WO2016126968A1 (en) 2015-02-06 2016-08-11 Cardiac Pacemakers, Inc. Systems and methods for safe delivery of electrical stimulation therapy
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
CN107530002B (en) 2015-03-04 2021-04-30 心脏起搏器股份公司 System and method for treating cardiac arrhythmias
EP3270768B1 (en) 2015-03-18 2023-12-13 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
WO2016178197A1 (en) 2015-05-07 2016-11-10 Vectorious Medical Technologies Ltd Deploying and fixating an implant across an organ wall
US20160331315A1 (en) * 2015-05-14 2016-11-17 Abraham Carter Systems and Methods for Wearable Health Monitoring
US20160367202A1 (en) * 2015-05-18 2016-12-22 Abraham Carter Systems and Methods for Wearable Sensor Techniques
US10791938B2 (en) 2015-06-14 2020-10-06 Facense Ltd. Smartglasses for detecting congestive heart failure
WO2017031221A1 (en) 2015-08-20 2017-02-23 Cardiac Pacemakers, Inc. Systems and methods for communication between medical devices
CN108136187B (en) 2015-08-20 2021-06-29 心脏起搏器股份公司 System and method for communication between medical devices
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
WO2017040115A1 (en) 2015-08-28 2017-03-09 Cardiac Pacemakers, Inc. System for detecting tamponade
US10137305B2 (en) 2015-08-28 2018-11-27 Cardiac Pacemakers, Inc. Systems and methods for behaviorally responsive signal detection and therapy delivery
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
USD766447S1 (en) 2015-09-10 2016-09-13 Bardy Diagnostics, Inc. Extended wear electrode patch
WO2017044389A1 (en) 2015-09-11 2017-03-16 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
US10065041B2 (en) 2015-10-08 2018-09-04 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
US10183170B2 (en) 2015-12-17 2019-01-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
WO2017127548A1 (en) 2016-01-19 2017-07-27 Cardiac Pacemakers, Inc. Devices for wirelessly recharging a rechargeable battery of an implantable medical device
EP3411113B1 (en) 2016-02-04 2019-11-27 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
US10172517B2 (en) * 2016-02-25 2019-01-08 Samsung Electronics Co., Ltd Image-analysis for assessing heart failure
WO2017173275A1 (en) 2016-03-31 2017-10-05 Cardiac Pacemakers, Inc. Implantable medical device with rechargeable battery
US10861604B2 (en) 2016-05-05 2020-12-08 Advinow, Inc. Systems and methods for automated medical diagnostics
US10360787B2 (en) 2016-05-05 2019-07-23 Hill-Rom Services, Inc. Discriminating patient care communications system
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
CN109414582B (en) 2016-06-27 2022-10-28 心脏起搏器股份公司 Cardiac therapy system for resynchronization pacing management using subcutaneous sensing of P-waves
US11207527B2 (en) 2016-07-06 2021-12-28 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10426962B2 (en) 2016-07-07 2019-10-01 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
SE541780C2 (en) * 2016-07-07 2019-12-17 Brighter Ab Publ Method involving a mobile phone for monitoring a medical device
US10688304B2 (en) 2016-07-20 2020-06-23 Cardiac Pacemakers, Inc. Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
EP3500342B1 (en) 2016-08-19 2020-05-13 Cardiac Pacemakers, Inc. Trans-septal implantable medical device
CN109641129B (en) 2016-08-24 2023-06-30 心脏起搏器股份公司 Cardiac resynchronization with timing management using fusion facilitation
WO2018039335A1 (en) 2016-08-24 2018-03-01 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using p-wave to pace timing
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
EP3515553B1 (en) 2016-09-21 2020-08-26 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
WO2018057626A1 (en) 2016-09-21 2018-03-29 Cardiac Pacemakers, Inc. Implantable cardiac monitor
WO2018081237A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Use of a separate device in managing the pace pulse energy of a cardiac pacemaker
US10463305B2 (en) 2016-10-27 2019-11-05 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
US10561330B2 (en) 2016-10-27 2020-02-18 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
WO2018081225A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
WO2018081017A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
EP3532157B1 (en) 2016-10-31 2020-08-26 Cardiac Pacemakers, Inc. Systems for activity level pacing
EP3532158B1 (en) 2016-10-31 2022-12-14 Cardiac Pacemakers, Inc. Systems for activity level pacing
US10583301B2 (en) 2016-11-08 2020-03-10 Cardiac Pacemakers, Inc. Implantable medical device for atrial deployment
EP3538213B1 (en) 2016-11-09 2023-04-12 Cardiac Pacemakers, Inc. Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
JP6843240B2 (en) 2016-11-21 2021-03-17 カーディアック ペースメイカーズ, インコーポレイテッド Implantable medical device with permeable housing and induction coil placed around the housing
JP6781346B2 (en) 2016-11-21 2020-11-04 カーディアック ペースメイカーズ, インコーポレイテッド Leadless cardiac pacemaker with multi-mode communication
WO2018093605A1 (en) 2016-11-21 2018-05-24 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker providing cardiac resynchronization therapy
WO2018106424A1 (en) 2016-12-05 2018-06-14 Medipines Corporation System and methods for respiratory measurements using breathing gas samples
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
EP3573708B1 (en) 2017-01-26 2021-03-10 Cardiac Pacemakers, Inc. Leadless implantable device with detachable fixation
JP7000438B2 (en) 2017-01-26 2022-01-19 カーディアック ペースメイカーズ, インコーポレイテッド Human device communication with redundant message transmission
EP3573709A1 (en) 2017-01-26 2019-12-04 Cardiac Pacemakers, Inc. Leadless device with overmolded components
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
AU2018248361B2 (en) 2017-04-03 2020-08-27 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
US11164679B2 (en) 2017-06-20 2021-11-02 Advinow, Inc. Systems and methods for intelligent patient interface exam station
CN111194180B (en) * 2017-07-27 2022-11-11 长桑医疗(海南)有限公司 System and method for determining blood pressure of a subject
EP3668592B1 (en) 2017-08-18 2021-11-17 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
WO2019036568A1 (en) 2017-08-18 2019-02-21 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
CN111107899A (en) 2017-09-20 2020-05-05 心脏起搏器股份公司 Implantable medical device with multiple modes of operation
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
CN111432874A (en) 2017-12-01 2020-07-17 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference within search window from a ventricular implanted leadless cardiac pacemaker
CN111417433A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker
CN111417432A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Leadless cardiac pacemaker with involution behavior
US11071870B2 (en) 2017-12-01 2021-07-27 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
US11110281B2 (en) 2018-01-04 2021-09-07 Cardiac Pacemakers, Inc. Secure transdermal communication with implanted device
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
US10874861B2 (en) 2018-01-04 2020-12-29 Cardiac Pacemakers, Inc. Dual chamber pacing without beat-to-beat communication
US11348688B2 (en) 2018-03-06 2022-05-31 Advinow, Inc. Systems and methods for audio medical instrument patient measurements
US10939806B2 (en) 2018-03-06 2021-03-09 Advinow, Inc. Systems and methods for optical medical instrument patient measurements
JP2021518208A (en) 2018-03-23 2021-08-02 メドトロニック,インコーポレイテッド AV Synchronized VfA Cardiac Treatment
EP3768377B1 (en) 2018-03-23 2023-11-22 Medtronic, Inc. Vfa cardiac resynchronization therapy
CN111936046A (en) 2018-03-23 2020-11-13 美敦力公司 VFA cardiac therapy for tachycardia
CN112770807A (en) 2018-09-26 2021-05-07 美敦力公司 Capture in atrial-to-ventricular cardiac therapy
US11894139B1 (en) 2018-12-03 2024-02-06 Patientslikeme Llc Disease spectrum classification
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US11537702B2 (en) 2019-05-13 2022-12-27 Cardiac Pacemakers, Inc. Implanted medical device authentication based on comparison of internal IMU signal to external IMU signal
US11096579B2 (en) 2019-07-03 2021-08-24 Bardy Diagnostics, Inc. System and method for remote ECG data streaming in real-time
US11116451B2 (en) 2019-07-03 2021-09-14 Bardy Diagnostics, Inc. Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities
US11696681B2 (en) 2019-07-03 2023-07-11 Bardy Diagnostics Inc. Configurable hardware platform for physiological monitoring of a living body
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11672934B2 (en) 2020-05-12 2023-06-13 Covidien Lp Remote ventilator adjustment
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation

Citations (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197856A (en) * 1978-04-10 1980-04-15 Northrop Robert B Ultrasonic respiration/convulsion monitoring apparatus and method for its use
US4531527A (en) * 1982-04-23 1985-07-30 Survival Technology, Inc. Ambulatory monitoring system with real time analysis and telephone transmission
US4686999A (en) * 1985-04-10 1987-08-18 Tri Fund Research Corporation Multi-channel ventilation monitor and method
US4809697A (en) * 1987-10-14 1989-03-07 Siemens-Pacesetter, Inc. Interactive programming and diagnostic system for use with implantable pacemaker
US4852570A (en) * 1989-02-09 1989-08-01 Levine Alfred B Comparative medical-physical analysis
US4958645A (en) * 1987-11-18 1990-09-25 Cme Telemetrix Inc. Multi-channel digital medical telemetry system
US4974607A (en) * 1987-08-20 1990-12-04 Satoru Miwa System for centralized management of medical data
US4987897A (en) * 1989-09-18 1991-01-29 Medtronic, Inc. Body bus medical device communication system
US5040536A (en) * 1990-01-31 1991-08-20 Medtronic, Inc. Intravascular pressure posture detector
US5113869A (en) * 1990-08-21 1992-05-19 Telectronics Pacing Systems, Inc. Implantable ambulatory electrocardiogram monitor
US5113859A (en) * 1988-09-19 1992-05-19 Medtronic, Inc. Acoustic body bus medical device communication system
US5199428A (en) * 1991-03-22 1993-04-06 Medtronic, Inc. Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload
US5331549A (en) * 1992-07-30 1994-07-19 Crawford Jr John M Medical monitor system
US5336245A (en) * 1992-05-20 1994-08-09 Angeion Corporation Storage interrogation apparatus for cardiac data
US5357427A (en) * 1993-03-15 1994-10-18 Digital Equipment Corporation Remote monitoring of high-risk patients using artificial intelligence
US5355889A (en) * 1992-06-09 1994-10-18 Albert Eisenstein Health Care Foundation Monitoring system for producing patient status indicator
US5390238A (en) * 1992-06-15 1995-02-14 Motorola, Inc. Health support system
US5416895A (en) * 1992-04-08 1995-05-16 Borland International, Inc. System and methods for improved spreadsheet interface with user-familiar objects
US5421343A (en) * 1992-04-03 1995-06-06 Feng; Genquan Computer network EEMPI system
US5437278A (en) * 1992-01-10 1995-08-01 Wilk; Peter J. Medical diagnosis system and method
US5438983A (en) * 1993-09-13 1995-08-08 Hewlett-Packard Company Patient alarm detection using trend vector analysis
US5464012A (en) * 1993-09-13 1995-11-07 Hewlett-Packard Company Patient alarm detection using target mode
US5544661A (en) * 1994-01-13 1996-08-13 Charles L. Davis Real time ambulatory patient monitor
US5553609A (en) * 1995-02-09 1996-09-10 Visiting Nurse Service, Inc. Intelligent remote visual monitoring system for home health care service
US5557514A (en) * 1994-06-23 1996-09-17 Medicode, Inc. Method and system for generating statistically-based medical provider utilization profiles
US5576952A (en) * 1993-03-09 1996-11-19 Metriplex, Inc. Medical alert distribution system with selective filtering of medical information
US5584868A (en) * 1992-11-03 1996-12-17 Cardiac Pacemakers, Inc. Cardiac stimulating apparatus and method for heart failure therapy
US5591215A (en) * 1994-11-30 1997-01-07 Telectronics Pacing Systems, Inc. Apparatus and method for detection of atrial fibrillation by ventricular stability and ventricular pacing
US5603331A (en) * 1996-02-12 1997-02-18 Cardiac Pacemakers, Inc. Data logging system for implantable cardiac device
US5660183A (en) * 1995-08-16 1997-08-26 Telectronics Pacing Systems, Inc. Interactive probability based expert system for diagnosis of pacemaker related cardiac problems
US5687734A (en) * 1994-10-20 1997-11-18 Hewlett-Packard Company Flexible patient monitoring system featuring a multiport transmitter
US5704345A (en) * 1993-11-05 1998-01-06 Resmed Limited Detection of apnea and obstruction of the airway in the respiratory system
US5704366A (en) * 1994-05-23 1998-01-06 Enact Health Management Systems System for monitoring and reporting medical measurements
US5711297A (en) * 1993-12-29 1998-01-27 First Opinion Corporation Computerized medical advice system and method including meta function
US5713350A (en) * 1995-09-06 1998-02-03 Fukuda Denshi Kabushiki Kaisha Patient information analysis management system and method
US5720770A (en) * 1995-10-06 1998-02-24 Pacesetter, Inc. Cardiac stimulation system with enhanced communication and control capability
US5720771A (en) * 1995-08-02 1998-02-24 Pacesetter, Inc. Method and apparatus for monitoring physiological data from an implantable medical device
US5724580A (en) * 1995-03-31 1998-03-03 Qmed, Inc. System and method of generating prognosis and therapy reports for coronary health management
US5724983A (en) * 1994-08-01 1998-03-10 New England Center Hospitals, Inc. Continuous monitoring using a predictive instrument
US5738102A (en) * 1994-03-31 1998-04-14 Lemelson; Jerome H. Patient monitoring system
US5743267A (en) * 1995-10-19 1998-04-28 Telecom Medical, Inc. System and method to monitor the heart of a patient
US5749907A (en) * 1997-02-18 1998-05-12 Pacesetter, Inc. System and method for identifying and displaying medical data which violate programmable alarm conditions
US5749906A (en) * 1995-02-21 1998-05-12 Medtronic, Inc. Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US5752976A (en) * 1995-06-23 1998-05-19 Medtronic, Inc. World wide patient location and data telemetry system for implantable medical devices
US5772586A (en) * 1996-02-12 1998-06-30 Nokia Mobile Phones, Ltd. Method for monitoring the health of a patient
US5772604A (en) * 1997-03-14 1998-06-30 Emory University Method, system and apparatus for determining prognosis in atrial fibrillation
US5778882A (en) * 1995-02-24 1998-07-14 Brigham And Women's Hospital Health monitoring system
US5785650A (en) * 1995-08-09 1998-07-28 Akasaka; Noboru Medical system for at-home patients
US5792062A (en) * 1996-05-14 1998-08-11 Massachusetts Institute Of Technology Method and apparatus for detecting nonlinearity in an electrocardiographic signal
US5819251A (en) * 1996-02-06 1998-10-06 Oracle Corporation System and apparatus for storage retrieval and analysis of relational and non-relational data
US5855593A (en) * 1995-03-30 1999-01-05 Medtronic, Inc. Prioritized rule based method and apparatus for diagnosis and treatment for arrhythmias
US5860918A (en) * 1996-11-22 1999-01-19 Hewlett-Packard Company Representation of a review of a patent's physiological parameters
US5876353A (en) * 1997-01-31 1999-03-02 Medtronic, Inc. Impedance monitor for discerning edema through evaluation of respiratory rate
US5879375A (en) * 1992-08-06 1999-03-09 Electric Boat Corporation Implantable device monitoring arrangement and method
US5891178A (en) * 1996-05-14 1999-04-06 Pacesetter, Inc. Programmer system and associated methods for rapidly evaluating and programming an implanted cardiac device
US5897493A (en) * 1997-03-28 1999-04-27 Health Hero Network, Inc. Monitoring system for remotely querying individuals
US5897959A (en) * 1995-11-24 1999-04-27 Skc Limited Biaxially extended polyester film
US5911132A (en) * 1995-04-26 1999-06-08 Lucent Technologies Inc. Method using central epidemiological database
US5931857A (en) * 1996-12-13 1999-08-03 Medtronic, Inc. Method and apparatus for diagnosis and treatment of arrhythmias
US5954640A (en) * 1996-06-27 1999-09-21 Szabo; Andrew J. Nutritional optimization method
US5957861A (en) * 1997-01-31 1999-09-28 Medtronic, Inc. Impedance monitor for discerning edema through evaluation of respiratory rate
US5974124A (en) * 1997-01-21 1999-10-26 Med Graph Method and system aiding medical diagnosis and treatment
US5987352A (en) * 1996-07-11 1999-11-16 Medtronic, Inc. Minimally invasive implantable device for monitoring physiologic events
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6047203A (en) * 1997-03-17 2000-04-04 Nims, Inc. Physiologic signs feedback system
US6060940A (en) * 1997-04-28 2000-05-09 Sgs-Thomson Microelectronics S.R.L. CMOS output stage for providing stable quiescent current
US6063248A (en) * 1998-11-12 2000-05-16 Hmt Technology Corporation Process chamber isolation system in a deposition apparatus
US6067466A (en) * 1998-11-18 2000-05-23 New England Medical Center Hospitals, Inc. Diagnostic tool using a predictive instrument
US6073046A (en) * 1998-04-27 2000-06-06 Patel; Bharat Heart monitor system
US6080106A (en) * 1997-10-28 2000-06-27 Alere Incorporated Patient interface system with a scale
US6093146A (en) * 1998-06-05 2000-07-25 Matsushita Electric Works, Ltd. Physiological monitoring
US6102856A (en) * 1997-02-12 2000-08-15 Groff; Clarence P Wearable vital sign monitoring system
US6122351A (en) * 1997-01-21 2000-09-19 Med Graph, Inc. Method and system aiding medical diagnosis and treatment
US6129675A (en) * 1998-09-11 2000-10-10 Jay; Gregory D. Device and method for measuring pulsus paradoxus
US6139494A (en) * 1997-10-15 2000-10-31 Health Informatics Tools Method and apparatus for an integrated clinical tele-informatics system
US6152882A (en) * 1999-01-26 2000-11-28 Impulse Dynamics N.V. Apparatus and method for chronic measurement of monophasic action potentials
US6155267A (en) * 1998-12-31 2000-12-05 Medtronic, Inc. Implantable medical device monitoring method and system regarding same
US6168563B1 (en) * 1992-11-17 2001-01-02 Health Hero Network, Inc. Remote health monitoring and maintenance system
US6171256B1 (en) * 1998-04-30 2001-01-09 Physio-Control Manufacturing Corporation Method and apparatus for detecting a condition associated with acute cardiac ischemia
US6171237B1 (en) * 1998-03-30 2001-01-09 Boaz Avitall Remote health monitoring system
US6223078B1 (en) * 1999-03-12 2001-04-24 Cardiac Pacemakers, Inc. Discrimination of supraventricular tachycardia and ventricular tachycardia events
US6225901B1 (en) * 1997-03-07 2001-05-01 Cardionet, Inc. Reprogrammable remote sensor monitoring system
US6248992B1 (en) * 1999-06-18 2001-06-19 Sandia Corporation High gain photoconductive semiconductor switch having tailored doping profile zones
US6249705B1 (en) * 1999-10-21 2001-06-19 Pacesetter, Inc. Distributed network system for use with implantable medical devices
US6250309B1 (en) * 1999-07-21 2001-06-26 Medtronic Inc System and method for transferring information relating to an implantable medical device to a remote location
US6263245B1 (en) * 1999-08-12 2001-07-17 Pacesetter, Inc. System and method for portable implantable device interogation
US6287252B1 (en) * 1999-06-30 2001-09-11 Monitrak Patient monitor
US6290646B1 (en) * 1999-04-16 2001-09-18 Cardiocom Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients
US6302844B1 (en) * 1999-03-31 2001-10-16 Walker Digital, Llc Patient care delivery system
US6306088B1 (en) * 1998-10-03 2001-10-23 Individual Monitoring Systems, Inc. Ambulatory distributed recorders system for diagnosing medical disorders
US6336922B1 (en) * 1996-06-19 2002-01-08 Kimberly-Clark Worldwide, Inc. Absorbent article having a fit panel
US6363282B1 (en) * 1999-10-29 2002-03-26 Medtronic, Inc. Apparatus and method to automatic remote software updates of medical device systems
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US6442433B1 (en) * 1999-10-26 2002-08-27 Medtronic, Inc. Apparatus and method for remote troubleshooting, maintenance and upgrade of implantable device systems
US6454705B1 (en) * 1999-09-21 2002-09-24 Cardiocom Medical wellness parameters management system, apparatus and method
US6477424B1 (en) * 1998-06-19 2002-11-05 Medtronic, Inc. Medical management system integrated programming apparatus for communication with an implantable medical device
US20030055679A1 (en) * 1999-04-09 2003-03-20 Andrew H. Soll Enhanced medical treatment system
US6662032B1 (en) * 1999-07-06 2003-12-09 Intercure Ltd. Interventive-diagnostic device

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH525271A (en) 1970-06-24 1972-07-15 Ciba Geigy Ag Process for the production of polyazo pigments of the 2-hydroxynaphthalene-3-carboxylic acid arylide series
US4142533A (en) * 1976-10-28 1979-03-06 Research Corporation Monitoring system for cardiac pacers
US4428378A (en) 1981-11-19 1984-01-31 Medtronic, Inc. Rate adaptive pacer
US4899758A (en) 1986-01-31 1990-02-13 Regents Of The University Of Minnesota Method and apparatus for monitoring and diagnosing hypertension and congestive heart failure
US4803625A (en) 1986-06-30 1989-02-07 Buddy Systems, Inc. Personal health monitor
US4933873A (en) 1988-05-12 1990-06-12 Healthtech Services Corp. Interactive patient assistance device
US5133346A (en) * 1990-12-03 1992-07-28 Arvee Medical, Incorporated Apnea monitor data system
AU1257392A (en) 1991-01-11 1992-08-17 Health Innovations Inc. Method and apparatus to control diet and weight using human behavior modification techniques
US5301105A (en) 1991-04-08 1994-04-05 Desmond D. Cummings All care health management system
US5181519A (en) 1991-05-17 1993-01-26 Caliber Medical Corporation Device for detecting abnormal heart muscle electrical activity
DE69227562T2 (en) 1991-09-11 1999-04-22 Hewlett Packard Co Data processing system and method for the automatic implementation of prioritized nursing diagnoses by evaluating patient data
US5331548A (en) * 1991-10-28 1994-07-19 Rollema Harm J Method and system for on-line measurement, storage, retrieval and analysis of urodynamical data
US5309919A (en) 1992-03-02 1994-05-10 Siemens Pacesetter, Inc. Method and system for recording, reporting, and displaying the distribution of pacing events over time and for using same to optimize programming
US5313593A (en) 1992-09-17 1994-05-17 International Business Machines Corp. Personal computer system with bus noise rejection
US5832448A (en) * 1996-10-16 1998-11-03 Health Hero Network Multiple patient monitoring system for proactive health management
US5416695A (en) * 1993-03-09 1995-05-16 Metriplex, Inc. Method and apparatus for alerting patients and medical personnel of emergency medical situations
US5606976A (en) 1994-07-26 1997-03-04 Trustees Of The University Of Pennsylvania Method and apparatus for unifying the ventilation/perfusion and pressure/flow models
US5520191A (en) 1994-10-07 1996-05-28 Ortivus Medical Ab Myocardial ischemia and infarction analysis and monitoring method and apparatus
US6038469A (en) 1994-10-07 2000-03-14 Ortivus Ab Myocardial ischemia and infarction analysis and monitoring method and apparatus
WO1996012187A1 (en) * 1994-10-13 1996-04-25 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
DE69637358T2 (en) 1995-05-12 2008-04-17 Seiko Epson Corp. Apparatus for controlling a physiological condition
US6083248A (en) * 1995-06-23 2000-07-04 Medtronic, Inc. World wide patient location and data telemetry system for implantable medical devices
US5788640A (en) 1995-10-26 1998-08-04 Peters; Robert Mitchell System and method for performing fuzzy cluster classification of stress tests
EP0809965B1 (en) 1995-12-18 2005-01-26 Seiko Epson Corporation Health care device and exercise supporting device
US5697959A (en) * 1996-01-11 1997-12-16 Pacesetter, Inc. Method and system for analyzing and displaying complex pacing event records
US5785660A (en) 1996-03-28 1998-07-28 Pacesetter, Inc. Methods and apparatus for storing intracardiac electrograms
US5772599A (en) 1996-05-09 1998-06-30 Albert Einstein Healthcare Network Apparatus and method for monitoring a system
US6050940A (en) * 1996-06-17 2000-04-18 Cybernet Systems Corporation General-purpose medical instrumentation
US5749908A (en) * 1996-12-18 1998-05-12 Pacesetter, Inc. Methods and apparatus for annotating data in an implantable device programmer using digitally recorded sound
US6004276A (en) 1997-03-03 1999-12-21 Quinton Instrument Company Open architecture cardiology information system
CA2284168A1 (en) 1997-03-13 1998-09-17 First Opinion Corporation Disease management system
US6063028A (en) 1997-03-20 2000-05-16 Luciano; Joanne Sylvia Automated treatment selection method
DE29708673U1 (en) 1997-05-15 1997-08-21 Filtertek Bv Pressure transmission device
US5993386A (en) 1997-07-15 1999-11-30 Ericsson; Arthur Dale Computer assisted method for the diagnosis and treatment of illness
US5976083A (en) 1997-07-30 1999-11-02 Living Systems, Inc. Portable aerobic fitness monitor for walking and running
US6014581A (en) 1998-03-26 2000-01-11 Ep Technologies, Inc. Interface for performing a diagnostic or therapeutic procedure on heart tissue with an electrode structure
US6283923B1 (en) 1998-05-28 2001-09-04 The Trustees Of Columbia University In The City Of New York System and method for remotely monitoring asthma severity
US6336900B1 (en) * 1999-04-12 2002-01-08 Agilent Technologies, Inc. Home hub for reporting patient health parameters
US6190324B1 (en) 1999-04-28 2001-02-20 Medtronic, Inc. Implantable medical device for tracking patient cardiac status
IL130371A (en) * 1999-06-08 2004-06-01 Oridion Medical Ltd Capnography waveform interpreter
US7429243B2 (en) 1999-06-03 2008-09-30 Cardiac Intelligence Corporation System and method for transacting an automated patient communications session
US6221011B1 (en) 1999-07-26 2001-04-24 Cardiac Intelligence Corporation System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system
US6827670B1 (en) * 1999-10-11 2004-12-07 Izex Technologies, Inc. System for medical protocol management
US6409675B1 (en) 1999-11-10 2002-06-25 Pacesetter, Inc. Extravascular hemodynamic monitor
US6440066B1 (en) * 1999-11-16 2002-08-27 Cardiac Intelligence Corporation Automated collection and analysis patient care system and method for ordering and prioritizing multiple health disorders to identify an index disorder
US6398728B1 (en) 1999-11-16 2002-06-04 Cardiac Intelligence Corporation Automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof
US6411840B1 (en) * 1999-11-16 2002-06-25 Cardiac Intelligence Corporation Automated collection and analysis patient care system and method for diagnosing and monitoring the outcomes of atrial fibrillation
US6336903B1 (en) * 1999-11-16 2002-01-08 Cardiac Intelligence Corp. Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof
US6589188B1 (en) * 2000-05-05 2003-07-08 Pacesetter, Inc. Method for monitoring heart failure via respiratory patterns
US6931272B2 (en) 2003-04-29 2005-08-16 Medtronic, Inc. Method and apparatus to monitor pulmonary edema
US7480528B2 (en) 2004-07-23 2009-01-20 Cardiac Pacemakers, Inc. Method and apparatus for monitoring heart failure patients with cardiopulmonary comorbidities
US7387610B2 (en) 2004-08-19 2008-06-17 Cardiac Pacemakers, Inc. Thoracic impedance detection with blood resistivity compensation

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197856A (en) * 1978-04-10 1980-04-15 Northrop Robert B Ultrasonic respiration/convulsion monitoring apparatus and method for its use
US4531527A (en) * 1982-04-23 1985-07-30 Survival Technology, Inc. Ambulatory monitoring system with real time analysis and telephone transmission
US4686999A (en) * 1985-04-10 1987-08-18 Tri Fund Research Corporation Multi-channel ventilation monitor and method
US4974607A (en) * 1987-08-20 1990-12-04 Satoru Miwa System for centralized management of medical data
US4809697A (en) * 1987-10-14 1989-03-07 Siemens-Pacesetter, Inc. Interactive programming and diagnostic system for use with implantable pacemaker
US4958645A (en) * 1987-11-18 1990-09-25 Cme Telemetrix Inc. Multi-channel digital medical telemetry system
US5113859A (en) * 1988-09-19 1992-05-19 Medtronic, Inc. Acoustic body bus medical device communication system
US4852570A (en) * 1989-02-09 1989-08-01 Levine Alfred B Comparative medical-physical analysis
US4987897A (en) * 1989-09-18 1991-01-29 Medtronic, Inc. Body bus medical device communication system
US5040536A (en) * 1990-01-31 1991-08-20 Medtronic, Inc. Intravascular pressure posture detector
US5113869A (en) * 1990-08-21 1992-05-19 Telectronics Pacing Systems, Inc. Implantable ambulatory electrocardiogram monitor
US5199428A (en) * 1991-03-22 1993-04-06 Medtronic, Inc. Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload
US5437278A (en) * 1992-01-10 1995-08-01 Wilk; Peter J. Medical diagnosis system and method
US5421343A (en) * 1992-04-03 1995-06-06 Feng; Genquan Computer network EEMPI system
US5416895A (en) * 1992-04-08 1995-05-16 Borland International, Inc. System and methods for improved spreadsheet interface with user-familiar objects
US5336245A (en) * 1992-05-20 1994-08-09 Angeion Corporation Storage interrogation apparatus for cardiac data
US5355889A (en) * 1992-06-09 1994-10-18 Albert Eisenstein Health Care Foundation Monitoring system for producing patient status indicator
US5390238A (en) * 1992-06-15 1995-02-14 Motorola, Inc. Health support system
US5331549A (en) * 1992-07-30 1994-07-19 Crawford Jr John M Medical monitor system
US5879375A (en) * 1992-08-06 1999-03-09 Electric Boat Corporation Implantable device monitoring arrangement and method
US5584868A (en) * 1992-11-03 1996-12-17 Cardiac Pacemakers, Inc. Cardiac stimulating apparatus and method for heart failure therapy
US6168563B1 (en) * 1992-11-17 2001-01-02 Health Hero Network, Inc. Remote health monitoring and maintenance system
US5576952A (en) * 1993-03-09 1996-11-19 Metriplex, Inc. Medical alert distribution system with selective filtering of medical information
US5357427A (en) * 1993-03-15 1994-10-18 Digital Equipment Corporation Remote monitoring of high-risk patients using artificial intelligence
US5464012A (en) * 1993-09-13 1995-11-07 Hewlett-Packard Company Patient alarm detection using target mode
US5438983A (en) * 1993-09-13 1995-08-08 Hewlett-Packard Company Patient alarm detection using trend vector analysis
US5704345A (en) * 1993-11-05 1998-01-06 Resmed Limited Detection of apnea and obstruction of the airway in the respiratory system
US5711297A (en) * 1993-12-29 1998-01-27 First Opinion Corporation Computerized medical advice system and method including meta function
US5544661A (en) * 1994-01-13 1996-08-13 Charles L. Davis Real time ambulatory patient monitor
US5738102A (en) * 1994-03-31 1998-04-14 Lemelson; Jerome H. Patient monitoring system
US5704366A (en) * 1994-05-23 1998-01-06 Enact Health Management Systems System for monitoring and reporting medical measurements
US5557514A (en) * 1994-06-23 1996-09-17 Medicode, Inc. Method and system for generating statistically-based medical provider utilization profiles
US5724983A (en) * 1994-08-01 1998-03-10 New England Center Hospitals, Inc. Continuous monitoring using a predictive instrument
US5687734A (en) * 1994-10-20 1997-11-18 Hewlett-Packard Company Flexible patient monitoring system featuring a multiport transmitter
US5591215A (en) * 1994-11-30 1997-01-07 Telectronics Pacing Systems, Inc. Apparatus and method for detection of atrial fibrillation by ventricular stability and ventricular pacing
US5553609A (en) * 1995-02-09 1996-09-10 Visiting Nurse Service, Inc. Intelligent remote visual monitoring system for home health care service
US5749906A (en) * 1995-02-21 1998-05-12 Medtronic, Inc. Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US5778882A (en) * 1995-02-24 1998-07-14 Brigham And Women's Hospital Health monitoring system
US6095985A (en) * 1995-02-24 2000-08-01 Brigham And Women's Hospital Health monitoring system
US5855593A (en) * 1995-03-30 1999-01-05 Medtronic, Inc. Prioritized rule based method and apparatus for diagnosis and treatment for arrhythmias
US5724580A (en) * 1995-03-31 1998-03-03 Qmed, Inc. System and method of generating prognosis and therapy reports for coronary health management
US5911132A (en) * 1995-04-26 1999-06-08 Lucent Technologies Inc. Method using central epidemiological database
US5752976A (en) * 1995-06-23 1998-05-19 Medtronic, Inc. World wide patient location and data telemetry system for implantable medical devices
US5720771A (en) * 1995-08-02 1998-02-24 Pacesetter, Inc. Method and apparatus for monitoring physiological data from an implantable medical device
US5785650A (en) * 1995-08-09 1998-07-28 Akasaka; Noboru Medical system for at-home patients
US5660183A (en) * 1995-08-16 1997-08-26 Telectronics Pacing Systems, Inc. Interactive probability based expert system for diagnosis of pacemaker related cardiac problems
US5713350A (en) * 1995-09-06 1998-02-03 Fukuda Denshi Kabushiki Kaisha Patient information analysis management system and method
US5720770A (en) * 1995-10-06 1998-02-24 Pacesetter, Inc. Cardiac stimulation system with enhanced communication and control capability
US5743267A (en) * 1995-10-19 1998-04-28 Telecom Medical, Inc. System and method to monitor the heart of a patient
US5897959A (en) * 1995-11-24 1999-04-27 Skc Limited Biaxially extended polyester film
US5819251A (en) * 1996-02-06 1998-10-06 Oracle Corporation System and apparatus for storage retrieval and analysis of relational and non-relational data
US5603331A (en) * 1996-02-12 1997-02-18 Cardiac Pacemakers, Inc. Data logging system for implantable cardiac device
US5772586A (en) * 1996-02-12 1998-06-30 Nokia Mobile Phones, Ltd. Method for monitoring the health of a patient
US5792062A (en) * 1996-05-14 1998-08-11 Massachusetts Institute Of Technology Method and apparatus for detecting nonlinearity in an electrocardiographic signal
US5891178A (en) * 1996-05-14 1999-04-06 Pacesetter, Inc. Programmer system and associated methods for rapidly evaluating and programming an implanted cardiac device
US6336922B1 (en) * 1996-06-19 2002-01-08 Kimberly-Clark Worldwide, Inc. Absorbent article having a fit panel
US5954640A (en) * 1996-06-27 1999-09-21 Szabo; Andrew J. Nutritional optimization method
US5987352A (en) * 1996-07-11 1999-11-16 Medtronic, Inc. Minimally invasive implantable device for monitoring physiologic events
US5860918A (en) * 1996-11-22 1999-01-19 Hewlett-Packard Company Representation of a review of a patent's physiological parameters
US5931857A (en) * 1996-12-13 1999-08-03 Medtronic, Inc. Method and apparatus for diagnosis and treatment of arrhythmias
US5974124A (en) * 1997-01-21 1999-10-26 Med Graph Method and system aiding medical diagnosis and treatment
US6122351A (en) * 1997-01-21 2000-09-19 Med Graph, Inc. Method and system aiding medical diagnosis and treatment
US5957861A (en) * 1997-01-31 1999-09-28 Medtronic, Inc. Impedance monitor for discerning edema through evaluation of respiratory rate
US5876353A (en) * 1997-01-31 1999-03-02 Medtronic, Inc. Impedance monitor for discerning edema through evaluation of respiratory rate
US6102856A (en) * 1997-02-12 2000-08-15 Groff; Clarence P Wearable vital sign monitoring system
US5749907A (en) * 1997-02-18 1998-05-12 Pacesetter, Inc. System and method for identifying and displaying medical data which violate programmable alarm conditions
US6225901B1 (en) * 1997-03-07 2001-05-01 Cardionet, Inc. Reprogrammable remote sensor monitoring system
US5772604A (en) * 1997-03-14 1998-06-30 Emory University Method, system and apparatus for determining prognosis in atrial fibrillation
US6047203A (en) * 1997-03-17 2000-04-04 Nims, Inc. Physiologic signs feedback system
US5897493A (en) * 1997-03-28 1999-04-27 Health Hero Network, Inc. Monitoring system for remotely querying individuals
US6060940A (en) * 1997-04-28 2000-05-09 Sgs-Thomson Microelectronics S.R.L. CMOS output stage for providing stable quiescent current
US6139494A (en) * 1997-10-15 2000-10-31 Health Informatics Tools Method and apparatus for an integrated clinical tele-informatics system
US6080106A (en) * 1997-10-28 2000-06-27 Alere Incorporated Patient interface system with a scale
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6171237B1 (en) * 1998-03-30 2001-01-09 Boaz Avitall Remote health monitoring system
US6073046A (en) * 1998-04-27 2000-06-06 Patel; Bharat Heart monitor system
US6171256B1 (en) * 1998-04-30 2001-01-09 Physio-Control Manufacturing Corporation Method and apparatus for detecting a condition associated with acute cardiac ischemia
US6093146A (en) * 1998-06-05 2000-07-25 Matsushita Electric Works, Ltd. Physiological monitoring
US6477424B1 (en) * 1998-06-19 2002-11-05 Medtronic, Inc. Medical management system integrated programming apparatus for communication with an implantable medical device
US6129675A (en) * 1998-09-11 2000-10-10 Jay; Gregory D. Device and method for measuring pulsus paradoxus
US6306088B1 (en) * 1998-10-03 2001-10-23 Individual Monitoring Systems, Inc. Ambulatory distributed recorders system for diagnosing medical disorders
US6063248A (en) * 1998-11-12 2000-05-16 Hmt Technology Corporation Process chamber isolation system in a deposition apparatus
US6067466A (en) * 1998-11-18 2000-05-23 New England Medical Center Hospitals, Inc. Diagnostic tool using a predictive instrument
US6155267A (en) * 1998-12-31 2000-12-05 Medtronic, Inc. Implantable medical device monitoring method and system regarding same
US6152882A (en) * 1999-01-26 2000-11-28 Impulse Dynamics N.V. Apparatus and method for chronic measurement of monophasic action potentials
US6223078B1 (en) * 1999-03-12 2001-04-24 Cardiac Pacemakers, Inc. Discrimination of supraventricular tachycardia and ventricular tachycardia events
US6302844B1 (en) * 1999-03-31 2001-10-16 Walker Digital, Llc Patient care delivery system
US20030055679A1 (en) * 1999-04-09 2003-03-20 Andrew H. Soll Enhanced medical treatment system
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US6290646B1 (en) * 1999-04-16 2001-09-18 Cardiocom Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients
US6248992B1 (en) * 1999-06-18 2001-06-19 Sandia Corporation High gain photoconductive semiconductor switch having tailored doping profile zones
US6287252B1 (en) * 1999-06-30 2001-09-11 Monitrak Patient monitor
US6662032B1 (en) * 1999-07-06 2003-12-09 Intercure Ltd. Interventive-diagnostic device
US6250309B1 (en) * 1999-07-21 2001-06-26 Medtronic Inc System and method for transferring information relating to an implantable medical device to a remote location
US6263245B1 (en) * 1999-08-12 2001-07-17 Pacesetter, Inc. System and method for portable implantable device interogation
US6454705B1 (en) * 1999-09-21 2002-09-24 Cardiocom Medical wellness parameters management system, apparatus and method
US6249705B1 (en) * 1999-10-21 2001-06-19 Pacesetter, Inc. Distributed network system for use with implantable medical devices
US6442433B1 (en) * 1999-10-26 2002-08-27 Medtronic, Inc. Apparatus and method for remote troubleshooting, maintenance and upgrade of implantable device systems
US6363282B1 (en) * 1999-10-29 2002-03-26 Medtronic, Inc. Apparatus and method to automatic remote software updates of medical device systems

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8676336B2 (en) 2002-10-11 2014-03-18 Cardiac Pacemaker, Inc. Methods and devices for detection of context when addressing a medical condition of a patient
US7986998B2 (en) 2002-10-11 2011-07-26 Cardiac Pacemakers, Inc. Methods and devices for detection of context when addressing a medical condition of a patient
US7400928B2 (en) 2002-10-11 2008-07-15 Cardiac Pacemakers, Inc. Methods and devices for detection of context when addressing a medical condition of a patient
US20040073093A1 (en) * 2002-10-11 2004-04-15 Cardiac Pacemakers, Inc. Methods and devices for detection of context when addressing a medical condition of a patient
US7292141B2 (en) 2004-04-29 2007-11-06 Zoe Medical Incorporated Audible alarm enhancement for monitoring systems
US20050242942A1 (en) * 2004-04-29 2005-11-03 Zoe Medical Incorporated Audible alarm enhancement for monitoring systems
US10073948B2 (en) 2004-08-06 2018-09-11 Medtronic Minimed, Inc. Medical data management system and process
US8715180B2 (en) * 2004-08-06 2014-05-06 Medtronic Minimed, Inc. Medical data management system and process
US20120216297A1 (en) * 2004-08-06 2012-08-23 Medtronic Minimed, Inc. Medical data management system and process
US8313433B2 (en) * 2004-08-06 2012-11-20 Medtronic Minimed, Inc. Medical data management system and process
US20060031094A1 (en) * 2004-08-06 2006-02-09 Medtronic Minimed, Inc. Medical data management system and process
US20060200007A1 (en) * 2005-03-03 2006-09-07 Cardiac Pacemakers, Inc. Automatic etiology sequencing system
US8740789B2 (en) 2005-03-03 2014-06-03 Cardiac Pacemakers, Inc. Automatic etiology sequencing system and method
US20070073171A1 (en) * 2005-09-28 2007-03-29 Cho Yong K Methods for detecting and monitoring sleep disordered breathing using an implantable medical device
US7488291B2 (en) 2005-09-28 2009-02-10 Medtronic, Inc. Methods for detecting and monitoring sleep disordered breathing using an implantable medical device
US20070129641A1 (en) * 2005-12-01 2007-06-07 Sweeney Robert J Posture estimation at transitions between states
US11357471B2 (en) 2006-03-23 2022-06-14 Michael E. Sabatino Acquiring and processing acoustic energy emitted by at least one organ in a biological system
US8920343B2 (en) 2006-03-23 2014-12-30 Michael Edward Sabatino Apparatus for acquiring and processing of physiological auditory signals
US8870791B2 (en) 2006-03-23 2014-10-28 Michael E. Sabatino Apparatus for acquiring, processing and transmitting physiological sounds
WO2008064725A1 (en) * 2006-12-01 2008-06-05 Dräger Medical AG & Co. KG Medical system
US8547231B2 (en) 2006-12-01 2013-10-01 Drager Medical Gmbh Medical system
US20110001611A1 (en) * 2006-12-01 2011-01-06 Olaf Schermeier Medical system
US20150148698A1 (en) * 2008-09-12 2015-05-28 Paul LeLorier Method of detecting and predicting neurocardiogenic syncope
US10070824B2 (en) * 2008-09-12 2018-09-11 Physiovoyance, Llc Method of detecting and predicting neurocardiogenic syncope
USRE49122E1 (en) * 2008-09-12 2022-07-05 Physiovoyance, Llc Method of detecting and predicting neurocardiogenic syncope
US8769002B2 (en) * 2009-04-17 2014-07-01 Arkray, Inc. Information provision system, information provision method, program, and server device
US20120110054A1 (en) * 2009-04-17 2012-05-03 Arkray, Inc. Information Provision System, Information Provision Method, Program, and Server Device
US8498683B2 (en) 2010-04-30 2013-07-30 Covidien LLP Method for respiration rate and blood pressure alarm management
WO2011137019A1 (en) * 2010-04-30 2011-11-03 Nellcor Puritan Bennett Llc Method for respiration rate and blood pressure alarm management

Also Published As

Publication number Publication date
EP1102198A3 (en) 2002-05-22
EP1102198A2 (en) 2001-05-23
AU751511B2 (en) 2002-08-15
US7959574B2 (en) 2011-06-14
US20020169367A1 (en) 2002-11-14
US8231539B2 (en) 2012-07-31
CA2325655A1 (en) 2001-05-16
US8231540B2 (en) 2012-07-31
US20070203415A1 (en) 2007-08-30
US7258670B2 (en) 2007-08-21
US20070293779A1 (en) 2007-12-20
US20070203423A1 (en) 2007-08-30
US8747329B2 (en) 2014-06-10
US20070265542A1 (en) 2007-11-15
US6398728B1 (en) 2002-06-04
US20070203422A1 (en) 2007-08-30
AU7157500A (en) 2001-05-24
US7207945B2 (en) 2007-04-24

Similar Documents

Publication Publication Date Title
US6398728B1 (en) Automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof
US8366629B2 (en) System and method for diagnosing and monitoring congestive heart failure
US6913577B2 (en) System and method for diagnosing and monitoring myocardial ischemia for automated remote patient care

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12